syndrome	score	normalized_score
NEUROFIBROMA	6.546256690000001	100.0
TUBEROUS SCLEROSIS COMPLEX	5.2383763	80.02094247239178
MUIR-TORRE SYNDROME; MRTES	3.7293866	56.96975808628121
NEUROFIBROMATOSIS, TYPE II	3.5160192500000003	53.71037856445559
BIRT-HOGG-DUBE SYNDROME	3.4739060999999998	53.06706205558217
FAMILIAL MULTINODULAR GOITER	3.2573062000000004	49.75830240472895
UVEAL MELANOMA	3.25	49.646693582374624
JUVENILE POLYPOSIS SYNDROME	3.14316728	48.01472702409413
CARNEY COMPLEX	3.1337352	47.87064345929276
GARDNER SYNDROME	3.0455758000000004	46.52392877676784
CUTANEOUS NEUROENDOCRINE CARCINOMA	2.9914859999999996	45.697658091681085
PITUITARY CARCINOMA	2.67294605	40.83167184817496
PEUTZ-JEGHERS SYNDROME	2.6268221600000006	40.12708765320353
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	2.57797253	39.38086531098125
TUBEROUS SCLEROSIS-1	2.5506008999999996	38.962738871762745
PHACE ASSOCIATION	2.509979514	38.34221040910633
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	2.5073806000000003	38.302509643874046
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	2.5044332	38.25748543936183
NEUROENDOCRINE NEOPLASM OF APPENDIX	2.4144686699999998	36.8831957611488
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	2.383333	36.40757020177282
TUBEROUS SCLEROSIS 2; TSC2	2.3006009	35.14376244234932
BASAL CELL NEVUS SYNDROME	2.29597502	35.073097935608146
HYPERPARATHYROIDISM 2	2.2126082	33.79959425330753
MENINGIOMA	2.20057897	33.61583686997156
BROOKE-SPIEGLER SYNDROME	2.19199295	33.48467763796167
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	2.1702838000000004	33.15305070935127
RETINOBLASTOMA	2.10727493	32.19053315185537
NUT MIDLINE CARCINOMA	2.08125	31.792978774866825
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	30.86755951820154
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	2.0097431	30.700646112305137
FAMILIAL GLUCOCORTICOID DEFICIENCY	2.00922439	30.692722347250328
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	30.551811435307464
TURCOT SYNDROME WITH POLYPOSIS	1.9952900100000002	30.47986207213637
MSH3-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.9713477	30.114121601913528
WERNER SYNDROME	1.9401063200000002	29.636881226544144
MUIR-TORRE SYNDROME	1.9375210999999999	29.597389649564743
BECKWITH-WIEDEMANN SYNDROME	1.9108207299999997	29.189517314818275
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	1.9024852999999997	29.06218607202217
PRIMARY SCLEROSING CHOLANGITIS	1.8697913300000002	28.562756068766376
NEUROFIBROMATOSIS TYPE 1	1.8418026299999999	28.13520332640668
PARAGANGLIOMAS 1	1.8215213700000001	27.82538871081146
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	1.8155618999999998	27.73435240896427
BENIGN SCHWANNOMA	1.7982143	27.4693521069367
HEREDITARY MIXED POLYPOSIS SYNDROME	1.7487488	26.7137217926601
NTHL1-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7432851	26.63025882659056
SILVER-RUSSELL SYNDROME; SRS	1.727682364	26.391912902517117
APC-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7269252000000002	26.380346536640314
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	1.721584864	26.29876806740372
VON HIPPEL-LINDAU DISEASE	1.71212586	26.154273214116813
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	1.6931597999999997	25.864549469721442
CATARACT 3, MULTIPLE TYPES; CTRCT3	1.6760999600000002	25.603944962323194
POLYEMBRYOMA	1.6666660000000002	25.459832678819076
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	1.6607143	25.368915070759314
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	1.6351865300000001	24.97895526305737
LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A	1.632857	24.943369582410917
HYPERPLASTIC POLYPOSIS SYNDROME	1.620902	24.76074612955637
COWDEN SYNDROME 7; CWS7	1.6043	24.507135542831882
FAMILIAL COLORECTAL CANCER TYPE X	1.5937041000000003	24.3452735734382
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	1.5811966	24.15421018267464
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	1.5811688	24.153785512495688
PTEN HAMARTOMA TUMOR SYNDROME	1.5473106	23.63657084152623
ADENOCARCINOMA OF OVARY	1.5454545	23.608217232923685
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	1.54428063	23.590285305478904
CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	1.533333	23.423050341767148
ANAPLASTIC THYROID CARCINOMA	1.5089958300000001	23.05127802741264
NEUROFIBROMATOSIS, TYPE I	1.4535843899999998	22.20481809429321
PARAGANGLIOMAS 2	1.45	22.15006329059791
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	1.4335498	21.898771586361363
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.4285074999999998	21.821745886961235
AICARDI SYNDROME; AIC	1.41844989	21.668106784856306
COWDEN SYNDROME	1.396846084	21.338089081257824
PEUTZ-JEGHERS SYNDROME	1.3897747999999999	21.23006881357107
CARNEY COMPLEX, TYPE 1; CNC1	1.3878175	21.200169283309904
CRANIOLENTICULOSUTURAL DYSPLASIA	1.3794964699999999	21.073058013556135
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	1.3702079999999999	20.93116822157488
ADENOCARCINOMA OF THE ANAL CANAL	1.3621212	20.807635027217362
LYNCH SYNDROME	1.3506483	20.63237608850929
NORRIE DISEASE	1.3505081900000002	20.630235781359193
LI-FRAUMENI SYNDROME; LFS	1.3464224	20.56782163853706
ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.3354323	20.39993790710947
AL AMYLOIDOSIS	1.311111	20.0284080213787
PARAGANGLIOMAS 4	1.3030023	19.90454028468596
MAFFUCCI SYNDROME	1.28126329	19.572457217530832
CATARACT 30, MULTIPLE TYPES	1.2777779999999999	19.519216256092147
ATELOSTEOGENESIS TYPE II	1.25765804	19.211865644089183
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	1.25	19.094882147067164
DIGEORGE SYNDROME; DGS	1.213392544	18.535670100648005
HEMANGIOBLASTOMA	1.20613497	18.42480408448511
VIPOMA	1.1612657	17.739385346345163
MONOSOMY 9Q22.3	1.156923774	17.673058494136136
ZOLLINGER-ELLISON SYNDROME	1.1410602300000001	17.430728491644285
PARATHYROID CARCINOMA	1.1379915	17.383850861491347
ACQUIRED HYPERTRICHOSIS LANUGINOSA	1.13778413	17.380683096922674
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME	1.1348214	17.33542471277581
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	1.119982094	17.1087408734044
GASTROINTESTINAL STROMAL TUMOR	1.1156589700000001	17.042701238774676
SAGLIKER SYNDROME	1.11545293	17.039553791160607
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	1.115452454	17.039546519829486
MIDDLE EAR NEUROENDOCRINE TUMOR	1.11261476	16.996198173829935
OSTEOID OSTEOMA	1.111111	16.973226877847956
METACHONDROMATOSIS	1.1	16.803496289419108
NOONAN SYNDROME 7; NS7	1.0982708	16.777081193252137
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	1.09704555	16.758364389771582
SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM	1.0960603	16.743313803663263
FOCAL DERMAL HYPOPLASIA	1.09430024	16.71642729304585
STURGE-WEBER SYNDROME	1.0833333	16.548897351594686
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.54889276882297
NON-INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.54889276882297
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1.0769231	16.45097574076338
GANGLIONEUROMA	1.0736263	16.40061413479342
BRANCHIOOTORENAL SYNDROME 1	1.07256173	16.38435186384358
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	1.06378252	16.250241479608093
CATECHOLAMINE-PRODUCING TUMOR	1.0555556	16.124567825341412
THYMIC NEUROENDOCRINE TUMOR	1.05441493	16.10714305796646
OTOSCLEROSIS 7	1.05030887	16.04441927253543
MOWAT-WILSON SYNDROME; MOWS	1.0486618699999999	16.01925985581845
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	15.993235670078802
KINDLER SYNDROME	1.025641	15.667595216160091
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	15.631159125842341
HEMIHYPERPLASIA, ISOLATED	1.0227273	15.623085809670561
N SYNDROME	1.021378854	15.602487075709215
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.01686623	15.533552656945993
EMANUEL SYNDROME	1.0155418339999998	15.513321308517153
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	1.01373517	15.485722879589675
LOWE OCULOCEREBRORENAL SYNDROME	1.01305321	15.475305322926467
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	1.0121646199999998	15.461731305864815
LYMPHANGIOLEIOMYOMATOSIS	1.0106728	15.438942404197107
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	1.00943396	15.420018001157848
PSEUDOAMINOPTERIN SYNDROME	1.007607704	15.392120286685548
PYOMYOSITIS	1.00520833	15.35546767568016
116100 CATARACT, MEMBRANOUS	1.00178253	15.30313547787262
BLAU SYNDROME	1.00178253	15.30313547787262
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.00124533	15.294929261321096
EHLERS-DANLOS SYNDROME, TYPE I	1.00065189	15.285863927832013
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	1.00065189	15.285863927832013
CURRARINO SYNDROME	1.000545554	15.284239549121617
CHRONIC ACTINIC DERMATITIS	1.0	15.275905717653732
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	15.275905717653732
SESSILE SERRATED POLYPOSIS CANCER SYNDROME	1.0	15.275905717653732
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	15.275905717653732
137245 GASTRIC LYMPHOMA, PRIMARY	1.0	15.275905717653732
GIGANTIFORM CEMENTOMA, FAMILIAL	1.0	15.275905717653732
MESOTHELIOMA, MALIGNANT	1.0	15.275905717653732
TERATOMA, OVARIAN	1.0	15.275905717653732
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	1.0	15.275905717653732
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	1.0	15.275905717653732
URETER, CANCER OF	1.0	15.275905717653732
AASE-SMITH SYNDROME I	1.0	15.275905717653732
DYSTROPHIA MYOTONICA 2	1.0	15.275905717653732
POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	1.0	15.275905717653732
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	1.0	15.275905717653732
ADIPOSIS DOLOROSA	1.0	15.275905717653732
ACATALASEMIA	1.0	15.275905717653732
STRABISMUS, SUSCEPTIBILITY TO	1.0	15.275905717653732
BROWN SYNDROME	1.0	15.275905717653732
SARCOMA, SYNOVIAL	1.0	15.275905717653732
RETINOBLASTOMA; RB1	0.9988035000000001	15.257628096462557
PROTEUS SYNDROME	0.9653825599999998	14.747092968027193
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.95435619	14.578655179499231
SUBEPENDYMOMA	0.9396221599999999	14.353579526378146
EPENDYMOMA	0.9396221599999999	14.353579526378146
8Q24.3 MICRODELETION SYNDROME	0.9240200540000001	14.11524322612531
ATYPICAL WERNER SYNDROME	0.92211495	14.086141037038985
GRFOMA	0.9214626700000002	14.076176869257475
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.909530444	13.89390130987974
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.9020199	13.779170947847447
EXOSTOSES, MULTIPLE, TYPE I	0.89509589	13.673400423899354
EXOSTOSES, MULTIPLE, TYPE II	0.89509589	13.673400423899354
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.873333	13.340952568115686
COLORECTAL CANCER	0.8530023	13.030382711741783
FAMILIAL ADENOMATOUS POLYPOSIS	0.8489899	12.969089667640269
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.8421565000000001	12.864703293509255
LI-FRAUMENI SYNDROME	0.8419582	12.861674081405445
KASABACH-MERRITT SYNDROME	0.818287	12.500075061981718
PARAGANGLIOMAS 3	0.816667	12.475328094719119
DUODENAL NEUROENDOCRINE TUMOR	0.8030306	12.267019733990907
SCHINZEL-GIEDION SYNDROME	0.80117766	12.238714397250437
NELSON SYNDROME	0.777778	11.881263397265283
NIJMEGEN BREAKAGE SYNDROME	0.7680872900000001	11.73322902496816
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	11.643220486057658
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.750545554	11.465263119708187
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.73721136	11.261571229343282
JUVENILE POLYPOSIS OF INFANCY	0.73594063	11.242159677670688
OVARIAN CANCER	0.7243902	11.065716397992329
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.71615788	10.939960253834775
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.71532724	10.927271475509464
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.7135353339999999	10.899898488398563
PALLISTER-HALL SYNDROME	0.709530444	10.83872016634899
FRONTONASAL DYSPLASIA 1; FND1	0.7066368999999999	10.794518661015108
LARYNGEAL NEUROENDOCRINE TUMOR	0.70520833	10.772695960384041
BAZEX SYNDROME	0.7	10.693134002357612
CARNEY TRIAD	0.69670407	10.642785686425626
ROTHMUND-THOMSON SYNDROME	0.690081394	10.541618312251057
BRANCHIOSKELETOGENITAL SYNDROME	0.68639558	10.485314165094248
COSTELLO SYNDROME; CSTLO	0.680100284	10.389147816933527
CARCINOID SYNDROME	0.67280197	10.277659460371694
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.66895653	10.2189168814888
AICARDI-GOUTIÈRES SYNDROME	0.667864444	10.20223427871723
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.650443264	9.936109975546954
OVARIAN FIBROTHECOMA	0.65	9.929338716474925
PINEOBLASTOMA	0.64914631	9.916297828522822
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.64806533	9.899784879960153
RING CHROMOSOME 7 SYNDROME	0.63674913	9.726919675678039
POLYMERASE PROOFREADING-RELATED ADENOMATOUS POLYPOSIS	0.6322656000000001	9.658429694115767
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.63199537	9.654301686113685
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.6267297000000001	9.573863807653408
MONOSOMY 22	0.62562625	9.557007609489263
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.6253919	9.553427700984331
NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI	0.625	9.547441073533582
DIAPHANOSPONDYLODYSOSTOSIS	0.620866454	9.484297414557997
TUMOR PREDISPOSITION SYNDROME; TPDS	0.6125259000000001	9.356887898020998
46,XY PARTIAL GONADAL DYSGENESIS	0.6060603	9.258120002012936
CATARACT 31, MULTIPLE TYPES	0.6055556000000001	9.250410252397238
INSULINOMA	0.60434131	9.231860872843347
LHERMITTE-DUCLOS DISEASE	0.6033566699999998	9.216819605037513
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.602597	9.205214957740985
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.60010509	9.167148775524108
TESTICULAR GERM CELL TUMOR; TGCT	0.5958330000000001	9.101888731466778
CATARACT 33, MULTIPLE TYPES; CTRCT33	0.5888886	8.995806731801101
NEUROFIBROMATOSIS TYPE 2	0.58445509	8.928080851042825
NK-CELL ENTEROPATHY	0.5833333	8.91094449276782
NIEMANN-PICK DISEASE TYPE B	0.56731859	8.666305292712252
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.56400376	8.615668262162202
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.5630902	8.601712805734783
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.56177353	8.58159947895352
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.5615076	8.577537157346024
PPOMA	0.5593429	8.544469404239019
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.55829547	8.528468962313179
ALPORT SYNDROME	0.55417768	8.465565990508079
COWDEN SYNDROME 6; CWS6	0.5520248400000001	8.432679409642887
COWDEN SYNDROME 5; CWS5	0.5520248400000001	8.432679409642887
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.54829517	8.375705322364926
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5454545	8.332311515269957
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.54065189	8.258947297711297
EAR EXOSTOSES	0.53855445	8.22690700202286
DERMOCHONDROCORNEAL DYSTROPHY	0.5384615	8.225487106586407
OCULOCEREBRORENAL SYNDROME OF LOWE	0.53573804	8.183883788400603
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.5352561	8.176521718399037
SÉZARY SYNDROME	0.53494004	8.171693615637915
MILROY DISEASE	0.53494004	8.171693615637915
CLASSIC MYCOSIS FUNGOIDES	0.53125	8.115324912503546
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.53125	8.115324912503546
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.530303	8.100858629788926
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.527220024	8.053763379083136
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.525237484	8.02347828496166
MUTYH-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.5245421	8.012855664540096
DEAFNESS-HYPOGONADISM SYNDROME	0.5232558	7.993206267015478
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.5208333	7.956200385414462
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5208333	7.956200385414462
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.51983357	7.940928604191351
MEDULLOBLASTOMA	0.517785734	7.9096460545301355
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.51769005	7.908184394767447
SOMATOSTATINOMA	0.5176759000000001	7.907968240701542
LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES	0.515873	7.880427310283183
RHYNS SYNDROME	0.51521605	7.870391804021971
DOWN SYNDROME	0.51446118	7.8588604810728855
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.51332659	7.841528591204693
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	7.8242440566442255
SPONDYLOPERIPHERAL DYSPLASIA	0.51058749	7.799686357853468
FAMILIAL PANCREATIC CARCINOMA	0.5104810000000001	7.798059626653596
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.507790364	7.7569577247970685
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.507263454	7.748908697315379
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.50671757	7.740569824798604
17Q24.2 MICRODELETION SYNDROME	0.50649351	7.737147105363507
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.505570684	7.723050102393708
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.50550626	7.722065967443753
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.50526139	7.718325356410673
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.50520833	7.717514816853292
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.504887484	7.712613603607407
CRYPTOCOCCOSIS	0.50401606	7.699301812743306
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.50296736	7.683281970417203
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.50296736	7.683281970417203
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.50178253	7.665182619045755
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.501197444	7.656244900473036
XYLT1-CDG	0.50065189	7.647911069005146
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.50065189	7.647911069005146
ANAL CANAL CARCINOMACLOACOGENIC CARCINOMA, INCLUDED	0.5	7.637952858826866
%300228 TESTICULAR GERM CELL TUMOR 1; TGCT1	0.5	7.637952858826866
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	7.637952858826866
CHILBLAIN LUPUS	0.5	7.637952858826866
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	7.637952858826866
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.5	7.637952858826866
FUNCTIONING GONADOTROPIC ADENOMA	0.5	7.637952858826866
RHABDOMYOSARCOMA 1	0.5	7.637952858826866
RHABDOMYOSARCOMA 2; RMS2	0.5	7.637952858826866
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.5	7.637952858826866
LAMBERT-EATON MYASTHENIC SYNDROME	0.5	7.637952858826866
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.5	7.637952858826866
FAMILIAL HYPERALDOSTERONISM TYPE II	0.5	7.637952858826866
FAMILIAL HYPERALDOSTERONISM TYPE I	0.5	7.637952858826866
MANDIBULOACRAL DYSPLASIA	0.5	7.637952858826866
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	7.637952858826866
DEAFNESS, UNILATERAL	0.5	7.637952858826866
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.5	7.637952858826866
PLEOMORPHIC LIPOSARCOMA	0.5	7.637952858826866
HIS BUNDLE TACHYCARDIA	0.5	7.637952858826866
ANGIOMA, TUFTED	0.5	7.637952858826866
LUNG CANCER	0.5	7.637952858826866
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	7.637952858826866
FANCONI-LIKE SYNDROME	0.5	7.637952858826866
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.5	7.637952858826866
UPINGTON DISEASE	0.5	7.637952858826866
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	7.637952858826866
REFRACTORY ANEMIA	0.5	7.637952858826866
RESTRICTIVE DERMOPATHY	0.5	7.637952858826866
NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3	0.5	7.637952858826866
%607107 NASOPHARYNGEAL CARCINOMA;;NPCA;;NPC;;NASOPHARYNGEAL CANCERNASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED	0.5	7.637952858826866
MEIGE DISEASE	0.5	7.637952858826866
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.48503474	7.409344958026691
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.47834564999999996	7.307163049849789
TREACHER-COLLINS SYNDROME	0.476243584	7.275052087821505
OVARIAN FIBROMA	0.4738095	7.237869250128655
PALLISTER-HALL SYNDROME	0.470766444	7.191383813579115
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.4541394	6.937390657071835
FRONTORHINY	0.45302786	6.9204108768304335
GONADOBLASTOMA	0.45	6.8741575729441795
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.45	6.8741575729441795
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.4464909	6.820552892190361
MELANOMA, CUTANEOUS MALIGNANT	0.4450757	6.798934430418738
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.444087	6.783831142435693
XERODERMA PIGMENTOSUM	0.44024810999999997	6.725188620735248
GANGLIOCYTOMA	0.43926080000000006	6.710106566261153
RHABDOID TUMOR	0.439121	6.707970994641824
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.43845601	6.697812670098642
BLOOM SYNDROME	0.43648789000000005	6.667747854537613
CARNEY-STRATAKIS SYNDROME	0.43333299999999997	6.619554052348044
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.43259917000000003	6.608344134455259
OROFACIODIGITAL SYNDROME TYPE 1	0.42162600999999994	6.4407191768705285
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.4136903	6.319494019107888
MULTIPLE OSTEOCHONDROMAS	0.41176289	6.290051085668624
TRICHOTHIODYSTROPHY	0.40846196399999996	6.239626451311672
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.4047616	6.183100039726672
PLEUROPULMONARY BLASTOMA	0.40384620000000004	6.169116475632733
NEUROENDOCRINE TUMOR OF STOMACH	0.40225240000000007	6.144769737099937
MCCUNE-ALBRIGHT SYNDROME	0.40181275999999994	6.138053837910226
MELANOSIS, NEUROCUTANEOUS; NCMS	0.399895854	6.108771362584622
POLAND SYNDROME	0.39934094	6.100294548639215
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.395833	6.046707587936029
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.3913057999999999	5.977550507571066
CRONKHITE-CANADA SYNDROME	0.39120563	5.976020320095331
BECKWITH-WIEDEMANN SYNDROME	0.39027907000000006	5.9618662768935815
WHIM SYNDROME	0.3888889	5.94063017104207
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.3888886	5.940625588270354
DERMATOMYOSITIS	0.38832853	5.932070011755068
SOTOS SYNDROME	0.387518624	5.919697964058906
ATYPICAL TERATOID RHABDOID TUMOR	0.38708697000000003	5.913104058252259
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.38453044399999997	5.8740508081115275
ALAGILLE SYNDROME 1; ALGS1	0.38168047	5.830514873989763
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.379069524	5.790630309059877
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.37696479999999993	5.7584787436741935
ELSAHY-WATERS SYNDROME; ESWS	0.376554144	5.752205601335806
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.37565189	5.738422854298431
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.3752243699999999	5.731892099086018
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.3749997	5.728460061348434
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.37333299999999997	5.70299970928882
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.37333299999999997	5.70299970928882
YELLOW NAIL SYNDROME	0.3732325	5.701464480764196
GALLBLADDER NEUROENDOCRINE TUMOR	0.37187533000000006	5.680732479801369
CRANIOLENTICULOSUTURAL DYSPLASIA	0.37102188999999997	5.667695410825694
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.36809239	5.622944645025827
ATELOSTEOGENESIS TYPE I	0.36781579999999997	5.618719482263381
THYMIC TUMOR	0.366667	5.601170521774941
ACITRETIN/ETRETINATE EMBRYOPATHY	0.36625969999999997	5.59494864537614
SCHWARTZ-JAMPEL SYNDROME	0.3659124399999999	5.589643934356626
GLYCOGEN STORAGE DISEASE IB	0.36523489	5.579293744437631
GLYCOGEN STORAGE DISEASE IA	0.36523489	5.579293744437631
LINEAR IGA DERMATOSIS	0.36111099999999996	5.516297589607656
INFANTILE MYOFIBROMATOSIS	0.35930290000000004	5.488677224479567
NANCE-HORAN SYNDROME	0.35878108999999997	5.480706104117037
OLLIER DISEASE	0.35873	5.479925658093923
BAZEX SYNDROME; BZX	0.3571425	5.455675157767147
MEDULLARY THYROID CARCINOMA	0.35621843000000003	5.441559151570636
MASTOCYTOSIS	0.35613497	5.44028422447944
AYME-GRIPP SYNDROME; AYGRP	0.35301900999999997	5.392685113299459
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	5.346567001178806
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.34999969999999997	5.34656241840709
C SYNDROME	0.34892882	5.330203756492169
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.34834379000000004	5.321266893370171
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.34740712399999996	5.306958471865238
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.34731936	5.3056177972758345
DUBOWITZ SYNDROME	0.34517338999999997	5.27283616188292
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.3446763	5.265242661909732
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.34414507	5.257127642515344
ILEAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
JEJUNAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
CRANIOPHARYNGIOMA	0.341530974	5.217194958482447
FAMILIAL ADENOMATOUS POLYPOSIS 3	0.3413545	5.214499158296831
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.34092341	5.2079138681010075
OTODENTAL SYNDROME	0.33958745999999995	5.187506021857507
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.33946797	5.185680703883305
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.339001564	5.178555929801157
EPISODIC ATAXIA TYPE 1	0.33868059	5.173652761239339
%109500 BASILAR IMPRESSION, PRIMARY	0.33868059	5.173652761239339
KLATSKIN TUMOR	0.33854133	5.171525438609098
BRONCHIAL NEUROENDOCRINE TUMOR	0.33854133	5.171525438609098
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	5.1661183790212775
CLEFT VELUM	0.33818737	5.1661183790212775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33806401399999997	5.164234004395571
PAPILLOMA OF CHOROID PLEXUS	0.33734906	5.153312434499111
NIJMEGEN BREAKAGE SYNDROME	0.33703809000000007	5.148562086098093
CLEIDOCRANIAL DYSPLASIA	0.33550234	5.125102113892206
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.335382314	5.123268608032539
IMMUNODEFICIENCY 36; IMD36	0.33515109000000004	5.119736452008881
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.33511553	5.11919324080156
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	5.110987024250037
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.33398489	5.101921690760952
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.333878554	5.10029731205056
ACROMELIC FRONTONASAL DYSPLASIA	0.333878554	5.10029731205056
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
SALIVARY GLAND ADENOMA, PLEOMORPHIC	0.333333	5.091963480582671
IMMUNODEFICIENCY 16	0.333333	5.091963480582671
CHOLANGIOCARCINOMA	0.333333	5.091963480582671
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.333333	5.091963480582671
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.333333	5.091963480582671
TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	0.333333	5.091963480582671
LEYDIG CELL HYPOPLASIA	0.333333	5.091963480582671
PELVIS-SHOULDER DYSPLASIA	0.333333	5.091963480582671
FAMILIAL ATRIAL MYXOMA	0.333333	5.091963480582671
BURKITT LYMPHOMA; BL	0.333333	5.091963480582671
PAPILLOMA OF CHOROID PLEXUS	0.333333	5.091963480582671
MYOFIBROMATOSIS, INFANTILE, 2; IMF2	0.333333	5.091963480582671
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.333333	5.091963480582671
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.333333	5.091963480582671
GESTATIONAL CHORIOCARCINOMA	0.333333	5.091963480582671
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	5.091963480582671
PLACENTAL INSUFFICIENCY	0.333333	5.091963480582671
PAI SYNDROME	0.333333	5.091963480582671
ANGIOLIPOMATOSIS, FAMILIAL	0.333333	5.091963480582671
RARE CIRCULATORY SYSTEM DISEASE	0.3309091	5.05493621271365
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.3286003	5.019667201592731
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.326984	4.994976755181288
FAMILIAL MULTIPLE LIPOMATOSIS	0.3269231	4.994046452523083
FAMILIAL MELANOMA	0.32634060000000004	4.98514823744255
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.32007503	4.889435980855189
PGM3-CDG	0.31673599999999996	4.8384292733867715
WISKOTT-ALDRICH SYNDROME	0.315873	4.825246166752438
DIETHYLSTILBESTROL SYNDROME	0.31309655999999997	4.782833531081714
MOHR-TRANEBJAERG SYNDROME	0.3125	4.773720536766791
45,X/46,XY MIXED GONADAL DYSGENESIS	0.31099283999999994	4.750697302705371
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.309239904	4.723919617640291
SYSTEMIC MASTOCYTOSIS	0.30613497	4.676488938596753
MARFAN SYNDROME; MFS	0.29927841000000005	4.571748774489318
WALDENSTRÖM MACROGLOBULINEMIA	0.29625945	4.525631426163949
ADRENOCORTICAL CARCINOMA	0.29611743	4.523461942033928
MALAKOPLAKIA	0.291667	4.455477592950911
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.291667	4.455477592950911
SEBOCYSTOMATOSIS	0.29090910000000003	4.443899984007501
THYROID CANCER, NONMEDULLARY, 1; NMTC1	0.29090910000000003	4.443899984007501
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.29	4.430012658119582
FRONTOOCULAR SYNDROME	0.288827884	4.412107524613428
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.2884615	4.406510677172972
FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	0.2835497	4.3314784834690006
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.28180676000000004	4.304853496357473
CATARACT 1, MULTIPLE TYPES	0.28165656000000006	4.302559055318682
ROBERTS SYNDROME	0.281564744	4.301156482759309
ESOPHAGEAL ATRESIA	0.28073019	4.288407914539018
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.28030299999999997	4.2818822003754935
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.27777759999999996	4.24330442807613
FAMILIAL BREAST-OVARIAN CANCER-1	0.27439020000000003	4.191558825048151
ADENOCARCINOMA OF THE ESOPHAGUS	0.27399197000000003	4.18547550111421
ROBERTS SYNDROME; RBS	0.27261583	4.164453716219917
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.27253035999999997	4.163148084558229
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27245221000000003	4.161954272526396
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.2717391	4.151060871400079
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.2712766	4.143995765005664
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.27029226	4.1289590799715485
MUCOLIPIDOSIS TYPE II	0.27021216	4.127735479923564
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.26875885	4.105534853385041
FAMILIAL THROMBOCYTOSIS	0.26793563	4.092959422280154
GLUCAGONOMA	0.2676759	4.088991811288109
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.26749963	4.0862991273872575
GLIOMA SUSCEPTIBILITY 3	0.2652346	4.0516987426596
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.26349144999999996	4.025070547607871
WILLIAMS SYNDROME	0.26329121	4.022011700246969
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2625	4.009925250884105
COACH SYNDROME	0.261237444	3.990638564464846
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.26099161400000004	3.986883288562276
ALPORT SYNDROME, X-LINKED; ATS	0.26093772	3.986060008899528
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.26081207	3.9841405913461054
HALLERMANN-STREIFF SYNDROME	0.26067929	3.9821122565849154
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.26067929	3.9821122565849154
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.26065831399999995	3.981791829186581
CUSHING SYNDROME	0.26009342	3.9731625617021136
NON-FUNCTIONING PARAGANGLIOMA	0.2600627	3.9726932858784667
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.25943396	3.9630887129175494
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.25943396	3.9630887129175494
OTOMANDIBULAR SYNDROME	0.25915935	3.9588937964484248
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25912647	3.958391524668428
PHACE SYNDROME	0.258864214	3.9543853267385387
46,XY SEX REVERSAL 6; SRXY6	0.2588235	3.95376338351315
46,XY SEX REVERSAL 10; SRXY10	0.2588235	3.95376338351315
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2588235	3.95376338351315
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.25821357	3.9444461503387815
CUTANEOUS MASTOCYTOSIS	0.25805807000000003	3.942070746999687
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25769095399999997	3.9364627175962443
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.2576657	3.936076939873251
ALLAN-HERNDON-DUDLEY SYNDROME	0.25740741	3.9321313261854383
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.257039064	3.926504507417963
BURKITT LYMPHOMA	0.25613497	3.912693652714067
PULMONARY BLASTOMA	0.25520833	3.89853838743986
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.2551938	3.8983164285297836
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.25509360400000003	3.8967858438804974
MALARIA	0.25375397	3.8763217212003336
POLYARTERITIS NODOSA	0.25306863	3.865852531975797
NOONAN SYNDROME 6; NS6	0.252701204	3.8602397670415822
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.252049314	3.850281556863301
MYH9-RELATED DISEASE	0.25150376	3.8419477253954124
SPINOCEREBELLAR ATAXIA TYPE 37	0.25150376	3.8419477253954124
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.251197444	3.8372684710596032
NOONAN SYNDROME 3; NS3	0.251197444	3.8372684710596032
ACUTE MONOBLASTIC LEUKEMIA	0.25066283	3.8291017580002653
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.250545554	3.8273102608813216
FUMARASE DEFICIENCY; FMRD	0.250545554	3.8273102608813216
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.2500003	3.8189810121851484
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	0.2500003	3.8189810121851484
MYOPIA 17	0.25	3.818976429413433
LICHEN PLANOPILARIS	0.25	3.818976429413433
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.25	3.818976429413433
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	3.818976429413433
ORAL SUBMUCOUS FIBROSIS	0.25	3.818976429413433
PLATELET DISORDER, UNDEFINED	0.25	3.818976429413433
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	3.818976429413433
FRASIER SYNDROME	0.25	3.818976429413433
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.25	3.818976429413433
MELANOMA, UVEAL	0.25	3.818976429413433
LYMPHANGIOLEIOMYOMATOSIS	0.25	3.818976429413433
MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	0.25	3.818976429413433
JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25	3.818976429413433
DYSTONIA 6, TORSION	0.25	3.818976429413433
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.25	3.818976429413433
GAMMA-HEAVY CHAIN DISEASE	0.25	3.818976429413433
ATAXIA-PANCYTOPENIA SYNDROME	0.25	3.818976429413433
SMALL CELL CARCINOMA OF THE BLADDER	0.25	3.818976429413433
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.25	3.818976429413433
CARNEY-STRATAKIS SYNDROME	0.24958278	3.812603016029913
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.247123	3.7750276486637433
BIRT-HOGG-DUBÉ SYNDROME	0.2464003	3.763987751601595
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.24629130400000004	3.7623227389819944
TRICHOHEPATOENTERIC SYNDROME 1	0.24424199000000002	3.731017611532126
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.24359010000000003	3.7210594013538447
ONDINE SYNDROME	0.24359010000000003	3.7210594013538447
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.240504554	3.6739248915703606
GCGR-RELATED HYPERGLUCAGONEMIA	0.23846150000000002	3.6427153912902854
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.23745613999999998	3.6273576067179847
WATSON SYNDROME	0.23676288999999998	3.616767585079221
HENNEKAM SYNDROME	0.23643332	3.6117331048318544
EPIDERMAL NEVUS SYNDROME	0.23637939400000002	3.610909336340124
HYPERCALCEMIA, INFANTILE, 1	0.236347	3.6104144886503065
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.235680244	3.6002291868576264
PRIMARY MYELOFIBROSIS	0.235628	3.5994311124393135
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23432161	3.5794748219688275
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.23376609999999998	3.5709889035836135
ENCHONDROMATOSIS, MULTIPLE	0.2328501	3.5569961739462435
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.2328501	3.5569961739462435
CATARACT 17, MULTIPLE TYPES	0.23165656	3.5387637694359952
DERMATOFIBROSARCOMA PROTUBERANS	0.23125	3.5325531972074256
7Q11.23 MICRODUPLICATION SYNDROME	0.22988127000000003	3.5116446067745013
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.2277778	3.479512197374588
HEMIFACIAL MICROSOMIA	0.22771232000000002	3.4785119310681964
OCULOCEREBROCUTANEOUS SYNDROME	0.22768686000000002	3.4781230065086253
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.2273234	3.4725708258164865
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.22673585400000001	3.463595528515702
CEREBROOCULONASAL SYNDROME	0.2254905	3.4445716182265986
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	0.22275640000000002	3.402805764403962
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.22161059	3.385302478873617
CLAPO SYNDROME	0.22037036	3.366356842325411
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.21941556000000004	3.351771407546196
DESMOID TUMOR	0.21875	3.3416043757367535
AYMÉ-GRIPP SYNDROME	0.21871411400000002	3.34105618458417
PARANEOPLASTIC PEMPHIGUS	0.21783220000000003	3.327584149469091
PAPILLORENAL SYNDROME	0.21698489	3.3146407217954663
117600 CEREBRAL SARCOMA	0.21666670000000002	3.309780081355166
INSULIN-RESISTANCE SYNDROME TYPE B	0.21631932999999998	3.304473689986024
DUPLICATION OF THE PITUITARY GLAND	0.215872794	3.2976524481504863
FAMILIAL PARATHYROID ADENOMA	0.214286	3.273412732613148
TETRASOMY 9P	0.21389045400000004	3.2673704092101525
AICARDI SYNDROME	0.21330571	3.2584379149971885
300270 ADRENOMYODYSTROPHY	0.211656964	3.2332518265488304
OCULOAURICULOFRONTONASAL SYNDROME	0.21126463	3.227258569355
MODY	0.211236	3.226821220174304
OROFACIODIGITAL SYNDROME TYPE 6	0.211218224	3.2265496756742666
TETRASOMY 5P	0.21065807400000003	3.217992877086523
SCARF SYNDROME	0.21024338000000004	3.211658050640847
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.20997834	3.2076093245894395
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.20997433999999998	3.207548220966568
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.20960622	3.201924854553786
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.20940313000000002	3.1988224708615878
ADNP SYNDROME	0.20930625999999997	3.1973426938747176
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20847326400000002	3.1846179255155356
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.20772889	3.173246938472863
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.20743829	3.1688077602713123
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.207094834	3.1635611587971506
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.20666700000000002	3.1570256069503437
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.20666700000000002	3.1570256069503437
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.2066369	3.156565802188242
CROUZON SYNDROME	0.20609970000000002	3.148359585636719
KAPOSIFORM LYMPHANGIOMATOSIS	0.20591140000000002	3.145483132590085
PROTEUS SYNDROME	0.20589312	3.1452038890335663
NEUROENDOCRINE TUMOR OF THE RECTUM	0.20520833000000002	3.134743101557174
NEUROENDOCRINE TUMOR OF THE COLON	0.20520833000000002	3.134743101557174
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.20520833000000002	3.134743101557174
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.20485437	3.1293360419693528
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20466795	3.1264883076254675
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.20178253000000002	3.082410903749636
OSTEOGENIC SARCOMA	0.20168049999999998	3.080852303089263
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.201197444	3.0734731851769164
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.20065189	3.0651393537090272
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.20054555400000001	3.0635149749986357
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.20054555400000001	3.0635149749986357
RETINAL CAPILLARY MALFORMATION	0.2	3.0551811435307465
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.2	3.0551811435307465
TERATOMA, PINEAL	0.2	3.0551811435307465
CAYLER CARDIOFACIAL SYNDROME	0.2	3.0551811435307465
CURRARINO SYNDROME	0.2	3.0551811435307465
INCESSANT INFANT VENTRICULAR TACHYCARDIA	0.2	3.0551811435307465
OVARIAN FIBROMATA	0.2	3.0551811435307465
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.2	3.0551811435307465
%606960 INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	0.2	3.0551811435307465
ACQUIRED VON WILLEBRAND SYNDROME	0.2	3.0551811435307465
PACHYONYCHIA CONGENITA 2	0.2	3.0551811435307465
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	3.0551811435307465
THYROID CANCER, NONMEDULLARY, 4; NMTC4	0.2	3.0551811435307465
THYROID CANCER, NONMEDULLARY, 5; NMTC5	0.2	3.0551811435307465
ROMANO-WARD SYNDROME	0.2	3.0551811435307465
HEPATIC ADENOMAS, FAMILIAL	0.2	3.0551811435307465
CAHMR SYNDROME	0.2	3.0551811435307465
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	3.0551811435307465
STEATOCYSTOMA MULTIPLEX	0.2	3.0551811435307465
MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	0.2	3.0551811435307465
LEUKEMIA, ACUTE MONOCYTIC	0.2	3.0551811435307465
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.2	3.0551811435307465
POLYNEUROPATHY ASSOCIATED WITH IGM MONOCLONAL GAMMAPATHY WITH ANTI-MAG	0.2	3.0551811435307465
EPISODIC ATAXIA, TYPE 4	0.2	3.0551811435307465
THYROID CANCER, NONMEDULLARY, 3; NMTC3	0.2	3.0551811435307465
SOMATOMAMMOTROPINOMA	0.19962136000000003	3.0493970745898142
ACROMEGALY	0.19962136000000003	3.0493970745898142
KERATOSIS, FAMILIAL ACTINIC	0.19861109999999998	3.033964438079497
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.1984126	3.0309321707945425
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.19551962	2.986739281071485
GLOMUVENOUS MALFORMATION	0.19548859999999998	2.986265422476123
DISTAL MONOSOMY 12Q	0.194157554	2.965932489274263
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.1935926	2.957302305235452
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.1916667	2.9278824384138225
PITUITARY GIGANTISM	0.19162887	2.9273045509005233
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.19111720000000001	2.9194883282219717
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.19047599999999998	2.909693417475812
ZUNICH NEUROECTODERMAL SYNDROME	0.18937806999999998	2.8929215423112282
SMITH-LEMLI-OPITZ SYNDROME	0.188410134	2.878135443234506
HIRSCHSPRUNG DISEASE	0.18710994999999997	2.8582739550349032
INCONTINENTIA PIGMENTI	0.18640430400000002	2.8474945732688646
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.18389917000000003	2.809226382474776
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.18357449	2.804266601406368
MÉNÉTRIER DISEASE	0.18346679000000002	2.8026213863605767
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.18261628400000002	2.7896291368922776
CARBOXYLESTERASE 1	0.18254	2.788463829700512
AREDYLD SYNDROME	0.18120779	2.7681131153443967
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.18083035999999997	2.762347530249382
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.18036560000000001	2.755247900308046
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.1785713	2.7278383426788593
ACQUIRED ICHTHYOSIS	0.17698399999999997	2.7035908975332275
FECHTNER SYNDROME	0.17610096	2.690101661748311
LEGIUS SYNDROME	0.17568530999999998	2.6837522315367677
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.17521301	2.6765374212663207
DUBOWITZ SYNDROME	0.17491619999999997	2.6720033796902634
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.17444901000000002	2.664866629298033
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	0.17424240000000002	2.661710474417709
WOLFRAM-LIKE SYNDROME	0.17410699999999998	2.659642116783538
DIENCEPHALIC SYNDROME	0.1734126	2.6490345278531993
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.17280197	2.6397066015448285
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.17276670000000002	2.6391678203501674
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.172619	2.6369115690756693
THYMIC CARCINOMA	0.17187533000000002	2.625551336270622
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.17089230400000002	2.61053472377662
HEREDITARY ACROKERATOTIC POIKILODERMA	0.17066734	2.607098194922753
601095 HARROD SYNDROME	0.17035704000000002	2.6023580813785654
LIG4 SYNDROME	0.170068194	2.597945697115644
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.16996164400000002	2.5963180493614284
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.16873000400000002	2.5775036328433374
VITREORETINOCHOROIDOPATHY; VRCP	0.16791233	2.5650129219115603
THYMOMA	0.166667	2.5459893782441947
TERMINAL OSSEOUS DYSPLASIA; TOD	0.166667	2.5459893782441947
ACUTE ERYTHROID LEUKEMIA	0.166667	2.5459893782441947
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.5459893782441947
CHOLANGIOCARCINOMA	0.166667	2.5459893782441947
DERMATOLEUKODYSTROPHY	0.166667	2.5459893782441947
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.5459893782441947
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.166667	2.5459893782441947
CATARACT, ANTERIOR POLAR, 2	0.166667	2.5459893782441947
HYPERPARATHYROIDISM 4	0.166667	2.5459893782441947
LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	0.166667	2.5459893782441947
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.166667	2.5459893782441947
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.166667	2.5459893782441947
B-CELL MALIGNANCY, LOW-GRADE	0.166667	2.5459893782441947
CATARACT, ANTERIOR POLAR, 1	0.166667	2.5459893782441947
CARCINOID TUMORS, INTESTINAL	0.166667	2.5459893782441947
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.16415475000000002	2.507612484105019
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	2.5005175896944545
LINEAR NEVUS SEBACEUS SYNDROME	0.16346900000000003	2.4971370317591384
POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	0.1625	2.4823346791187313
UNILATERAL POLYMICROGYRIA	0.16242903	2.4812505480899496
FAMILIAL KERATOACANTHOMA	0.16233770000000003	2.4798553996207566
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.16206185999999997	2.475641693787598
SIMPSON-GOLABI-BEHMEL SYNDROME	0.16193362400000003	2.4736827727419897
POTOCKI-SHAFFER SYNDROME	0.16155518400000002	2.467901758982201
LARGE CONGENITAL MELANOCYTIC NEVUS	0.16025640000000002	2.4480616570506037
COMMON VARIABLE IMMUNODEFICIENCY	0.15872999999999998	2.4247445145631765
MONOSOMY 18Q	0.15843866400000003	2.420294093295019
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.157808	2.4106601294915
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.157554004	2.406780110542839
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.1570693	2.399375817937869
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.1567459	2.39443559002878
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.15653548	2.3912212339476713
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.15625	2.3868602683833955
AFRICAN IRON OVERLOAD	0.15625	2.3868602683833955
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.15625	2.3868602683833955
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.15625	2.3868602683833955
KBG SYNDROME	0.155978534	2.382713379361847
PARAGANGLIOMAS 7; PGL7	0.15555560000000002	2.376252679453057
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.15508276	2.3690296201935213
OROFACIODIGITAL SYNDROME I; OFD1	0.1544129	2.3587969019894937
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.15402438999999998	2.352862059859128
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.15294285	2.336340556789257
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.15294285	2.336340556789257
MOSAIC TRISOMY 1	0.15280083	2.3341710726592355
DESMOID DISEASE, HEREDITARY	0.1527778	2.333819268550558
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.1524338	2.3285643569836854
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.15233366999999998	2.3270347805441762
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15233366999999998	2.3270347805441762
AXIN2-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.1523199	2.3268244313224447
SMITH-MAGENIS SYNDROME; SMS	0.15090209400000001	2.305166160540521
9Q31.1Q31.3 MICRODELETION SYNDROME	0.15059994	2.3005504845243085
RING CHROMOSOME 13 SYNDROME	0.15019667999999997	2.2943903227846074
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.149812814	2.2885264219603947
HYDRANENCEPHALY	0.14969186399999998	2.2866788011638444
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.14926725999999998	2.280192590492506
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.14820459	2.263959343763527
CARCINOMA OF ESOPHAGUS	0.14806533	2.2618320211332863
PYODERMA GANGRENOSUM	0.1477273	2.2566683067235482
IMMUNODEFICIENCY 21; IMD21	0.1477273	2.2566683067235482
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14719892999999998	2.248596976419511
FREE SIALIC ACID STORAGE DISEASE	0.147092594	2.246972597709119
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.14699916999999998	2.2455454614933528
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14647624999999997	2.237557384875477
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.14588485999999998	2.2285233669931137
STEINERT MYOTONIC DYSTROPHY	0.14588485999999998	2.2285233669931137
ULBRIGHT-HODES SYNDROME	0.1458333	2.2277357412943117
C SYNDROME	0.145299774	2.2195856484203946
MONOSOMY 13Q14	0.14529141999999998	2.2194580335040293
DISTAL TRISOMY 14Q	0.14502633999999998	2.2154086964163935
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14501264999999997	2.215199569267119
SARCOSINEMIA	0.14464788399999998	2.209627438242113
AUTOIMMUNE HYPOPARATHYROIDISM	0.14463953	2.209499823325748
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14410232999999997	2.2012936067742244
ANAUXETIC DYSPLASIA 2; ANXD2	0.14350888999999997	2.19222827328514
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14350888999999997	2.19222827328514
ATELOSTEOGENESIS TYPE III	0.143402554	2.1906038945747475
DYSSPONDYLOENCHONDROMATOSIS	0.14303648000000002	2.1850117826650637
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	2.182270063106859
L-2-HYDROXYGLUTARIC ACIDURIA	0.14285699999999998	2.182270063106859
CHROMOSOME 13Q14 DELETION SYNDROME	0.14285699999999998	2.182270063106859
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	2.182270063106859
PERINEURAL CYST	0.14285699999999998	2.182270063106859
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	2.182270063106859
NEUROBLASTOMA	0.14285699999999998	2.182270063106859
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14285699999999998	2.182270063106859
JOUBERT SYNDROME 5	0.14285699999999998	2.182270063106859
GASTROESOPHAGEAL REFLUX	0.14285699999999998	2.182270063106859
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	2.182270063106859
ODONTOMATOSIS-AORTAE ESOPHAGUS STENOSIS SYNDROME	0.14285699999999998	2.182270063106859
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	2.182270063106859
MUNGAN SYNDROME	0.14285699999999998	2.182270063106859
ODONTOMA-DYSPHAGIA SYNDROME	0.14285699999999998	2.182270063106859
%613065 LEUKEMIA, ACUTE LYMPHOBLASTIC; ALLLEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO,INCLUDED	0.14285699999999998	2.182270063106859
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	2.182270063106859
BLADDER CANCER	0.14285699999999998	2.182270063106859
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	2.182270063106859
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	2.182270063106859
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	2.182270063106859
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	2.182270063106859
GLIOBLASTOMA	0.14285699999999998	2.182270063106859
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	2.182270063106859
ALSTROM SYNDROME; ALMS	0.14280520400000002	2.1814788322943075
ROTHMUND-THOMSON SYNDROME TYPE 2	0.14256844000000002	2.1778620477529733
PSEUDOACHONDROPLASIA	0.14239046	2.1751432420533447
KAPOSI SARCOMA	0.14153073	2.1620100876307067
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.14066847	2.1488382851666024
OSTEOMA OF MIDDLE EAR	0.14052279999999998	2.1466130439807114
NEPHROBLASTOMA	0.14005683	2.1394949301934565
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.13977016	2.1351157863013768
XQ12-Q13.3 DUPLICATION SYNDROME	0.1397212	2.13436787795744
OROFACIODIGITAL SYNDROME VI	0.139526394	2.1313920398682074
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	0.13942310000000002	2.129814130463008
DISTAL 17P13.1 MICRODELETION SYNDROME	0.13906931	2.124409667779159
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.138572054	2.1168136320056217
RING CHROMOSOME 12 SYNDROME	0.13809891400000002	2.109585989974371
METACHONDROMATOSIS	0.13703700000000002	2.0933642918301145
RING CHROMOSOME 22 SYNDROME	0.136998024	2.092768898128863
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.136236	2.0811282913502738
COSTELLO SYNDROME	0.13568289000000003	2.0726790351387825
MYXOPAPILLARY EPENDYMOMA	0.13526606	2.0663115793584925
CHARGE SYNDROME	0.13303366	2.0322096474344025
TRISOMY 8P	0.1330228	2.0320437510983087
PROTEUS-LIKE SYNDROME	0.13198723	2.0162244814142785
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	2.015568686781819
GAUCHER DISEASE, TYPE I	0.1319443	2.015568686781819
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.13113497	2.0032054380073503
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.13113497	2.0032054380073503
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.13050626	1.9936013233236047
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.13045630000000003	1.992838139073951
HADDAD SYNDROME	0.12967219000000002	1.9808601486416813
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.129585454	1.9795351776833545
BLACKFAN-DIAMOND ANEMIA	0.12911339000000002	1.9723239725266566
MELANOMA-ASTROCYTOMA SYNDROME	0.1287878	1.9673502903840452
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12866691000000002	1.9655035861418382
CHOROIDAL OSTEOMA, BILATERAL	0.1277777	1.9519200980186429
MICROPHTHALMIA, SYNDROMIC 3	0.127701204	1.9507515523348655
LISSENCEPHALY, X-LINKED, 2	0.12645501000000003	1.9317148102849604
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.12511583	1.9112576228659923
CENTRAL PRECOCIOUS PUBERTY	0.125	1.9094882147067165
MASTOCYTOSIS, CUTANEOUS; MASTC	0.125	1.9094882147067165
CUTANEOUS MASTOCYTOMA	0.125	1.9094882147067165
CONGENITAL FACTOR XIII DEFICIENCY	0.125	1.9094882147067165
RENAL AGENESIS	0.125	1.9094882147067165
SAPHO SYNDROME	0.125	1.9094882147067165
BULLOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067165
THYROID CARCINOMA, FAMILIAL MEDULLARY	0.125	1.9094882147067165
PSEUDOXANTHOMATOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067165
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.125	1.9094882147067165
CHROMOSOME 14Q32 DUPLICATION SYNDROME, 700-KB	0.125	1.9094882147067165
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.12397756	1.8938695176647584
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.12359660000000001	1.8880500086225616
TUFTED ANGIOMA	0.12305788000000001	1.8798205726943469
MARDEN-WALKER SYNDROME	0.12289959	1.8774025495782993
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.12225332400000001	1.8675302510937741
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.1217391	1.8596750137520195
PETTIGREW SYNDROME	0.12171901399999999	1.8593681819097743
STURGE-WEBER SYNDROME	0.12161563000000002	1.857788897673061
ARIMA SYNDROME	0.12137885400000001	1.8541719298208574
OPTIC PATHWAY GLIOMA	0.12056758399999999	1.8417790457892962
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.12054495999999999	1.8414334436983402
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.12054495999999999	1.8414334436983402
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.12050763	1.8408631941379003
X-LINKED ACROGIGANTISM	0.12020027	1.8361679917565221
DIAMOND-BLACKFAN ANEMIA 1	0.11962918	1.8274440747602274
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.11892522999999999	1.816690600930285
OROFACIODIGITAL SYNDROME TYPE 3	0.11886179999999999	1.8157216502306142
COG8-CDG	0.11851840999999999	1.810476056966229
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.11722736999999998	1.7907542516485093
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.11667495000000001	1.7823155358119636
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11631932999999998	1.7768831182206508
PRIMROSE SYNDROME; PRIMS	0.11624769999999998	1.7757889050940956
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.11617079400000001	1.7746140962889738
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.115998484	1.7719819049747647
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.115998484	1.7719819049747647
CHROMOSOME 16P13.3 DELETION SYNDROME	0.115841224	1.7695796160416066
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.11476063999999998	1.7530727167376012
NF1-MICRODELETION SYNDROME	0.11464456999999999	1.7512996423609533
DEMENTIA, FAMILIAL DANISH	0.11262844999999999	1.720501583325477
DEAFNESS, X-LINKED 4	0.11261476	1.7202924561762027
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11176288999999999	1.7072793703725049
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11176288999999999	1.7072793703725049
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.11176288999999999	1.7072793703725049
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.1117424	1.7069663670643505
W SYNDROME	0.11165655399999999	1.7056549916621124
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.11165655399999999	1.7056549916621124
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11165655399999999	1.7056549916621124
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.11158136399999999	1.704506396311202
UNCOMBABLE HAIR SYNDROME 2	0.11111099999999999	1.6973211601942233
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11111099999999999	1.6973211601942233
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	1.6973211601942233
ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	0.11111099999999999	1.6973211601942233
OSTEOMAS OF MANDIBLE	0.11111099999999999	1.6973211601942233
MYELOMA, MULTIPLE	0.11111099999999999	1.6973211601942233
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.11111099999999999	1.6973211601942233
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.11111099999999999	1.6973211601942233
ANDROGEN INSENSITIVITY SYNDROME	0.11111099999999999	1.6973211601942233
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.11111099999999999	1.6973211601942233
RETINITIS PIGMENTOSA 74; RP74	0.11111099999999999	1.6973211601942233
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	1.6973211601942233
CONGENITAL MACROGLOSSIA	0.11111099999999999	1.6973211601942233
SUBCORNEAL PUSTULAR DERMATOSIS	0.11111099999999999	1.6973211601942233
WAGR 11P13 DELETION SYNDROME	0.11111099999999999	1.6973211601942233
ATELOSTEOGENESIS, TYPE II	0.11111099999999999	1.6973211601942233
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	1.6973211601942233
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.11052036000000001	1.688298599241149
POEMS SYNDROME	0.11028073000000001	1.6846380339540274
BLUE RUBBER BLEB NEVUS	0.110119	1.682167461722311
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.11002494000000002	1.6807306100305088
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.10931498	1.6698853280072035
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.10851126	1.6576077770638107
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.10841774000000001	1.6561791743610956
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.10840336	1.6559595068368758
15Q OVERGROWTH SYNDROME	0.107665	1.644680389091189
TURNPENNY-FRY SYNDROME; TPFS	0.106798634	1.631445863758208
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.10648395000000001	1.6266387806433542
IDIOPATHIC ANTERIOR UVEITIS	0.1055556	1.61245739357037
NEPHRONOPHTHISIS 11; NPHP11	0.10544052400000001	1.6106995034440057
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.10542907000000001	1.6105245332199158
PITT-HOPKINS SYNDROME	0.10532445400000001	1.6089264290673575
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.1045032	1.5963810303931114
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.10389831000000001	1.58714078778356
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.10366646	1.5835990690429218
NEPHRONOPHTHISIS 1	0.10364964	1.5833421283087508
NEPHRONOPHTHISIS 4	0.10364964	1.5833421283087508
CERNUNNOS-XLF DEFICIENCY	0.10364964	1.5833421283087508
PHEOCHROMOCYTOMA	0.10339536	1.5794577710028659
DEXTROCARDIA	0.103177154	1.5761244767198397
KNOBLOCH SYNDROME	0.10302786000000001	1.5738438756516284
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10267860000000001	1.5685086128206804
PENDRED SYNDROME	0.10267860000000001	1.5685086128206804
SAY SYNDROME	0.10267209000000001	1.5684091666744586
MALT LYMPHOMA	0.10225240000000001	1.5619980218038165
MALAN OVERGROWTH SYNDROME	0.10197789000000002	1.5578046329252635
CRANIOACROFACIAL SYNDROME	0.1018981	1.5565857684080517
MELAS	0.10188404999999999	1.5563711419327184
RUIJS-AALFS SYNDROME; RJALS	0.10155330000000001	1.551318636116605
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.10150376000000001	1.5505618677473523
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	0.1010101	1.5430207641307754
FRYNS MICROPHTHALMIA SYNDROME	0.10093160000000001	1.5418216055319396
OCULOCUTANEOUS ALBINISM TYPE 4	0.10081233	1.5399996482569949
OCULOCUTANEOUS ALBINISM	0.10081233	1.5399996482569949
OCULOCUTANEOUS ALBINISM TYPE 2	0.10081233	1.5399996482569949
OCULOCUTANEOUS ALBINISM TYPE 1B	0.10081233	1.5399996482569949
PSEUDOPROGERIA SYNDROME	0.10065189000000001	1.5375487819436544
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10043867000000001	1.5342916533265365
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.10043773400000003	1.534277355078785
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	1.5275905717653733
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.1	1.5275905717653733
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	1.5275905717653733
GRANULOMATOUS SLACK SKIN	0.1	1.5275905717653733
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.1	1.5275905717653733
POTOCKI-SHAFFER SYNDROME	0.1	1.5275905717653733
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.1	1.5275905717653733
LERI-WEILL DYSCHONDROSTEOSIS	0.1	1.5275905717653733
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.1	1.5275905717653733
GENOCHONDROMATOSIS TYPE 1	0.1	1.5275905717653733
MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	0.1	1.5275905717653733
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.1	1.5275905717653733
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1	1.5275905717653733
SENIOR-LOKEN SYNDROME 3	0.1	1.5275905717653733
MADELUNG DEFORMITY	0.1	1.5275905717653733
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.1	1.5275905717653733
PARAGANGLIOMAS 6	0.1	1.5275905717653733
UPINGTON DISEASE	0.1	1.5275905717653733
EXOSTOSES, MULTIPLE, TYPE III	0.1	1.5275905717653733
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.099567	1.520976104589629
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.09920630000000001	1.5154660853972717
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.09920630000000001	1.5154660853972717
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.09920630000000001	1.5154660853972717
TOWNES-BROCKS SYNDROME 1; TBS1	0.09908121400000003	1.5135552834546733
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.09905811400000002	1.5132024100325954
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.09842603000000001	1.5035467544429577
OROFACIODIGITAL SYNDROME TYPE 4	0.09810512400000002	1.4986446246427285
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.09748805	1.489218260397913
ALKAPTONURIA	0.09737915999999999	1.4875548670243175
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.09729471400000002	1.4862648778900847
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.09728500000000001	1.4861164877419433
SYNDROMIC DIARRHEA	0.097149384	1.484044830512138
WERNER SYNDROME; WRN	0.09697222	1.4813384899515754
BRANCHIOOCULOFACIAL SYNDROME	0.09653540000000001	1.47466566881599
CLASSICAL EHLERS-DANLOS SYNDROME	0.0964775	1.4737811938749377
2Q24 MICRODELETION SYNDROME	0.09617288000000002	1.4691278474752263
MANTLE CELL LYMPHOMA	0.09611743	1.4682807985031823
THROMBOCYTHEMIA, ESSENTIAL	0.09579100000000002	1.4632942845997687
MONOSOMY X	0.09550853000000001	1.458979299511703
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.09550853000000001	1.458979299511703
TURNER SYNDROME	0.09550853000000001	1.458979299511703
MOSAIC MONOSOMY X	0.09550853000000001	1.458979299511703
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.09534759000000001	1.456520795245504
HOLOPROSENCEPHALY	0.09514469400000002	1.453421375079015
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.09459914000000001	1.445087543611126
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.09458885000000002	1.4449303545412913
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.09455874	1.4444703970201325
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.09444267	1.4426973226434845
DUANE-RADIAL RAY SYNDROME; DRRS	0.09427518000000001	1.4401387611948349
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.09416450000000001	1.438448023950005
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.09387646000000001	1.434047952067092
THYMOMA, FAMILIAL	0.0935898	1.4296689609340691
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0935898	1.4296689609340691
VERRUCOUS HEMANGIOMA	0.0931677	1.4232210011306476
LYMPHATIC MALFORMATION 1	0.0931677	1.4232210011306476
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.09296447999999999	1.4201166315707057
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.09269998400000001	1.4160762156120097
GITELMAN SYNDROME	0.09221547	1.408674825429126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.09210654400000001	1.407010882122925
DUANE RETRACTION SYNDROME 1	0.09180788000000001	1.4024485190176679
STUVE-WIEDEMANN SYNDROME	0.09156099000000001	1.3986770506550361
MENTAL RETARDATION, X-LINKED 2	0.09156099000000001	1.3986770506550361
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.09156099000000001	1.3986770506550361
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.09145465400000001	1.3970526719446439
BETA-THALASSEMIA MAJOR	0.09124328	1.3938237426494802
BALLER-GEROLD SYNDROME	0.09119176	1.3930367279869067
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0909091	1.388718840476755
PENILE AGENESIS	0.0909091	1.388718840476755
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0909091	1.388718840476755
B-CELL CLL/LYMPHOMA 2	0.0909091	1.388718840476755
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0909091	1.388718840476755
PRIMARY EFFUSION LYMPHOMA	0.0909091	1.388718840476755
GIANT AXONAL NEUROPATHY	0.0909091	1.388718840476755
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0909091	1.388718840476755
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0909091	1.388718840476755
RENAL DYSPLASIA, DIFFUSE CYSTIC	0.0909091	1.388718840476755
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0909091	1.388718840476755
NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC	0.0909091	1.388718840476755
GOITER, MULTINODULAR 1	0.0909091	1.388718840476755
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	1.388718840476755
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0909091	1.388718840476755
LEUKONYCHIA TOTALIS	0.0909091	1.388718840476755
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	1.388718840476755
POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	0.0909091	1.388718840476755
ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	0.0909091	1.388718840476755
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0909091	1.388718840476755
POLYPOSIS, GASTRIC	0.0909091	1.388718840476755
BOHRING-OPITZ SYNDROME	0.09080120400000001	1.3870706313534429
22Q11.2 DELETION SYNDROME	0.090697504	1.3854865199305222
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.09037555000000001	1.380568380981101
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.090237154	1.3784542567334004
CAMPOMELIC DYSPLASIA	0.09019834000000002	1.3778613377288755
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.09018677	1.3776845954997219
MELNICK-NEEDLES SYNDROME	0.08992622000000002	1.3737044582649875
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.08991225000000001	1.373491053862112
NON-HISTAMINIC ANGIOEDEMA	0.08946827000000002	1.3667088572415882
NATIVE AMERICAN MYOPATHY	0.08883956000000001	1.357104742557842
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.08878462000000001	1.356265484297714
LIPOSARCOMA	0.0883703	1.3499363710407755
ADDISON DISEASE	0.08826640000000001	1.3483492044367114
LICHEN SCLEROSUS ET ATROPHICUS; LSA	0.088141	1.3464336058597175
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.088141	1.3464336058597175
CHEILITIS GLANDULARIS	0.088141	1.3464336058597175
RECOMBINANT 8 SYNDROME	0.08791350399999999	1.342958398412574
3C SYNDROME	0.08749810400000002	1.3366127871774611
LARYNGOTRACHEAL ANGIOMA	0.08734936000000001	1.3343405878573944
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.08733214	1.3340775367609363
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08722847000000002	1.3324938836151872
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.08716514400000003	1.3315265216097112
DISTAL 16P11.2 MICRODELETION SYNDROME	0.08684621400000002	1.3266545769991798
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.08663575999999999	1.3234397015372763
PHELAN-MCDERMID SYNDROME	0.086262834	1.3177429191216146
DDOST-CDG	0.08604957	1.314485118364645
KAGAMI-OGATA SYNDROME	0.08572510400000001	1.3095286063400609
WARSAW BREAKAGE SYNDROME; WABS	0.085396304	1.3045058885400962
8Q12 MICRODUPLICATION SYNDROME	0.08538261400000002	1.3042967613908218
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	1.3034389581811525
TRISOMY 13	0.08518086	1.301214786308662
VACTERL/VATER ASSOCIATION	0.08460196	1.2923715644887124
LOEYS-DIETZ SYNDROME 5	0.08423979000000001	1.2868390897149498
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08398519000000002	1.282949844119235
THANATOPHORIC DYSPLASIA, TYPE I	0.08387885400000002	1.2813254654088426
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.08387885400000002	1.2813254654088426
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.08387885400000002	1.2813254654088426
BLOOM SYNDROME	0.083753	1.2794029315706528
OCULOSKELETODENTAL SYNDROME; OCSKD	0.083460224	1.2749305129982613
THANATOPHORIC DYSPLASIA, TYPE II	0.08333330000000001	1.272991633940954
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08333330000000001	1.272991633940954
SILLENCE SYNDROME	0.08333330000000001	1.272991633940954
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.08333330000000001	1.272991633940954
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.08333330000000001	1.272991633940954
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	0.08333330000000001	1.272991633940954
LARON SYNDROME	0.08333330000000001	1.272991633940954
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.08333330000000001	1.272991633940954
ENDOMETRIAL CANCER	0.08333330000000001	1.272991633940954
IMMUNOERYTHROMYELOID HYPOPLASIA	0.08333330000000001	1.272991633940954
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0833333	1.2729916339409537
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0833333	1.2729916339409537
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08283596999999998	1.2653944677503925
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.08253970000000001	1.260868675163424
CAP POLYPOSIS	0.08213143	1.2546319811360773
THYMIC EPITHELIAL NEOPLASM	0.08213143	1.2546319811360773
CARDIOFACIOCUTANEOUS SYNDROME	0.081904834	1.2511705220040796
ZIMMERMANN-LABAND SYNDROME 1	0.08183355	1.2500815943409027
FRASIER SYNDROME	0.0815508	1.245762331999236
EPIDERMODYSPLASIA VERRUCIFORMIS	0.08119660000000001	1.240351606194043
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.08086963400000001	1.2353569044051649
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.080772684	1.233875905345838
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.08062	1.2315435189572437
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.08057274	1.2308215796530275
PACHYDERMOPERIOSTOSIS	0.08023807	1.2257091922865002
PIERPONT SYNDROME	0.080081134	1.2233118527467945
BECKER NEVUS SYNDROME	0.07986044	1.2199405520103428
XERODERMA PIGMENTOSUM VARIANT	0.0797535	1.2183069466528968
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07968588000000001	1.2172739899082694
CHANARIN-DORFMAN SYNDROME	0.07967219	1.2170648627589944
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.07936510000000001	1.2123737848721603
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.07870563000000001	1.2022997833285394
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0786003	1.2006907721792985
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.0784615	1.1985704764656884
3Q13 MICRODELETION SYNDROME	0.0784615	1.1985704764656884
GYRATE ATROPHY OF CHOROID AND RETINA	0.07844055000000001	1.1982504462409036
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.078334824	1.1966353858329986
PETERS ANOMALY	0.07816843000000001	1.1940935667770156
POLYCYTHEMIA VERA	0.07793563	1.1905373359259457
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.07778673000000001	1.188262753564587
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.07777780000000001	1.1881263397265285
248100 MACROSOMIA ADIPOSA CONGENITA	0.0776914	1.186806501472523
HERMANSKY-PUDLAK SYNDROME	0.07750019000000001	1.1838855955402505
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07733947	1.1814304519733092
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.07692310000000001	1.1750700231096498
MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE	0.07692310000000001	1.1750700231096498
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.07692310000000001	1.1750700231096498
GOOD SYNDROME	0.07692310000000001	1.1750700231096498
MYASTHENIA GRAVIS; MG	0.07692310000000001	1.1750700231096498
RETINITIS PIGMENTOSA 83; RP83	0.07692310000000001	1.1750700231096498
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.07692310000000001	1.1750700231096498
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	1.1750700231096498
CHRONIC MYELOID LEUKEMIA	0.07692310000000001	1.1750700231096498
EXUDATIVE VITREORETINOPATHY 4	0.07692310000000001	1.1750700231096498
MEDULLOBLASTOMA	0.07692310000000001	1.1750700231096498
JUVENILE XANTHOGRANULOMA	0.07692310000000001	1.1750700231096498
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.07692310000000001	1.1750700231096498
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.07692310000000001	1.1750700231096498
GLIOMA SUSCEPTIBILITY 9; GLM9	0.07670450000000001	1.1717307101197707
RAMOS-ARROYO SYNDROME	0.07638890000000001	1.1669096342752792
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.07578561	1.1576938331148758
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.075720654	1.1567015713830797
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.07571430000000001	1.15660450827815
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.07566015	1.1557773179835389
LINEAR VERRUCOUS NEVUS SYNDROME	0.07550936	1.153473864160374
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.07549020000000001	1.1531811778068237
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.07534063999999999	1.1508965133476912
AURICULOCONDYLAR SYNDROME	0.075139964	1.1478310056918957
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.07487628	1.1438029937686416
1P36 DELETION SYNDROME	0.074786794	1.1424360140695917
CAMPOMELIA, CUMMING TYPE	0.07444227	1.137173097928123
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.07440685	1.1366320253476034
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.07399663000000001	1.1303655433041078
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07387137400000002	1.1284521444575373
OROFACIODIGITAL SYNDROME IX; OFD9	0.07387137400000002	1.1284521444575373
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0737813	1.1270761825259252
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.07356858999999999	1.123826844620723
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.07325580000000001	1.1190486940712983
NEVUS COMEDONICUS SYNDROME	0.07321113000000001	1.1183663193628908
PENDRED SYNDROME	0.07293236000000002	1.1141078551259807
ESSENTIAL THROMBOCYTHEMIA	0.0727273	1.1109753778995182
STORAGE POOL PLATELET DISEASE	0.0727273	1.1109753778995182
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0727273	1.1109753778995182
OROFACIODIGITAL SYNDROME TYPE 2	0.072718514	1.110841163791883
GRANT SYNDROME	0.0724646	1.1069623974674905
DISTAL TRISOMY 17Q	0.072297834	1.1044148957745805
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.07208049000000001	1.1010947693222828
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.07197869999999999	1.0995398348792824
SCIMITAR SYNDROME	0.0715198	1.092529721745451
LIP, HAMARTOMATOUS	0.07142860000000001	1.0911365591440014
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.07142860000000001	1.0911365591440014
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.07142860000000001	1.0911365591440014
CONGENITAL PANFOLLICULAR NEVUS	0.07142860000000001	1.0911365591440014
49,XYYYY SYNDROME	0.07130093	1.0891862842610285
SLC35A2-CDG	0.071217944	1.0879185979491435
SPONDYLO-OCULAR SYNDROME	0.07119433	1.0875578727115265
OROFACIODIGITAL SYNDROME TYPE 14	0.070902294	1.0830967583093658
OROFACIODIGITAL SYNDROME XIV; OFD14	0.070902294	1.0830967583093658
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.070787914	1.0813495002133804
NON-DISTAL MONOSOMY 20Q	0.07053283	1.0774528610792988
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406	1.072583360613682
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.07019710000000001	1.072324281252711
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0694118	1.0603281124926371
PYRUVATE DEHYDROGENASE DEFICIENCY	0.069403464	1.0602007725425748
SHWACHMAN-DIAMOND SYNDROME	0.069389224	1.0599832436451555
OCULOCUTANEOUS ALBINISM TYPE 1A	0.069264	1.058070333627568
CHROMOSOME 2Q37 DELETION SYNDROME	0.06883262400000001	1.0514806745227094
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	1.0496120646317033
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0686937	1.04935848459679
VELOCARDIOFACIAL SYNDROME	0.06852519	1.0467843417243083
ZELLWEGER SYNDROME	0.06833339	1.0438544230076623
RAMON SYNDROME	0.06829460000000001	1.0432618706248746
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.06800167	1.0387870995630022
ALEXANDER DISEASE	0.06792583	1.0376285748733753
ASPARTYLGLUCOSAMINURIA	0.06782155	1.0360356034251383
PELIZAEUS-MERZBACHER DISEASE	0.06742896000000001	1.0300384355994447
PERLMAN SYNDROME	0.067352104	1.0288643905896087
OROFACIODIGITAL SYNDROME IV; OFD4	0.06731859	1.0283524338853873
DISTAL MONOSOMY 7Q36	0.06729967	1.0280634137492095
OROFACIODIGITAL SYNDROME XVI; OFD16	0.067212254	1.0267280551749949
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.0666667	1.018394223707106
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0666667	1.018394223707106
RARE HEREDITARY HEMOCHROMATOSIS	0.0666667	1.018394223707106
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0663642	1.0137732622275157
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	1.012606183030687
SMITH-MAGENIS SYNDROME	0.066120644	1.010052723734547
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	0.0660569	1.0090789764004808
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	0.0660569	1.0090789764004808
CARTILAGE-HAIR HYPOPLASIA	0.06553331	1.0010806649257744
SCLERODERMA	0.06547837	1.0002414066656464
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.06540245	0.9990816599035622
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.06524512	0.9966783016570039
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.065212024	0.9961727302813722
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06508900999999999	0.9942935800154207
HURLER SYNDROME	0.065071964	0.9940331869265576
GABRIELE-DE VRIES SYNDROME	0.06506300000000001	0.9938962537077048
CZECH DYSPLASIA, METATARSAL TYPE	0.065	0.9929338716474926
CATARACT, NUCLEAR TOTAL	0.06498956	0.9927743911918002
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.06498956	0.9927743911918002
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.06498956	0.9927743911918002
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.06498956	0.9927743911918002
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.06493442	0.9919320777505288
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.06480114000000001	0.9898961050364801
OSTEOGENESIS IMPERFECTA	0.06471368999999999	0.988560227081471
CRI-DU-CHAT SYNDROME	0.06468858999999999	0.9881768018479578
ASPARTYLGLUCOSAMINURIA; AGU	0.06449095	0.985157671841921
TRISOMY 12P	0.064443094	0.984426628097897
KLEEFSTRA SYNDROME	0.06426157	0.9816536845884056
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.06417109	0.9802715206390722
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.06406486	0.9786487611746858
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.06403018	0.9781189927643976
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.063924744	0.9765083623691511
VASCULAR EHLERS-DANLOS SYNDROME	0.063798754	0.9745837510077838
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.06349145	0.9698894040771261
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.06308533399999999	0.9636856143506952
10Q22.3Q23.3 MICRODELETION SYNDROME	0.063045554	0.9630779388212471
MONOSOMY 7 OF BONE MARROW	0.0627273	0.9582163207229809
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0627273	0.9582163207229809
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	0.9577366572834466
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.06268889	0.9576295731843657
RECOMBINANT CHROMOSOME 8 SYNDROME	0.062513574	0.9549514624975697
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	0.9547441073533582
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	0.9547441073533582
ADAMS-OLIVER SYNDROME 5; AOS5	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	0.9547441073533582
POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	0.9547441073533582
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	0.9547441073533582
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	0.9547441073533582
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	0.9547441073533582
X-LINKED CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	0.9547441073533582
HEMANGIOMAS OF SMALL INTESTINE	0.0625	0.9547441073533582
HUMERO-RADIO-ULNAR SYNOSTOSIS	0.0625	0.9547441073533582
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	0.9547441073533582
APERT SYNDROME	0.062259369999999994	0.951068266160519
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.06220229000000001	0.9501963174621555
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.062192784	0.9500511047024035
POTOCKI-LUPSKI SYNDROME	0.061840004	0.9446620706833296
CRISPONI SYNDROME	0.06179086	0.9439113515727413
KYPHOMELIC DYSPLASIA	0.06170715	0.9426326055051165
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.06169183	0.9423985786295221
GLYCEROL KINASE DEFICIENCY; GKD	0.061526264000000004	0.939869408023473
ACQUIRED GENERALIZED LIPODYSTROPHY	0.0613275	0.9368331078994091
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.0612766	0.9360555642983807
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.0612766	0.9360555642983807
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.06113848400000001	0.9339457173042813
KYRLE DISEASE	0.0611111	0.9335274019021089
FETAL ALCOHOL SYNDROME	0.061050774	0.9326058676137857
THAUVIN-ROBINET-FAIVRE SYNDROME	0.060966893999999994	0.931324524642189
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.060915994	0.9305469810411604
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0608465	0.9294853972492177
MENTAL RETARDATION, X-LINKED 97; MRX97	0.060580730000000006	0.925425519786637
PAGET DISEASE OF BONE 3; PDB3	0.060340950000000004	0.921762663113658
NOONAN SYNDROME 2; NS2	0.060225244	0.919995149166691
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.060221449999999996	0.9199371923803983
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.06020027	0.9196136486972983
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.060068830000000004	0.9176057836497701
MYCETOMA	0.0597381	0.9125535833517704
PMM2-CDG	0.05967424400000001	0.9115781251162639
RING CHROMOSOME Y SYNDROME	0.05947539	0.9085404501606855
OSLAM SYNDROME	0.05947539	0.9085404501606855
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05883489	0.8987562325485284
DYSKERATOSIS CONGENITA	0.058831923999999994	0.8987109242121696
46,XY SEX REVERSAL 1; SRXY1	0.0588235	0.8985822399824043
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.0588235	0.8985822399824043
GONADOBLASTOMA	0.0588235	0.8985822399824043
46,XY SEX REVERSAL 7	0.0588235	0.8985822399824043
HYPOKALEMIC PERIODIC PARALYSIS	0.0588235	0.8985822399824043
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.05867694	0.8963434032404248
GALACTORRHEA	0.0583136	0.8907930556569725
MATERNAL PHENYLKETONURIA	0.058112524	0.8877214376388897
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.057981130000000006	0.8857142752830245
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.05787022000000001	0.8840200245798794
SECKEL SYNDROME	0.05778789	0.8827623592621449
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.057632609999999994	0.8803903166223075
CUTIS LAXA	0.057587823999999996	0.8797061699088368
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.05695214	0.8699955210586157
ZIMMERMANN-LABAND SYNDROME	0.05693593	0.8697478986269327
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.056867194	0.868697893971524
NOCARDIOSIS	0.05684339	0.868334266311821
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.056690500000000005	0.865998733086649
19P13.3 MICRODUPLICATION SYNDROME	0.056372774	0.8611451806666016
RAMON SYNDROME	0.05635813	0.8609214803032722
IMMUNODEFICIENCY 58; IMD58	0.056207490000000006	0.858620317865965
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.056101154	0.8569959391555726
HOLOPROSENCEPHALY 7	0.056101154	0.8569959391555726
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.056101154	0.8569959391555726
FABRY DISEASE	0.05608428000000001	0.8567381735224928
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.05602236	0.8557922894404556
PAPILLON-LEFÈVRE SYNDROME	0.055944	0.8545952694684203
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.055691109999999995	0.8507321456714827
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.05565281	0.8501470784824968
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.055555600000000004	0.8486621076876836
SCHEIE SYNDROME	0.055555600000000004	0.8486621076876836
ACROKERATOELASTOIDOSIS OF COSTA	0.055555600000000004	0.8486621076876836
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.055555600000000004	0.8486621076876836
LIPOID PROTEINOSIS	0.055555600000000004	0.8486621076876836
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.055555600000000004	0.8486621076876836
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.055555600000000004	0.8486621076876836
CATARACT, AGE-RELATED NUCLEAR	0.055555600000000004	0.8486621076876836
WHIM SYNDROME	0.055555600000000004	0.8486621076876836
AUTOSOMAL AGAMMAGLOBULINEMIA	0.055555600000000004	0.8486621076876836
VIRAL HEMORRHAGIC FEVER	0.05527142	0.8443210008008408
MAST CELL SARCOMA	0.05520833	0.843357243909114
CUSHING DISEASE	0.05511409	0.8419176425542824
WOLF-HIRSCHHORN SYNDROME	0.055041794000000005	0.8408132556745188
KID SYNDROME	0.05501756000000001	0.8404430593753573
DISTAL MONOSOMY 10Q	0.054999903999999995	0.8401733479840063
PEROXISOME BIOGENESIS DISORDER 14B	0.05488846	0.8384709399472081
FETAL HYDANTOIN SYNDROME	0.054823774000000006	0.8374828027099561
KBG SYNDROME	0.054733204	0.8360992639291082
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.054712154000000006	0.8357777061137516
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.054706010000000006	0.8356838509490223
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0545894	0.8339025275832866
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.054574814	0.8336797132224889
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.054522853999999996	0.8328859771613996
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.054365670000000005	0.830484849197076
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0539773	0.8245521456935107
LEPRECHAUNISM	0.05394513000000001	0.8240607198065739
SECONDARY POLYCYTHEMIA	0.05390831	0.8234982609580499
ANTLEY-BIXLER SYNDROME	0.05387693	0.8230189030366298
EAR WAX, WET/DRY	0.053802	0.821874279421206
RABIES	0.05375397	0.821140577669587
BENIGN FAMILIAL INFANTILE EPILEPSY	0.05375397	0.821140577669587
SPONTANEOUS PERIODIC HYPOTHERMIA	0.05375397	0.821140577669587
LEGIONELLOSIS	0.05375397	0.821140577669587
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.053636550000000005	0.8193468808202203
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.05353357	0.8177737680494164
HYALINE FIBROMATOSIS SYNDROME; HFS	0.05353357	0.8177737680494164
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.053519314000000005	0.8175559947375054
RECURRENT ACUTE PANCREATITIS	0.05325797	0.8135637284336309
48,XYYY SYNDROME	0.053177154	0.8123291908371528
ISOTRETINOIN-LIKE SYNDROME	0.0530914	0.8110192208182413
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.053030299999999995	0.8100858629788926
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.052956739999999995	0.808962167354302
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.052914344	0.8083145300554965
TAKAYASU ARTERITIS	0.05282733	0.8069853123953804
CHIME SYNDROME	0.05276278	0.805999252681306
ACRORENAL SYNDROME	0.0526316	0.8039953593692641
RHOMBENCEPHALOSYNAPSIS	0.0526316	0.8039953593692641
CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS	0.0526316	0.8039953593692641
ACROCEPHALOPOLYDACTYLY	0.0526316	0.8039953593692641
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0526316	0.8039953593692641
ALG11-CDG	0.052452874	0.8012651578439707
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.05240412	0.8005203963366122
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.052381000000000004	0.8001672173964202
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.052289364	0.798767394500077
KOOLEN-DE VRIES SYNDROME; KDVS	0.052217794	0.7976740979278647
DIASTROPHIC DWARFISM	0.05210381	0.7959328890905436
TIETZ SYNDROME	0.0520833	0.7956195802642745
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0520833	0.7956195802642745
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.05181176400000001	0.791471621929326
COLCHICINE POISONING	0.05163506	0.7887723082853935
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.05163506	0.7887723082853935
PSEUDOXANTHOMA ELASTICUM	0.051579599999999996	0.7879251065542924
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.051548079999999996	0.7874436100060719
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.05150376	0.7867665818646655
WITTEVEEN-KOLK SYNDROME	0.051310853999999996	0.7838197679962957
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.05131012	0.7838085554814991
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.05126899	0.783180257479332
ELLIS VAN CREVELD SYNDROME	0.051245330000000006	0.7828188295500523
MUCOLIPIDOSIS III GAMMA	0.05107880000000001	0.7802749329708915
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.050672770000000006	0.7740724569723525
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.050651890000000005	0.773753496060968
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.05064392	0.7736317470923981
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.05058387	0.7727144289540531
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.050535374	0.7719736086303697
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.050525694	0.7718257378630229
ACROOSTEOLYSIS DOMINANT TYPE	0.05040008	0.7699068702422054
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0502451	0.7675394103740835
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.05006505000000001	0.7647889835496201
RETINITIS PIGMENTOSA 77; RP77	0.05	0.7637952858826866
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.05	0.7637952858826866
RETINITIS PIGMENTOSA 25; RP25	0.05	0.7637952858826866
LEUKEMIA, ACUTE, ?X-LINKED	0.05	0.7637952858826866
FIBROMATOSIS, GINGIVAL, 1	0.05	0.7637952858826866
NASU-HAKOLA DISEASE	0.05	0.7637952858826866
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.05	0.7637952858826866
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.05	0.7637952858826866
RETICULUM CELL SARCOMA	0.05	0.7637952858826866
RETINITIS PIGMENTOSA 10; RP10	0.05	0.7637952858826866
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.05	0.7637952858826866
RETINITIS PIGMENTOSA 72; RP72	0.05	0.7637952858826866
RETINITIS PIGMENTOSA 14	0.05	0.7637952858826866
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.05	0.7637952858826866
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.05	0.7637952858826866
RETINITIS PIGMENTOSA 56; RP56	0.05	0.7637952858826866
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.05	0.7637952858826866
JUVENILE HYALINE FIBROMATOSIS	0.05	0.7637952858826866
PROGRESSIVE OSSEOUS HETEROPLASIA	0.05	0.7637952858826866
HEREDITARY GINGIVAL FIBROMATOSIS	0.05	0.7637952858826866
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.049996584000000004	0.7637431033887551
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.049888560000000005	0.7620929389495112
CANAVAN DISEASE	0.049682003999999995	0.7589376089680955
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.04961327	0.7578876348644984
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.04957668999999999	0.7573288422333464
2Q37 MICRODELETION SYNDROME	0.04951996399999999	0.7564623012056069
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.049451084	0.755410096819775
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.04945050000000001	0.7554011756908359
HYPERKERATOSIS LENTICULARIS PERSTANS	0.04945050000000001	0.7554011756908359
N SYNDROME	0.049434149999999996	0.7551514146323521
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.04903763	0.7490942124971881
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.04899805	0.7484895921488834
ACUTE INTERMITTENT PORPHYRIA	0.04888261	0.7467261415928375
XP22.13P22.2 DUPLICATION SYNDROME	0.048771409999999994	0.7450274608770343
TEMPI SYNDROME	0.0487661	0.7449463458176736
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.048708949999999994	0.7440733278059096
NIPPLES, SUPERNUMERARY	0.0483036	0.7378812394232588
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.048272999999999996	0.7374137967082985
HUNTER-MACDONALD SYNDROME	0.048188800000000004	0.7361275654468722
VELO-FACIAL-SKELETAL SYNDROME	0.04814634	0.7354789504901006
SMITH-MCCORT DYSPLASIA 2; SMC2	0.048034179999999996	0.7337656049048085
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.047909400000000005	0.7318594773893597
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.047782583999999996	0.7299222481298696
CEREBRAL ARTERIOVENOUS MALFORMATION	0.047619	0.7274233543689531
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.047619	0.7274233543689531
PERIORAL MYOCLONIA WITH ABSENCES	0.047619	0.7274233543689531
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.047619	0.7274233543689531
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	0.047619	0.7274233543689531
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.047609814	0.7272830298990307
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.04734266	0.7232020105829366
DYSOSTOSIS, STANESCU TYPE	0.0472352	0.7215604617545175
CARTILAGE-HAIR HYPOPLASIA; CHH	0.047123	0.7198465051329968
MYCOSIS FUNGOIDES	0.047123	0.7198465051329968
ACTH-DEPENDENT CUSHING SYNDROME	0.04704225	0.7186129757462962
DYSOSTEOSCLEROSIS	0.0470212	0.7182914179309395
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.04701429	0.7181858614224306
DEAFNESS, MID-TONE NEURAL	0.04695826	0.7173299524250706
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	0.7173299524250706
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.04687502999999999	0.7160585387921901
LOEYS-DIETZ SYNDROME 3; LDS3	0.04678056	0.7146154239790434
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.046775354000000005	0.7145358976138774
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04677135	0.7144747328873838
KAPUR-TORIELLO SYNDROME	0.0466369	0.7124208873636453
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.046404933999999995	0.708877396617944
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.04639932	0.7087916376832452
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0462766	0.7069169785335747
PITUITARY APOPLEXY	0.04613497	0.7047534520067833
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.046106390000000004	0.7043168666213729
TOWNES-BROCKS SYNDROME	0.04609026	0.7040704662621471
OCCIPITAL HORN SYNDROME	0.04601439399999999	0.7029115443989714
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.046000054	0.7026924879109804
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.045809814000000004	0.6997863996072541
TRISOMY 20P	0.04573774	0.6986854039785597
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.045725944000000004	0.6985052093947144
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.045712253999999994	0.6982960822454395
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.04559286	0.6964722307581861
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.045468839999999996	0.6945777129310826
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	0.6943586564430915
SMALL CELL CANCER OF THE LUNG	0.0454545	0.6943586564430915
X-LINKED ADRENOLEUKODYSTROPHY	0.0454545	0.6943586564430915
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	0.6943586564430915
PERRAULT SYNDROME 4	0.0454545	0.6943586564430915
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0454545	0.6943586564430915
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	0.6943586564430915
MERCURY POISONING	0.0454545	0.6943586564430915
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0454545	0.6943586564430915
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	0.6943586564430915
SANDIFER SYNDROME	0.0454545	0.6943586564430915
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0454545	0.6943586564430915
INHERITED EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430915
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430915
POROKERATOSIS	0.0454545	0.6943586564430915
PALMOPLANTAR KERATODERMA-XX SEX REVERSAL-PREDISPOSITION TO SQUAMOUS CELL CARCINOMA SYNDROME	0.0454545	0.6943586564430915
49,XXXYY SYNDROME	0.04535673999999999	0.6928652839001336
MACS SYNDROME	0.04512116	0.6892665860311689
SLC39A8-CDG	0.045056030000000004	0.6882716662917782
ACHONDROGENESIS TYPE 1B	0.04504045	0.6880336676806971
KYPHOMELIC DYSPLASIA	0.04504045	0.6880336676806971
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04490424	0.6859529365628954
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.04446273	0.679208471429494
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04444441	0.6789286168367467
CONGENITAL TRACHEAL STENOSIS	0.0442684	0.6762399046713824
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.044257279999999996	0.676070036599802
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.04418546	0.6749729210511602
LEUKOCYTE ADHESION DEFICIENCY	0.04418546	0.6749729210511602
DOORS SYNDROME	0.044143984	0.6743393375856148
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.044110750000000004	0.6738316581349945
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0440891	0.6735009347762071
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	0.6735009347762071
FOCAL DERMAL HYPOPLASIA; FDH	0.04402178	0.6724725608032947
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.04400524	0.6722198973227247
NATHALIE SYNDROME	0.043986620000000004	0.671935459958262
BRANCHIO-OCULO-FACIAL SYNDROME	0.04397182	0.6717093765536407
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.04392598	0.6710091290355434
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.04380909	0.6692235284162069
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.04377360000000001	0.6686813865222875
WILSON DISEASE	0.04366983	0.6670962057859664
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.043478300000000004	0.6641704115638642
LIPOMA OF THE CONJUNCTIVA	0.043478300000000004	0.6641704115638642
RENAL CELL CARCINOMA, NONPAPILLARY	0.043478300000000004	0.6641704115638642
FIBROCHONDROGENESIS	0.043408440000000006	0.663103236790429
VISCERAL STEATOSIS, CONGENITAL	0.04332631	0.661848626653838
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04328629	0.6612372849070175
MENKES DISEASE	0.043171970000000004	0.6594909433653754
HAMAMY SYNDROME; HMMS	0.043170459999999994	0.6594678767477417
YOU-HOOVER-FONG SYNDROME; YHFS	0.043124894000000004	0.6587718148278111
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.04296736	0.6563653402964863
RENAL TUBULAR DYSGENESIS	0.04288616	0.6551249367522127
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.042756550000000004	0.6531450266121477
KNIEST DYSPLASIA	0.04272139	0.6526079257671149
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.042328083999999995	0.6465998203929273
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.042318589999999996	0.646454790944044
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.042124560000000005	0.6434908069576477
CITRULLINEMIA TYPE II	0.042100924000000005	0.6431297456501053
WIDOW'S PEAK SYNDROME	0.04208075000000001	0.6428215695281574
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.042062880000000004	0.6425485890929828
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.04199507	0.6415127299262687
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.041922764	0.640408190287448
FLYNN-AIRD SYNDROME	0.04189459	0.6399778069197589
PAPILLARY TUMOR OF THE PINEAL REGION	0.04184927000000001	0.6392855028726349
PINEOCYTOMA	0.04184927000000001	0.6392855028726349
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.04183067000000001	0.6390013710262865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04178253	0.6382659889250385
ANDROGEN INSENSITIVITY SYNDROME	0.0416667	0.6364965807657628
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.041666699999999994	0.6364965807657625
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	0.6364965807657625
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	0.6364965807657625
PREMATURE OVARIAN FAILURE 8; POF8	0.041666699999999994	0.6364965807657625
HISTIDINEMIA	0.041666699999999994	0.6364965807657625
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	0.6364965807657625
CHROMOSOME 17Q12 DELETION SYNDROME	0.041594049999999994	0.635386786215375
MARFANOID HYPERMOBILITY SYNDROME	0.04157558	0.6351046402367702
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.04157368	0.6350756160159066
15Q26 OVERGROWTH SYNDROME	0.04151129	0.6341225522581821
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04150376	0.6340075246881283
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.04149592	0.6338877615873018
ACROCRANIOFACIAL DYSOSTOSIS	0.04149282	0.633840406279577
HALLERMANN-STREIFF SYNDROME; HSS	0.04148936	0.633787551645794
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.041428860000000005	0.632863359349876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.04142694400000001	0.632834090714521
9P13 MICRODELETION SYNDROME	0.04138457	0.6321867894856411
COG1-CDG	0.041295729999999996	0.6308296780216847
COFFIN-LOWRY SYNDROME	0.041223029999999994	0.6297191196760112
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.041201804	0.6293948733012483
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04105306	0.6271226739811817
RUBINSTEIN-TAYBI SYNDROME	0.040997224	0.6262697285095308
DYSTONIA, JUVENILE-ONSET	0.040891979999999994	0.6246620310881819
CONGENITAL ANALBUMINEMIA	0.040661459999999996	0.6211406293021484
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04065189	0.6209944388844306
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04065189	0.6209944388844306
SJOGREN-LARSSON SYNDROME; SLS	0.04065189	0.6209944388844306
NON-DISTAL TRISOMY 10Q	0.04065189	0.6209944388844306
CHROMOSOME 1P36 DELETION SYNDROME	0.040608184	0.6203267901491347
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0405229	0.6190239998059104
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.040518454	0.6189560831290898
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.040510814000000006	0.6188393752094069
ERYTHROKERATODERMIA VARIABILIS	0.0404102	0.6173024052315308
NAIL-PATELLA SYNDROME	0.04033698	0.6161839034148843
OCULODENTODIGITAL DYSPLASIA	0.04014033	0.6131798965555076
FG SYNDROME TYPE 1	0.040127694	0.6129868702108593
FANCONI ANEMIA	0.04008864399999999	0.6123903460925849
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.040056230000000005	0.611895192884653
COCAINE EMBRYOFETOPATHY	0.04	0.6110362287061493
DOHLE BODIES AND LEUKEMIA	0.04	0.6110362287061493
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.04	0.6110362287061493
LEUKEMIA, ACUTE MYELOID; AML	0.04	0.6110362287061493
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.04	0.6110362287061493
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	0.6110362287061493
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04	0.6110362287061493
MECKEL SYNDROME, TYPE 5	0.04	0.6110362287061493
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.04	0.6110362287061493
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	0.6110362287061493
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.039972900000000006	0.6106222516612009
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.03996526	0.610505543741518
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.039963724	0.6104820799503357
MUCOLIPIDOSIS TYPE III	0.039899760000000006	0.6095049719170118
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.039882724	0.6092447315872057
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.039706830000000005	0.6065577914269048
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	0.6064717880777143
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.039337170000000005	0.6009109001193169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039247870000000004	0.5995467617387304
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.039247870000000004	0.5995467617387304
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.039206653999999994	0.5989171500086714
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.03911528000000001	0.5975213293996268
245800 LAURENCE-MOON SYNDROME	0.039113390000000005	0.5974924579378204
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.039113390000000005	0.5974924579378204
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.039113390000000005	0.5974924579378204
8P23.1 DUPLICATION SYNDROME	0.039100004	0.5972879746638838
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.03901432	0.5959790739583722
PEROXISOME BIOGENESIS DISORDER 11B	0.03901428	0.5959784629221435
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.039007054	0.5958680792274278
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.038980224	0.5954582266770232
MEIER-GORLIN SYNDROME 5; MGORS5	0.03875161	0.5919659407672875
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03875161	0.5919659407672875
THANATOPHORIC DYSPLASIA TYPE 2	0.038742650000000003	0.5918290686520573
CHRISTIANSON SYNDROME	0.03855577	0.5889743073915422
OCULOCEREBROCUTANEOUS SYNDROME	0.038554450000000004	0.5889541431959949
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0384615	0.587534247759539
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	0.587534247759539
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	0.587534247759539
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0384615	0.587534247759539
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	0.587534247759539
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	0.587534247759539
PANCREATIC CANCER	0.0384615	0.587534247759539
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	0.587534247759539
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0384615	0.587534247759539
TROPICAL CALCIFIC PANCREATITIS	0.0384615	0.587534247759539
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	0.587534247759539
PHOCOMELIA, SCHINZEL TYPE	0.0384615	0.587534247759539
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0384615	0.587534247759539
GERMAN SYNDROME	0.038157074000000006	0.5828838648855367
WAGR SYNDROME	0.038148720000000004	0.5827562499691713
THANATOPHORIC DYSPLASIA TYPE 1	0.03809076	0.5818708584737761
THANATOPHORIC DYSPLASIA	0.03809076	0.5818708584737761
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.5816255274279506
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03804568	0.5811822206440242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.038011144	0.5806546519641593
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.03790377	0.579014416863632
ECTODERMAL DYSPLASIA SYNDROME	0.0378869	0.5787567123341751
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.03784364	0.5780958766528294
3MC SYNDROME 2	0.037791134000000004	0.5772937999472183
HYPOPHOSPHATEMIC RICKETS	0.03768889	0.5757319302430225
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.03768889	0.5757319302430225
WILDERVANCK SYNDROME	0.03766026	0.5752945810623261
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.03761486	0.5746010549427446
BRANCHIOGENIC DEAFNESS SYNDROME	0.03761152000000001	0.5745500334176478
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0375	0.5728464644120148
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03749747	0.5728078163705492
HARLEQUIN ICHTHYOSIS	0.03749683	0.57279803979089
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03749683	0.57279803979089
MUCOPOLYSACCHARIDOSIS TYPE 6	0.03743017999999999	0.5717799006748082
MORQUIO SYNDROME A	0.03743017999999999	0.5717799006748082
FOUNTAIN SYNDROME	0.03739065999999999	0.5711761968808465
ODONTOCHONDRODYSPLASIA; ODCD	0.03728678	0.5695893357948968
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.037218060000000004	0.5685395755539797
AMISH INFANTILE EPILEPSY SYNDROME	0.037218060000000004	0.5685395755539797
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03721176	0.5684433373479585
MIRAGE SYNDROME; MIRAGE	0.03708264399999999	0.5664709735053177
EXOSTOSES OF HEEL	0.037037	0.5657737200647412
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	0.5657737200647412
PEYRONIE DISEASE	0.037037	0.5657737200647412
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	0.5657737200647412
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037037	0.5657737200647412
GENITOURINARY TRACT ANOMALIES	0.037037	0.5657737200647412
DK PHOCOMELIA SYNDROME	0.037037	0.5657737200647412
DENTIN DYSPLASIA	0.037037	0.5657737200647412
URINARY BLADDER, ATONY OF	0.037037	0.5657737200647412
ADENOMYOSIS	0.037037	0.5657737200647412
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	0.5657737200647412
HYPERLYSINEMIA, TYPE I	0.037037	0.5657737200647412
TESTICULAR TORSION	0.037037	0.5657737200647412
PULMONARY ARTERIAL HYPERTENSION	0.037037	0.5657737200647412
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	0.5657737200647412
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	0.5657737200647412
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.037037	0.5657737200647412
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	0.5657737200647412
LÉRI-WEILL DYSCHONDROSTEOSIS	0.037037	0.5657737200647412
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	0.5657737200647412
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	0.5657737200647412
CROSSED POLYSYNDACTYLY	0.03695963000000001	0.5645918232393665
RAINE SYNDROME	0.036911744	0.5638603212181709
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.036911744	0.5638603212181709
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.036797934000000004	0.5621217703884447
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.03666926	0.5601561584961312
SECKEL SYNDROME 2; SCKL2	0.03655963	0.5584814609523049
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0365572	0.558444340501411
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.036510834	0.5577360578569063
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.03643797	0.5566229942626951
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.03636619000000001	0.5555264897502821
MICROHYDRANENCEPHALY; MHAC	0.03636619000000001	0.5555264897502821
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.03636619000000001	0.5555264897502821
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03636619000000001	0.5555264897502821
DEND SYNDROME	0.03627416	0.5541206481470862
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.03627416	0.5541206481470862
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036259854	0.5539021110398895
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.036259854	0.5539021110398895
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.036259854	0.5539021110398895
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.5539021110398895
THUMBS, CONGENITAL CLASPED	0.0361093	0.5516022623304738
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.035948139999999996	0.5491403973650167
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.035905309999999996	0.5484861303231297
WYBURN-MASON SYNDROME	0.035884834000000004	0.5481733408776551
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	0.5455682795720007
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	0.5455682795720007
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	0.5455682795720007
ALKAPTONURIA	0.035714300000000004	0.5455682795720007
SECONDARY SYRINGOMYELIA	0.035714300000000004	0.5455682795720007
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	0.5455682795720007
OTOSCLEROSIS 4	0.035714300000000004	0.5455682795720007
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.035714300000000004	0.5455682795720007
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.035634373999999996	0.5443473375316114
DERMOCHONDROCORNEAL DYSTROPHY	0.0355346	0.5428231993145383
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03550317	0.5423430775978324
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035485594	0.542074588278939
ACROCEPHALOSYNDACTYLY	0.0354377	0.5413429640504976
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0353603	0.5401606089479513
9Q33.3Q34.11 MICRODELETION SYNDROME	0.03531458	0.53946219453854
MAPLE SYRUP URINE DISEASE; MSUD	0.03530537	0.5393215034468806
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.035302004	0.5392700847482348
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03526606	0.5387210075931195
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.035210224	0.5378680621214685
SUSAC SYNDROME	0.03520464	0.5377827614639413
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.03513469	0.5367142118589914
BRACHYDACTYLY, TYPE A6	0.03513469	0.5367142118589914
MOSAIC TRISOMY 9	0.035028354	0.5350898331485989
THREE M SYNDROME 2; 3M2	0.0349232	0.5334835105587649
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.03490792	0.533250094719399
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.034876279999999996	0.5327667650624924
SPONDYLOCOSTAL DYSOSTOSIS 5	0.034876279999999996	0.5327667650624924
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.03475939	0.5309811644431559
CHST3-RELATED SKELETAL DYSPLASIA	0.03475939	0.5309811644431559
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.03469252	0.5299596646278164
FANCONI ANEMIA	0.03466467	0.5295342306535799
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.03464309	0.5292045766081929
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.034490534	0.5268741455355305
ISOLATED POLYCYSTIC LIVER DISEASE	0.0344828	0.5267560016807101
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.0344828	0.5267560016807101
RCAD (RENAL CYSTS AND DIABETES)	0.0344828	0.5267560016807101
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	0.5267560016807101
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	0.5267560016807101
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	0.5267560016807101
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	0.5267560016807101
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0344828	0.5267560016807101
CERVICAL VERTEBRAL BRIDGE	0.0344828	0.5267560016807101
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0344828	0.5267560016807101
HANAC SYNDROME	0.0344828	0.5267560016807101
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	0.5267560016807101
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344828	0.5267560016807101
DIAPHANOSPONDYLODYSOSTOSIS	0.0344828	0.5267560016807101
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03446282	0.5264507890844713
HARROD SYNDROME	0.03446261999999999	0.5264477339033278
RENPENNING SYNDROME	0.034434650000000004	0.5260204668204052
TRISOMY 18	0.034351384000000006	0.524748503254919
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03415532	0.5217534480762929
DENT DISEASE	0.034040629999999995	0.520001454449535
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.03388835	0.5176752395268508
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.03377555	0.5159521173618995
INFANTILE SIALIC ACID STORAGE DISEASE	0.033759084	0.5157005842983526
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.033672254	0.5143741774048887
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.033649809999999995	0.5140313249769616
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.033589289999999994	0.5131068271629292
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.033578224	0.5129377839902577
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.033422733999999996	0.5105625334102197
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.033373490000000006	0.5098102867090597
MARFAN SYNDROME	0.033309740000000004	0.5088364477195593
ALSTRÖM SYNDROME	0.033278023999999996	0.508351957093818
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.033235313999999995	0.507699523160617
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.03303959	0.504709661789935
PETERS PLUS SYNDROME	0.032948434	0.5033171713283366
PIEBALDISM	0.032767450000000004	0.5005524768079328
WT LIMB-BLOOD SYNDROME	0.03275376	0.5003433496586581
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.03275376	0.5003433496586581
JACOBSEN SYNDROME	0.032737524	0.5000953300534262
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.03272119	0.49984581340943407
NOONAN SYNDROME 5; NS5	0.032665283999999996	0.49899179862438287
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.032577424	0.4976496575480299
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0325397	0.49707338928073713
X-LINKED RECESSIVE OCULAR ALBINISM	0.03249533	0.49639559734404487
WAARDENBURG SYNDROME TYPE 1	0.03249533	0.49639559734404487
MERRF	0.03245865	0.4958352771223213
FASCIAL DYSTROPHY, CONGENITAL	0.0323877	0.49475145161165374
MILD CANAVAN DISEASE	0.0322581	0.4927716942306458
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.03223533	0.49242386185745485
COFFIN-SIRIS SYNDROME 1; CSS1	0.032200254000000005	0.49188804418850246
CORNELIA DE LANGE SYNDROME	0.03213984	0.49096516562047615
BARDET-BIEDL SYNDROME 1; BBS1	0.032117863999999996	0.4906294623164249
MICROFORM HOLOPROSENCEPHALY	0.03203968	0.4894351309037959
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031972994	0.4884164418551084
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.031930749999999994	0.48777112649397175
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.03190189	0.4873302638549604
PERRAULT SYNDROME 3	0.03190189	0.4873302638549604
DE SANCTIS-CACCHIONE SYNDROME	0.031806759999999996	0.4858770669440399
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.031806759999999996	0.4858770669440399
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.031801504	0.485796776783588
HYDROXYKYNURENINURIA	0.031795554	0.48570588514456786
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.031698253999999995	0.4842195395182402
KEUTEL SYNDROME; KTLS	0.03154258	0.4818414781715502
RIN2 SYNDROME	0.031311370000000005	0.4783095360105715
TRANSALDOLASE DEFICIENCY	0.031262594	0.47756443843328716
7P22.1 MICRODUPLICATION SYNDROME	0.031262594	0.47756443843328716
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	0.4773720536766791
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.03125	0.4773720536766791
XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	0.03125	0.4773720536766791
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.03125	0.4773720536766791
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.03125	0.4773720536766791
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03125	0.4773720536766791
POROKERATOSIS 1, MULTIPLE TYPES; POROK1	0.03125	0.4773720536766791
BETA-THALASSEMIA INTERMEDIA	0.03125	0.4773720536766791
PRIMARY ERYTHROMELALGIA	0.03125	0.4773720536766791
GENERALIZED ERUPTIVE HISTIOCYTOSIS	0.03125	0.4773720536766791
TYROSINEMIA TYPE 1	0.03125	0.4773720536766791
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	0.4773720536766791
WILSON DISEASE	0.03125	0.4773720536766791
CYLINDROMATOSIS, FAMILIAL	0.03125	0.4773720536766791
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	0.4773720536766791
FAMILIAL TUMORAL CALCINOSIS	0.03125	0.4773720536766791
HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	0.03125	0.4773720536766791
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.03125	0.4773720536766791
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	0.4773720536766791
HEPATOCELLULAR CARCINOMA	0.03125	0.4773720536766791
WAARDENBURG SYNDROME, TYPE 1; WS1	0.03125	0.4773720536766791
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	0.4773720536766791
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766791
DEAFNESS, X-LINKED 3	0.03125	0.4773720536766791
USHER SYNDROME, TYPE IIA	0.03125	0.4773720536766791
FLOTCH SYNDROME	0.03125	0.4773720536766791
USHER SYNDROME, TYPE IF	0.03125	0.4773720536766791
TYROSINEMIA, TYPE I; TYRSN1	0.03125	0.4773720536766791
USHER SYNDROME, TYPE IE; USH1E	0.03125	0.4773720536766791
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	0.4773720536766791
POROKERATOSIS PLANTARIS PALMARIS ET DISSEMINATA	0.03125	0.4773720536766791
PRIMARY BILIARY CHOLANGITIS	0.03125	0.4773720536766791
USHER SYNDROME, TYPE IC	0.03125	0.4773720536766791
USHER SYNDROME, TYPE IIC	0.03125	0.4773720536766791
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766791
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	0.4773720536766791
RETINITIS PUNCTATA ALBESCENS	0.03125	0.4773720536766791
HEMOCHROMATOSIS, TYPE 1	0.03125	0.4773720536766791
AUTOIMMUNE HEPATITIS	0.03125	0.4773720536766791
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	0.4773720536766791
ERYTHROKERATODERMA ''EN COCARDES''	0.03125	0.4773720536766791
SMITH-FINEMAN-MYERS SYNDROME	0.0312434	0.4772712326989426
BLAU SYNDROME	0.03119433	0.4765216440053773
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.03115553	0.4759289388635323
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.03111537	0.47531545848991136
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.030962914	0.4729865550078208
DISTAL TRISOMY 18Q	0.030748014	0.46970376286909704
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.03074516	0.4696601654341788
SCALP-EAR-NIPPLE SYNDROME; SENS	0.030710559999999998	0.46913161909634793
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.03039184	0.4642628824260173
FLYNN-AIRD SYNDROME	0.03038592	0.4641724490641689
BOHRING-OPITZ SYNDROME	0.030335334	0.4633997020975356
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10	0.030302999999999997	0.4629057709620609
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.030302999999999997	0.4629057709620609
MULTIPLE SYMMETRIC LIPOMATOSIS	0.030302999999999997	0.4629057709620609
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9	0.030302999999999997	0.4629057709620609
NEUROCUTANEOUS MELANOCYTOSIS	0.030302999999999997	0.4629057709620609
EXTENSOR TENDONS OF FINGER ANOMALIES	0.030302999999999997	0.4629057709620609
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II	0.030302999999999997	0.4629057709620609
LIPOMATOSIS, MULTIPLE	0.030302999999999997	0.4629057709620609
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.030302999999999997	0.4629057709620609
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.030225514	0.46172210213162285
15Q13.3 MICRODELETION SYNDROME	0.030220574	0.46164663915737764
3Q29 MICRODELETION SYNDROME	0.030216954000000004	0.4615913403786798
TRISOMY 17P	0.030109623999999998	0.45995177741800397
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.030054434000000005	0.4591087001814468
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.03005102	0.4590565482393266
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	0.45795637750954116
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.029959769999999997	0.4576626218425907
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.45762571525437684
ROSSELLI-GULIENETTI SYNDROME	0.029957354	0.45762571525437684
3MC SYNDROME 1	0.02978061	0.45492579057421584
INTERMEDIATE NEMALINE MYOPATHY	0.02967996	0.453388270663734
POLYMYOSITIS	0.02959853	0.45214435366114547
SILVER-RUSSELL SYNDROME	0.029437660000000004	0.44968691870834654
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.02943324	0.44961939920507454
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.0294118	0.449291883786488
AREDYLD	0.0294118	0.449291883786488
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0294118	0.449291883786488
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.449291883786488
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0294118	0.449291883786488
DARWINIAN POINT OF PINNA	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	0.449291883786488
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.449291883786488
HAIRY EARS, Y-LINKED	0.0294118	0.449291883786488
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.449291883786488
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.0294118	0.449291883786488
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.449291883786488
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.449291883786488
OSSIFIED EAR CARTILAGES	0.0294118	0.449291883786488
EAR WITHOUT HELIX	0.0294118	0.449291883786488
EAR MALFORMATION	0.0294118	0.449291883786488
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.0294118	0.449291883786488
MUSICAL PERFECT PITCH	0.0294118	0.449291883786488
EAR FOLDING	0.0294118	0.449291883786488
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.029407354	0.44922396710966733
GAUCHER DISEASE, PERINATAL LETHAL	0.029300100000000003	0.44758556511782616
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	0.4473023498258208
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.029255003999999998	0.44689668287358275
DE BARSY SYNDROME	0.029160863999999998	0.44545860910932283
ISOLATED HEMIHYPERPLASIA	0.02913756	0.44510261940247864
48,XXYY SYNDROME	0.029099273999999998	0.44451776607617255
PETERS-PLUS SYNDROME; PTRPLS	0.029070814	0.4440830137994481
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.02902313	0.4433545975112076
CEDNIK SYNDROME	0.029002934	0.44304608531933376
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.0289827	0.4427369926430428
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.02893219	0.4419654066452441
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.028864404	0.4409299141002672
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.028819714	0.4402472338737453
KEPPEN-LUBINSKY SYNDROME	0.02868401	0.4381742323642368
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.02853357	0.435876125108073
WAARDENBURG SYNDROME TYPE 2	0.02853076	0.4358331998130064
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0284774	0.43501807748391236
WEAVER SYNDROME	0.028467193999999998	0.434862171590158
OCULOPHARYNGODISTAL MYOPATHY	0.02846413	0.43481536621503913
JEUNE SYNDROME	0.02842969	0.4342892640221231
22Q11.2 DISTAL DELETION SYNDROME	0.02842969	0.4342892640221231
NOONAN SYNDROME 8; NS8	0.02842969	0.4342892640221231
NOONAN SYNDROME 10; NS10	0.02842969	0.4342892640221231
15Q24 RECURRENT MICRODELETION SYNDROME	0.02842969	0.4342892640221231
MENKES DISEASE	0.02842969	0.4342892640221231
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	0.4331101168597774
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.43266488531173075
OMODYSPLASIA 1; OMOD1	0.02831805	0.43258386190780423
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.02827233	0.4318854474983931
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.028224443999999998	0.4311539454771975
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.028111464	0.42942807364921703
DEAFNESS, X-LINKED 2	0.02811017	0.42940830662721835
OSTEOGENESIS IMPERFECTA, TYPE V	0.0279787	0.4273999833025184
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.02790338	0.4262494020838647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.027810340000000003	0.4248281318158943
DWARFISM, LEVI TYPE	0.027777800000000002	0.4243310538438418
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3	0.027777800000000002	0.4243310538438418
LYNCH SYNDROME I	0.027777800000000002	0.4243310538438418
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.4243310538438418
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.4243310538438418
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.4243310538438418
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.4243310538438418
PENTALOGY OF CANTRELL	0.027777800000000002	0.4243310538438418
METHANE PRODUCTION	0.027777800000000002	0.4243310538438418
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.4243310538438418
IMMUNODEFICIENCY 61; IMD61	0.027777800000000002	0.4243310538438418
MEESTER-LOEYS SYNDROME; MRLS	0.027777800000000002	0.4243310538438418
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.4243310538438418
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.4243310538438418
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.4243310538438418
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.4243310538438418
NASAL BONES, ABSENCE OF	0.027777800000000002	0.4243310538438418
CLEFT CHIN	0.027777800000000002	0.4243310538438418
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.4243310538438418
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.4243310538438418
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.4243310538438418
DIMPLES, FACIAL	0.027777800000000002	0.4243310538438418
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.4243310538438418
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.4243310538438418
OROFACIAL CLEFT 3	0.027777800000000002	0.4243310538438418
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.027777800000000002	0.4243310538438418
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	0.4243310538438418
RENPENNING SYNDROME 1; RENS1	0.02770484	0.4232165237626818
DISTAL MONOSOMY 15Q	0.027685904	0.4229272592120123
STICKLER SYNDROME	0.02750425	0.4201523298347777
XQ21 MICRODELETION SYNDROME	0.027478554	0.4197598001614568
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.02741225	0.41874694650875344
WOODHOUSE-SAKATI SYNDROME	0.02732681	0.4174417731242372
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.02732681	0.4174417731242372
COFFIN-LOWRY SYNDROME; CLS	0.027278959999999998	0.4167108210356474
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.027247970000000003	0.41623742071745734
POLYCYSTIC KIDNEY DISEASE 2	0.02724356	0.41617005397324247
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.027239554	0.4161088586949376
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.027158450000000004	0.414869921637613
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.027074614000000004	0.4135892508058678
IMMUNODEFICIENCY 55; IMD55	0.027069229999999996	0.4135070053294838
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	0.41286190383102733
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	0.41286190383102733
CINCA SYNDROME; CINCA	0.02690544	0.4110049647319894
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.02679012	0.4092433472846295
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.026701509999999998	0.40788974927898825
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.02667631	0.40750479645490345
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.02662419	0.4067086162488993
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.026518539999999997	0.4050947168098291
OSTEOGENESIS IMPERFECTA, TYPE I	0.02651745	0.405078066072597
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.02650376	0.4048689389233222
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.026422724	0.4036310406275865
XFE PROGEROID SYNDROME; XFEPS	0.02639535	0.4032128779844714
15Q24 MICRODELETION SYNDROME	0.026384614	0.4030488758606867
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.026376939999999998	0.4029316485602094
2Q31.1 MICRODELETION SYNDROME	0.026342964	0.4024126343875464
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.02630173	0.40178274769118466
ACRORENAL-MANDIBULAR SYNDROME	0.02618089	0.3999368072442634
MONOSOMY 22Q13.3	0.026110004	0.39885395939156176
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02609937	0.3986915154101603
COHEN-GIBSON SYNDROME; COGIS	0.026037034	0.39773927655134456
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.025937784000000002	0.3962231429088675
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.0258646	0.3951051910248267
CONGENITAL MYASTHENIC SYNDROME	0.025815539999999998	0.39435575509031856
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.025815539999999998	0.39435575509031856
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.02580042	0.39412478339586765
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.025750429999999998	0.3933611408690421
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02574928	0.39334357357746685
AGNATHIA-OTOCEPHALY COMPLEX	0.02568767	0.3924024250262022
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.02565189	0.39185585311962456
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.02565189	0.39185585311962456
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.025650890000000003	0.39184057721390697
CHEILITIS GLANDULARIS	0.025641000000000004	0.39168949850635937
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.025641000000000004	0.39168949850635937
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.025641000000000004	0.39168949850635937
SQUAMOUS CELL CARCINOMA, HEAD AND NECK	0.025641000000000004	0.39168949850635937
ESOPHAGEAL CANCER	0.025641000000000004	0.39168949850635937
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.025641000000000004	0.39168949850635937
DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS	0.025641000000000004	0.39168949850635937
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.025641000000000004	0.39168949850635937
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.025629994	0.3915213718880308
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.025615614	0.3913017043638109
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025545554	0.39023147440923217
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.025428154	0.3884380830779796
PRADER-WILLI-LIKE SYNDROME	0.025400694	0.38801860670697286
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.025394913999999998	0.38793031197192474
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02531944	0.38677737826379055
BUSCHKE-OLLENDORFF SYNDROME	0.02515377	0.3842466189635469
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.02503833	0.38248316840750096
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.3818976429413433
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.3818976429413433
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.3818976429413433
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.3818976429413433
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.3818976429413433
HOOFT DISEASE	0.025	0.3818976429413433
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.3818976429413433
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.3818976429413433
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.3818976429413433
CRISS-CROSS HEART	0.02496664	0.3813880387266023
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02492624	0.3807708921356091
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.024893219999999997	0.38026648172881217
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.02484936	0.37959648050403594
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.024833924	0.3793606816233782
COCKAYNE SYNDROME	0.02481757	0.3791108594612717
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	0.3784338313198653
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	0.3782247041705906
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02475956	0.3782247041705906
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	0.3782247041705906
PALLISTER-KILLIAN SYNDROME	0.02466247	0.3767415664844636
FRYNS SYNDROME	0.024639579999999998	0.37639190100258646
DILATED CARDIOMYOPATHY WITH ATAXIA	0.024523339999999998	0.3746162297219664
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.02450113	0.37427695185597737
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.024498494000000003	0.3742366845685057
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	0.37399908313097324
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	0.37399908313097324
BREAST CANCER	0.0243902	0.372582395634718
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.024374134000000002	0.37233697293345824
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.024357654	0.37208522600723126
WEAVER SYNDROME	0.024254504	0.37050951633245527
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.02424475	0.37036051514808527
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.02424396	0.3703484471825683
WOLMAN DISEASE	0.024219064000000002	0.3699681382338217
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.024194270000000004	0.36958938742745817
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02409888	0.3681322187810511
X-LINKED AGAMMAGLOBULINEMIA	0.024030680000000002	0.3670904020111072
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.023924743999999998	0.3654721336630018
GAPO SYNDROME	0.02390844	0.36522307529618114
MUCKLE-WELLS SYNDROME	0.02390769	0.3652116183668929
KLEEFSTRA SYNDROME	0.023894724	0.36501355097335786
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	0.0238095	0.36371167718447656
FAMILIAL MULTIPLE TRICHOEPITHELIOMA	0.0238095	0.36371167718447656
TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	0.0238095	0.36371167718447656
ROMBO SYNDROME	0.0238095	0.36371167718447656
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.023789304	0.3634031649926028
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.02360409	0.3605738533910133
11Q22.2Q22.3 MICRODELETION SYNDROME	0.023529984	0.3594418171219008
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.023511729999999998	0.3591629707389307
HENNEKAM-BEEMER SYNDROME	0.023423239999999998	0.35781120584197557
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023339604	0.3565335901913739
WHITE-SUTTON SYNDROME; WHSUS	0.023276074	0.3555631119011313
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.023272854	0.3555139234847205
LIG4 SYNDROME	0.023272854	0.3555139234847205
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.023272854	0.3555139234847205
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.02325681	0.35526883685338645
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	0.3552534081886116
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	0.3552534081886116
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	0.3552534081886116
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	0.3552534081886116
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	0.3552534081886116
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	0.3552534081886116
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	0.3552534081886116
USHER SYNDROME, TYPE IV; USH4	0.0232558	0.3552534081886116
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	0.3552534081886116
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	0.3552534081886116
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.023245594	0.35509750229485726
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.02324375	0.3550693335247139
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.02316021	0.3537931843610611
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.02316021	0.3537931843610611
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.02315953	0.35378279674517316
CK SYNDROME	0.023152604000000004	0.3536769958221727
TETRASOMY 18P	0.02307696	0.3525214652100665
X-LINKED RETINOSCHISIS	0.02305913	0.3522490958111207
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.022972104	0.35091969484013613
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.022882614	0.34955265403746333
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.022829924	0.3487477665652001
PRIMARY PERITONEAL CARCINOMA	0.02280167	0.34831616112505354
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02278036	0.34799063157421034
FEMORAL-FACIAL SYNDROME	0.02273052	0.34722928043324247
DENYS-DRASH SYNDROME	0.0227273	0.34718009201683164
WILMS TUMOR 3	0.0227273	0.34718009201683164
WILMS TUMOR 4	0.0227273	0.34718009201683164
WILMS TUMOR 6	0.0227273	0.34718009201683164
CHROMOSOME 5Q DELETION SYNDROME	0.0227273	0.34718009201683164
WILMS TUMOR 5	0.0227273	0.34718009201683164
NEPHROTIC SYNDROME, TYPE 4	0.0227273	0.34718009201683164
NEUTROPHILIA, HEREDITARY	0.0227273	0.34718009201683164
MULTIPLE TUMOR-ASSOCIATED CHROMOSOME REGION 1	0.0227273	0.34718009201683164
ALPHA-THALASSEMIA	0.0227273	0.34718009201683164
GRAY PLATELET SYNDROME	0.0227273	0.34718009201683164
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0227273	0.34718009201683164
WILMS TUMOR 1	0.0227273	0.34718009201683164
SIMOSA CRANIOFACIAL SYNDROME	0.02271518	0.34699494803953373
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.022708114	0.34688700848973275
MARDEN-WALKER SYNDROME	0.022675993999999998	0.3463963463980817
20Q11.2 MICRODUPLICATION SYNDROME	0.022616064	0.3454808613684227
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.02261583	0.3454772868064848
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.02261583	0.3454772868064848
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.02261583	0.3454772868064848
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.3445929646244898
NEPHROSIALIDOSIS	0.02255794	0.3445929646244898
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02252193	0.3440428792595971
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.022474044	0.3433113772384015
DYSTONIA 28, CHILDHOOD-ONSET	0.022474044	0.3433113772384015
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.022460524	0.34310484699309884
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.02239099	0.3420426521649275
STICKLER SYNDROME, TYPE III	0.02233706	0.3412188225695744
CRANDALL SYNDROME	0.02233706	0.3412188225695744
19Q13.11 MICRODELETION SYNDROME	0.02221401	0.33933912237101715
CEREBROCOSTOMANDIBULAR SYNDROME	0.02217222	0.3387007422710764
INDOMETHACIN EMBRYOFETOPATHY	0.022101959999999997	0.337627457135354
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.022094184	0.3375086716924936
CAMURATI-ENGELMANN DISEASE	0.02206375	0.3370437647778825
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.02201429	0.33628821848108736
PYCNODYSOSTOSIS	0.02192849	0.33497754577051264
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.02192849	0.33497754577051264
MALIGNANT PERITONEAL MESOTHELIOMA	0.02187503	0.3341608958508469
PERITONEAL CYSTIC MESOTHELIOMA	0.02187503	0.3341608958508469
HEPATOCELLULAR CARCINOMA	0.02187503	0.3341608958508469
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.33335316706012025
PEHO SYNDROME	0.021822154	0.33335316706012025
AICARDI-GOUTIERES SYNDROME 7	0.021822154	0.33335316706012025
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	0.33335316706012025
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.021822154	0.33335316706012025
JOUBERT SYNDROME 30; JBTS30	0.021822154	0.33335316706012025
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.021822154	0.33335316706012025
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.021822154	0.33335316706012025
GM1 GANGLIOSIDOSIS	0.02175022	0.33225431005822653
NON-DISTAL TRISOMY 13Q	0.0217391	0.3320844419866462
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.3320844419866462
KLIPPEL-TRÉNAUNAY SYNDROME	0.0217391	0.3320844419866462
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.0217391	0.3320844419866462
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.3320844419866462
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.0217391	0.3320844419866462
LUMBAR SYNDROME	0.0217391	0.3320844419866462
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.02169183	0.3313623499233727
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.021676044	0.3311212044757138
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.02162906	0.33040348132147557
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.021621814	0.3302927921086455
HISTIOCYTOID CARDIOMYOPATHY	0.021541369999999997	0.3290639371490945
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.021501463999999998	0.32845433685552583
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.021485189999999998	0.3282057367658767
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.021454654	0.3277392717088825
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021378854	0.3265813580554843
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.3265813580554843
MECKEL SYNDROME 13; MKS13	0.021378854	0.3265813580554843
CHARGE SYNDROME	0.021359484	0.32628546376173345
SHUKLA-VERNON SYNDROME; SHUVER	0.021299354	0.32536692355093083
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.021292274	0.32525877013844984
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.02128225	0.3251056444595361
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.32501933559223134
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.32501933559223134
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0212766	0.32501933559223134
HUNTINGTON DISEASE; HD	0.0212766	0.32501933559223134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.32501933559223134
FIBROSCLEROSIS, MULTIFOCAL	0.0212766	0.32501933559223134
KURU, SUSCEPTIBILITY TO	0.0212766	0.32501933559223134
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.0212766	0.32501933559223134
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0212766	0.32501933559223134
PRIMARY BASILAR INVAGINATION	0.0212766	0.32501933559223134
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.32501933559223134
ISOLATED CEREBELLAR AGENESIS	0.0212766	0.32501933559223134
CENTRIFUGAL LIPODYSTROPHY	0.0212766	0.32501933559223134
JUVENILE ABSENCE EPILEPSY	0.0212766	0.32501933559223134
SERTOLI CELL-ONLY SYNDROME	0.0212766	0.32501933559223134
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0212766	0.32501933559223134
JUVENILE MYOCLONIC EPILEPSY	0.0212766	0.32501933559223134
ACROPECTORAL SYNDROME	0.0212766	0.32501933559223134
BREAST, UNILATERAL GIANT	0.0212766	0.32501933559223134
HERNIA, HIATUS	0.0212766	0.32501933559223134
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.0212766	0.32501933559223134
RAVINE SYNDROME	0.0212766	0.32501933559223134
NEUROFERRITINOPATHY	0.0212766	0.32501933559223134
PYLE DISEASE; PYL	0.0212766	0.32501933559223134
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.32501933559223134
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.32501933559223134
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021215234	0.3240819143619618
CLASSIC HODGKIN LYMPHOMA	0.02108133	0.32203640948274515
FOLLICULAR LYMPHOMA	0.02108133	0.32203640948274515
HODGKIN LYMPHOMA	0.02108133	0.32203640948274515
FELTY SYNDROME	0.02108133	0.32203640948274515
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.319746703974726
11P15.4 MICRODUPLICATION SYNDROME	0.020902294	0.3193014724266792
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.020902294	0.3193014724266792
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020897924	0.3192347167186931
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	0.31912955738373283
SHORT SYNDROME	0.0208909	0.31912741875693235
LATERAL MENINGOCELE SYNDROME	0.020860044	0.31865606541010844
AL KAISSI SYNDROME; ALKAS	0.020848854	0.31848512802512785
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.3182475265875955
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.3182475265875955
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.3182475265875955
POLYCYSTIC KIDNEY DISEASE 5; PKD5	0.0208333	0.3182475265875955
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.3182475265875955
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.3182475265875955
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.3182475265875955
UNIQUE GREEN PHENOMENON	0.0208333	0.3182475265875955
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.3182475265875955
POLYCYSTIC KIDNEY DISEASE 3	0.0208333	0.3182475265875955
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.3182475265875955
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.3182475265875955
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.3182475265875955
PUPIL, EGG-SHAPED	0.0208333	0.3182475265875955
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.3182475265875955
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.3182475265875955
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0208333	0.3182475265875955
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.3182475265875955
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0208333	0.3182475265875955
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0208333	0.3182475265875955
IMINOGLYCINURIA	0.0208333	0.3182475265875955
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	0.3182475265875955
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.3182475265875955
MECKEL SYNDROME, TYPE 1; MKS1	0.0208333	0.3182475265875955
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.3182475265875955
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.3182475265875955
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.3182475265875955
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.3182475265875955
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0208333	0.3182475265875955
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.3182475265875955
DERMOIDS OF CORNEA	0.0208333	0.3182475265875955
611426 TENTED EYEBROWS	0.0208333	0.3182475265875955
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.3182475265875955
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.3182475265875955
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.3182475265875955
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.3182475265875955
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.3182475265875955
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.3182475265875955
POLYCYSTIC KIDNEYS	0.0208333	0.3182475265875955
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.020829264	0.31818587303211904
SHORT RIB-POLYDACTYLY SYNDROME	0.020740849999999998	0.31683526910399834
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.315748082894073
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.315748082894073
SHPRINTZEN OMPHALOCELE SYNDROME	0.02046719	0.3126548647453053
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.3114046846213725
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.02038241	0.3113597734585626
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02037166	0.31119555747209776
INTESTINAL LYMPHANGIECTASIA	0.02031634	0.31035049436779716
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0203033	0.310151296557239
DESBUQUOIS DYSPLASIA 2; DBQD2	0.020283124	0.30984308988347964
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.0202581	0.30946082561880106
JOUBERT SYNDROME 2	0.020256134000000002	0.30943079318816014
CINCA SYNDROME	0.020237284	0.3091428423653824
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.02020027	0.3085774199911491
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020110374	0.307204177170755
WIEDEMANN-STEINER SYNDROME	0.02003146	0.30599869434695204
SYSTEMIC SCLEROSIS	0.02002387	0.305882750222555
2P15P16.1 MICRODELETION SYNDROME	0.019974294	0.30512543192069663
GENITOPATELLAR SYNDROME	0.019947064	0.30470946900800494
RICHIERI COSTA-DA SILVA SYNDROME	0.019938539999999998	0.3045792571876676
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.01991379	0.3042011785211557
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01989805	0.3039607357651598
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.019893474	0.3038908332205959
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01988045	0.30369187982452917
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.01982544	0.302851552251001
CRANIOFRONTONASAL SYNDROME; CFNS	0.019802804	0.3025057668491762
MENTAL RETARDATION, X-LINKED 98; MRX98	0.019712024	0.3011190201281276
MULTIPLE CARBOXYLASE DEFICIENCY	0.019695614	0.30086834251530087
GORLIN SYNDROME	0.01969456	0.3008522417106745
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.019669034	0.3004623089413256
LOWRY-MACLEAN SYNDROME	0.01960251	0.29944609458936444
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.019588314	0.2992292378317966
LATERAL MENINGOCELE SYNDROME	0.01958472	0.29917433622664735
ALPHA-HEAVY CHAIN DISEASE	0.019522639999999997	0.2982260079996954
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.01951446	0.29810105109092505
HAREL-YOON SYNDROME; HAYOS	0.019509744000000002	0.2980290099195606
CORNELIA DE LANGE SYNDROME 1	0.019491349999999998	0.29774802490979
ACRO-RENAL-MANDIBULAR SYNDROME	0.01942084	0.2966709207976383
CLASSIC GALACTOSEMIA	0.01941514	0.2965838481350477
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.2965580929580077
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.2965580929580077
BAND HETEROTOPIA; BH	0.019413454	0.2965580929580077
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01940872	0.29648577682034033
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.019381594	0.2960714026018432
TETRASOMY 12P	0.01931969	0.29512576293429765
GENITOPATELLAR SYNDROME; GTPTS	0.019295174	0.2947512588297236
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.01923023	0.29375918040879634
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.01916334	0.2927373750753425
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.019132654	0.2922686186324905
YUNIS-VARON SYNDROME	0.01911075	0.29193401519365103
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.01907171	0.29133764383443383
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.019029964	0.2906999358743447
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.019029964	0.2906999358743447
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.018890544000000002	0.2885701690991894
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.2882242614901188
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.2882242614901188
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.2882242614901188
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.2882242614901188
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.2882242614901188
KNUCKLE PADS	0.0188679	0.2882242614901188
RAYNAUD DISEASE	0.0188679	0.2882242614901188
SPINAL ARACHNOIDITIS	0.0188679	0.2882242614901188
VESICOURETERAL REFLUX 1	0.0188679	0.2882242614901188
CARPAL DISPLACEMENT	0.0188679	0.2882242614901188
TRACHEOBRONCHOMEGALY	0.0188679	0.2882242614901188
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.2882242614901188
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.2882242614901188
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.2882242614901188
THROMBOCYTOPENIA 3	0.0188679	0.2882242614901188
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.2882242614901188
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.2882242614901188
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.2882242614901188
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.2882242614901188
PUBIC BONE DYSPLASIA	0.0188679	0.2882242614901188
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.2882242614901188
VAN DEN BOSCH SYNDROME	0.0188679	0.2882242614901188
LETTERER-SIWE DISEASE	0.0188679	0.2882242614901188
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.2882242614901188
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.2882242614901188
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.2882242614901188
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.2882242614901188
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.2882242614901188
TOE, MISSHAPEN	0.0188679	0.2882242614901188
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.2882242614901188
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.2882242614901188
MONOPHALANGY OF GREAT TOE	0.0188679	0.2882242614901188
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.2882242614901188
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.2882242614901188
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.2882242614901188
HHHH SYNDROME	0.0188679	0.2882242614901188
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.2882242614901188
MEVALONIC ACIDURIA; MEVA	0.018837134	0.2877542829748095
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.018822349999999998	0.2875284439846797
XP21 MICRODELETION SYNDROME	0.018804743999999998	0.28725949638861464
CODAS SYNDROME	0.018772064	0.2867602797897618
MCDONOUGH SYNDROME	0.018753480000000003	0.28647639235790495
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.018716014	0.28590406527428724
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01864341	0.2847949734155627
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.018627084000000002	0.2845455789788163
COFFIN-SIRIS SYNDROME 6; CSS6	0.018623014	0.28448340604254546
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01860536	0.28421372520300603
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.01860536	0.28421372520300603
MOMO SYNDROME	0.01856392	0.2835806916700665
ATAXIA-TELANGIECTASIA	0.01856392	0.2835806916700665
FRASER SYNDROME	0.01855297	0.28341342050245816
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.01851617	0.2828512671720485
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.018457584	0.28195631295967405
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.018456904	0.281945925343786
LYSOSOMAL ACID LIPASE DEFICIENCY	0.018450514	0.28184831230625024
NEU-LAXOVA SYNDROME	0.01844923	0.2818286980433088
GALACTOSEMIA	0.018402004	0.28110727811988684
ALAGILLE SYNDROME	0.0184001	0.2810781927954004
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.018396410000000002	0.28102182470330234
ALLAN-HERNDON-DUDLEY SYNDROME	0.018396410000000002	0.28102182470330234
MENTAL RETARDATION, X-LINKED 102	0.01836539	0.28054796610794064
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.018186980000000002	0.27782259176885404
MEHMO SYNDROME	0.0180993	0.27648320035553015
CURRY-JONES SYNDROME	0.018066914	0.27598847487295824
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.018045384	0.27565958462285717
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.018045384	0.27565958462285717
EEC SYNDROME	0.01802865	0.27540395761657793
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018017364	0.2752315537446485
LARSEN-LIKE SYNDROME	0.017978354	0.2746356406626028
JOUBERT SYNDROME 35; JBTS35	0.017934193999999997	0.2739610566661112
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.01791203	0.27362248149178514
AASE-SMITH SYNDROME	0.01791203	0.27362248149178514
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01791135	0.27361209387589713
MICROSPORIDIOSIS	0.01790496	0.2735144808383614
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.01790496	0.2735144808383614
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01789329	0.2733362110186363
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.01787422	0.27304489949660066
HOYERAAL-HREIDARSSON SYNDROME	0.017864144	0.27289097947058955
16P13.2 MICRODELETION SYNDROME	0.017846874	0.27262716457884567
HEC SYNDROME	0.01783732	0.27248121857561924
SHORT STATURE DUE TO GHSR DEFICIENCY	0.01782585	0.2723060039370378
ALAGILLE SYNDROME 2	0.01772951	0.270834323180199
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.017718354	0.27066390517601285
RHYNS SYNDROME; RHYNS	0.01770136	0.270404306434247
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.01765958	0.2697660790933635
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.017655324	0.26970106483862916
RIFT VALLEY FEVER	0.01763261	0.2693540879161584
MARBURG HEMORRHAGIC FEVER	0.01763261	0.2693540879161584
CENTRAL DIABETES INSIPIDUS	0.01763261	0.2693540879161584
TRIOPIA	0.01752136	0.26765464340506934
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.01750815	0.26745284869053915
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01750815	0.26745284869053915
RETT SYNDROME; RTT	0.01750815	0.26745284869053915
CROME SYNDROME	0.01749326	0.26722539045440336
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.017411784	0.26598077076015175
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.017393494	0.26570137444457587
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.017348239999999997	0.26501007860722914
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.017328534	0.2647090516091571
GALACTOSE EPIMERASE DEFICIENCY	0.017321024	0.2645943295572175
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.01731859	0.2645571480027007
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.01731859	0.2645571480027007
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.017310394	0.2644319466794388
SOTOS SYNDROME 2	0.01725946	0.2636538836976159
FRAGILE X SYNDROME	0.01725946	0.2636538836976159
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.017249654000000003	0.2635040881661486
16Q24.3 MICRODELETION SYNDROME	0.017248780000000002	0.2634907370245514
ALCOHOL DEPENDENCE	0.0172414	0.26337800084035506
MYOPATHY, CONGENITAL	0.0172414	0.26337800084035506
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.26337800084035506
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.26337800084035506
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.26337800084035506
JUMPING FRENCHMAN OF MAINE	0.0172414	0.26337800084035506
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.26337800084035506
DIASTEMATOMYELIA	0.0172414	0.26337800084035506
MOTION SICKNESS	0.0172414	0.26337800084035506
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.26337800084035506
PALMOMENTAL REFLEX	0.0172414	0.26337800084035506
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.26337800084035506
SICKLE CELL ANEMIA	0.0172414	0.26337800084035506
CARDIAC ARRHYTHMIA	0.0172414	0.26337800084035506
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.26337800084035506
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.26337800084035506
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.26337800084035506
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.26337800084035506
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.26337800084035506
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.26337800084035506
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.26337800084035506
RHEUMATOID ARTHRITIS	0.0172414	0.26337800084035506
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.26337800084035506
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.26337800084035506
269800 SENILE PLAQUE FORMATION	0.0172414	0.26337800084035506
TRANSSEXUALITY	0.0172414	0.26337800084035506
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.26337800084035506
CERVICAL RIB	0.0172414	0.26337800084035506
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.26337800084035506
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.26337800084035506
ERYTHERMALGIA, PRIMARY	0.0172414	0.26337800084035506
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.26337800084035506
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.26337800084035506
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.26337800084035506
MOSAIC TRISOMY 15	0.0172414	0.26337800084035506
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.26337800084035506
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.26337800084035506
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.26337800084035506
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.26337800084035506
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.26337800084035506
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.017237024	0.2633111534769346
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.017225464	0.2631345640068385
LELIS SYNDROME	0.01722023	0.2630546099163123
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.2629327692923083
SECKEL SYNDROME 9; SCKL9	0.017211574	0.2629223816764203
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.017137430000000002	0.2617897649228906
MEIER-GORLIN SYNDROME 7	0.017118124	0.26149484828710556
SPONDYLOOCULAR SYNDROME; SOS	0.01709608	0.2611581062214656
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.01704947	0.26044609625596576
CHROMOSOME 10Q26 DELETION SYNDROME	0.016850304	0.25740365521780356
WARBURG MICRO SYNDROME 2; WARBM2	0.01684137	0.257267180276122
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01682755	0.25705606725910407
POLYVALVULAR HEART DISEASE SYNDROME	0.01678812	0.25645373829665696
CYCLIC VOMITING SYNDROME	0.016717790000000003	0.25537938384753445
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.016716924	0.25536615491318293
22Q11.2 MICRODUPLICATION SYNDROME	0.016701644	0.2551327390738171
JOUBERT SYNDROME 14	0.016676523999999998	0.2547490083221896
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.01666817	0.2546213934058244
ACQUIRED PURPURA FULMINANS	0.0166667	0.25459893782441945
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.25459893782441945
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.25459893782441945
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.25459893782441945
TRIGEMINAL NEURALGIA	0.0166667	0.25459893782441945
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0166667	0.25459893782441945
ADAMANTINOMA OF LONG BONES	0.0166667	0.25459893782441945
CHYLOUS ASCITES	0.0166667	0.25459893782441945
ICHTHYOSIS, X-LINKED	0.0166667	0.25459893782441945
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.25459893782441945
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.25459893782441945
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.25459893782441945
DERMATOLEUKODYSTROPHY	0.0166667	0.25459893782441945
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	0.25459893782441945
HURIEZ SYNDROME; HRZ	0.0166667	0.25459893782441945
ANTISYNTHETASE SYNDROME	0.0166667	0.25459893782441945
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0166667	0.25459893782441945
ONCOCYTOMA	0.0166667	0.25459893782441945
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0166667	0.25459893782441945
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.25459893782441945
PITYRIASIS RUBRA PILARIS	0.0166667	0.25459893782441945
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.25459893782441945
NASOPHARYNGEAL CARCINOMA	0.0166667	0.25459893782441945
GENITOPALATOCARDIAC SYNDROME	0.016665959999999997	0.2545876336541883
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.016619474	0.2538775179009975
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.016590104	0.2534288645500701
MENTAL RETARDATION, X-LINKED 107; MRX107	0.016559684	0.25296417149813905
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.016559684	0.25296417149813905
RENAL COLOBOMA SYNDROME	0.016461379999999998	0.25146248886247075
CHÉDIAK-HIGASHI SYNDROME	0.016418554	0.25080828292420654
17Q12 MICRODELETION SYNDROME	0.016413494	0.25073098684127526
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.016413494	0.25073098684127526
MCDONOUGH SYNDROME	0.01639933	0.25051461891269033
SALLA DISEASE	0.016390294	0.25037658582862565
CRANIOFACIOFRONTODIGITAL SYNDROME	0.016380560000000002	0.25022789016237
WIEACKER-WOLFF SYNDROME	0.016359904	0.24991235105386614
SCHAAF-YANG SYNDROME; SHFYNG	0.016172954000000003	0.2470565204799508
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.016123484	0.24630082142409843
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.01609037	0.24579497508216405
FAMILIAL HYPOALDOSTERONISM	0.01607392	0.24554368643310864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.016063973999999998	0.24539175227484086
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.01604455	0.24509503308218117
MOYNAHAN SYNDROME	0.01604455	0.24509503308218117
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.01601413	0.24463034003025017
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.01601413	0.24463034003025017
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.01601413	0.24463034003025017
ADULT-ONSET NEMALINE MYOPATHY	0.01601413	0.24463034003025017
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.01601413	0.24463034003025017
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01601413	0.24463034003025017
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.01601413	0.24463034003025017
NEMALINE MYOPATHY 1; NEM1	0.01601413	0.24463034003025017
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.016002374	0.2444507564826334
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.015951904000000003	0.24367978152106348
SIALIDOSIS TYPE 1	0.01590359	0.24294174141222066
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01589	0.24273414185351783
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01588199	0.24261178184871937
HEREDITARY METHEMOGLOBINEMIA	0.01588199	0.24261178184871937
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01588199	0.24261178184871937
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.015872999999999998	0.24247445145631763
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631763
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.015872999999999998	0.24247445145631763
SCHNITZLER SYNDROME	0.015872999999999998	0.24247445145631763
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.015872999999999998	0.24247445145631763
OMENN SYNDROME	0.015872999999999998	0.24247445145631763
FOLLICULAR LYMPHOMA	0.015872999999999998	0.24247445145631763
THYROID LYMPHOMA	0.015872999999999998	0.24247445145631763
AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631763
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.015872999999999998	0.24247445145631763
LYMPHOMA, NON-HODGKIN, FAMILIAL	0.015872999999999998	0.24247445145631763
BARDET-BIEDL SYNDROME	0.015867939999999997	0.2423971553733863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.015859104	0.24226217747046513
MULTIPLE EPIPHYSEAL DYSPLASIA	0.015776850000000002	0.2410056731215653
KOOLEN-DE VRIES SYNDROME	0.015751364	0.24061635138844517
HEREDITARY FRUCTOSE INTOLERANCE	0.01573754	0.2404051772678043
CRANIOFACIAL DYSSYNOSTOSIS	0.015714890000000002	0.24005917800329948
CORNELIA DE LANGE SYNDROME 3	0.015704104	0.23989441208422882
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01561998	0.23860934179163693
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.015566159999999999	0.2377871925459128
16P11.2P12.2 MICRODELETION SYNDROME	0.015564304000000001	0.23775884046490087
TEMTAMY SYNDROME	0.015514514	0.23699825311921885
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.015489483999999998	0.23661589719910595
MECKEL SYNDROME	0.01548113	0.23648828228274069
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.01548113	0.23648828228274069
WARBURG MICRO SYNDROME 1	0.01543344	0.2357597743390658
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015406350000000001	0.23534595005317457
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.015395614000000002	0.23518194792938987
NOONAN SYNDROME	0.01535897	0.2346221776402721
OROFACIODIGITAL SYNDROME XVII	0.01532724	0.23413747315185096
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015326644	0.23412836871204326
WOLCOTT-RALLISON SYNDROME	0.015321089999999999	0.2340435263316874
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.01531355	0.23392834600257628
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.015219374	0.23248972230571055
BOR SYNDROME	0.015216049999999998	0.23243894519510505
VICI SYNDROME; VICIS	0.015132914	0.2311689674973622
MONOSOMY 5P	0.01510155	0.23068985399043368
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.015086344000000002	0.2304575685680911
PEDIATRIC-ONSET GRAVES DISEASE	0.015083884	0.23041998984002562
TRANSKETOLASE DEFICIENCY	0.015081534	0.23038409146158914
CHOPS SYNDROME; CHOPS	0.015073244	0.2302574542031898
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.015065284	0.23013585799367725
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.015063	0.23010096782501815
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.015019614	0.22943820737955203
KNIEST-LIKE DYSPLASIA, LETHAL	0.01498231	0.2288683549926607
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.01492604	0.22800877977792827
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.01492604	0.22800877977792827
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.014898439999999999	0.22758716478012103
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014896304	0.22755453544550816
MCKUSICK-KAUFMAN SYNDROME	0.014896043999999999	0.22755056371002153
MARINESCO-SJOGREN SYNDROME; MSS	0.014844094	0.22675698040798944
OCULOFACIOCARDIODENTAL SYNDROME	0.014820844	0.22640181560005398
WARBURG MICRO SYNDROME 3; WARBM3	0.014781550000000001	0.22580156416078453
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.01476957	0.22561855881028703
FRYNS SYNDROME; FRNS	0.01476957	0.22561855881028703
TYROSINE TRANSAMINASE DEFICIENCY	0.014760740000000001	0.22548367256280014
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.014760740000000001	0.22548367256280014
PYCNODYSOSTOSIS	0.014730350000000001	0.22501943778804068
SIALIDOSIS TYPE 2	0.014680304	0.22425493981049496
MARSHALL-SMITH SYNDROME; MRSHSS	0.01467535	0.22417926297356972
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.014668750000000001	0.2240784419958332
SAETHRE-CHOTZEN SYNDROME	0.01466561	0.22403047565187975
MULIBREY NANISM	0.014540790000000001	0.22212373710020222
FRYNS-SMEETS-THIRY SYNDROME	0.014540790000000001	0.22212373710020222
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.014540790000000001	0.22212373710020222
JOUBERT SYNDROME 21	0.014530643999999999	0.22196874776079087
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.014523184000000001	0.22185478950413723
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01444966	0.22073164381215243
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.014434454000000001	0.2204993583898098
FEINGOLD SYNDROME 1; FGLDS1	0.014421220000000002	0.2202971970535424
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.014355344	0.2192908814884862
FORSYTHE-WAKELING SYNDROME; FWS	0.014355344	0.2192908814884862
N-ACETYLASPARTATE DEFICIENCY; NACED	0.014355344	0.2192908814884862
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.014355344	0.2192908814884862
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.014355344	0.2192908814884862
JUBERG-MARSIDI SYNDROME	0.01435075	0.2192207039776193
PAGOD SYNDROME	0.014350489999999999	0.21921673224213267
SENGERS SYNDROME	0.01432893	0.21888738371486008
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014318974	0.2187352967975351
KAGAMI-OGATA SYNDROME	0.014296504000000002	0.21839204719605945
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.01428898	0.2182771112814398
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.014244414	0.21759632526722686
TRISOMY X	0.014244153999999998	0.21759235353174025
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.014227624000000001	0.21733984281022745
HALL-RIGGS SYNDROME	0.01419427	0.2168303302509208
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.014171194	0.21647782345058023
MUCOPOLYSACCHARIDOSIS TYPE 4	0.01413475	0.21592110834260606
CONO-SPONDYLAR DYSPLASIA	0.01406481	0.21485271149671337
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.013998779999999999	0.2138440434421767
HYPERTRICHOSIS CUBITI	0.013998064000000001	0.21383310589368287
ANGELMAN SYNDROME	0.013985984	0.2136485729526136
TYPICAL NEMALINE MYOPATHY	0.013956360000000001	0.21319603952163385
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.013950893999999998	0.21311254142098113
LASSA FEVER	0.01394173	0.21297255302098456
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0139381	0.21291710148322948
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.013909620000000001	0.2124820436883907
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.2121655269219209
BETHLEM MYOPATHY	0.013888900000000001	0.2121655269219209
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.2121655269219209
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.2121655269219209
MAJEED SYNDROME	0.013888900000000001	0.2121655269219209
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.2121655269219209
RING CHROMOSOME 10 SYNDROME	0.013888900000000001	0.2121655269219209
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.013888900000000001	0.2121655269219209
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.013888900000000001	0.2121655269219209
INFANTILE NEUROAXONAL DYSTROPHY	0.013888900000000001	0.2121655269219209
WHIPPLE DISEASE	0.013888900000000001	0.2121655269219209
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.2121655269219209
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.013888900000000001	0.2121655269219209
2Q32Q33 MICRODELETION SYNDROME	0.013878164000000002	0.2120015247981362
PITT-HOPKINS-LIKE SYNDROME	0.01386023	0.21172756670499573
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.01381767	0.21107742415765246
OVARIAN DYSGENESIS 4; ODG4	0.01380979	0.21095705002059734
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01380979	0.21095705002059734
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.01380979	0.21095705002059734
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.01380979	0.21095705002059734
SECKEL SYNDROME 4	0.01380979	0.21095705002059734
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01380979	0.21095705002059734
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.01380979	0.21095705002059734
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.01380979	0.21095705002059734
CHOREOACANTHOCYTOSIS	0.01377772	0.21046715172423217
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.013761404000000001	0.21021791004654294
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	0.2100582157281706
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013748874000000001	0.21002650294790073
ALAZAMI SYNDROME; ALAZS	0.013703454	0.20933267131020492
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.013703454	0.20933267131020492
MULTINODULAR GOITER-CYSTIC KIDNEY-POLYDACTYLY SYNDROME	0.013698599999999998	0.20925852206385137
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.013698599999999998	0.20925852206385137
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.013698599999999998	0.20925852206385137
PRUNE BELLY SYNDROME	0.013698599999999998	0.20925852206385137
INFUNDIBULOPELVIC DYSGENESIS	0.013698599999999998	0.20925852206385137
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.013698599999999998	0.20925852206385137
TRISOMY 1Q	0.013698599999999998	0.20925852206385137
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.013698599999999998	0.20925852206385137
RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	0.013698599999999998	0.20925852206385137
THOMAS SYNDROME	0.013698599999999998	0.20925852206385137
RADIO-RENAL SYNDROME	0.013698599999999998	0.20925852206385137
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.013696719999999999	0.20922980336110217
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013690069999999999	0.2091282185880798
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.013687979999999999	0.2090962919451299
LAMB-SHAFFER SYNDROME	0.013665624000000001	0.2087547837969061
PFEIFFER SYNDROME	0.0136411	0.20838015748508631
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.0136212	0.208076166961305
THORACOMELIC DYSPLASIA	0.0136212	0.208076166961305
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.0136212	0.208076166961305
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.013616864000000001	0.20800993063411327
ISOLATED COMPLEX I DEFICIENCY	0.013600014	0.2077525316227708
ABRUZZO-ERICKSON SYNDROME	0.01358897	0.20758382452002502
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.013498180000000002	0.20619692503991927
MARFANOID HABITUS WITH SITUS INVERSUS	0.013456969999999999	0.20556740496529471
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.01345251	0.20549927442579402
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01344043	0.20531474148472473
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.20531474148472473
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.01342028	0.20500693198451403
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.013408634000000001	0.20482902878652623
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.013392544000000001	0.2045832394635292
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.01333261	0.20366769333024728
BARDET-BIEDL SYNDROME 16; BBS16	0.013299004	0.20315433124269985
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.013290844000000001	0.20302967985204382
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.013285314	0.20294520409342515
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.013279494	0.2028562983221484
FLOATING-HARBOR SYNDROME	0.0132451	0.20233089882089542
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.013224204	0.20201169349501935
SHORT SYNDROME	0.0132056	0.2017275005450481
PARANA HARD SKIN SYNDROME	0.01315862	0.20100983849443274
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.20099883984231603
WEAVER-WILLIAMS SYNDROME	0.0131579	0.20099883984231603
FG SYNDROME 2; FGS2	0.0131579	0.20099883984231603
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0131579	0.20099883984231603
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.20099883984231603
ALG13-CDG	0.0131579	0.20099883984231603
GRANGE SYNDROME; GRNG	0.0131579	0.20099883984231603
FILIPPI SYNDROME; FLPIS	0.0131579	0.20099883984231603
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.20099883984231603
4Q21 MICRODELETION SYNDROME	0.01313755	0.2006879751609618
MALIGNANT ATROPHIC PAPULOSIS	0.013125830000000002	0.20050894154595092
BEHÇET DISEASE	0.013125830000000002	0.20050894154595092
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0130836	0.19986384004749436
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01301853	0.1988698368624466
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.012989210000000001	0.198421947306805
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.012981409999999999	0.1983027952422073
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.012969834	0.19812596135761976
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.012958314000000002	0.1979499829237524
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.012955294	0.19790384968848507
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01293708	0.19762561434174372
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01290377	0.19711677392228866
SCALP-EAR-NIPPLE SYNDROME	0.01289363	0.19696187623831166
CRYPTOSPORIDIOSIS	0.01287403	0.1966624684862457
SECONDARY SHORT BOWEL SYNDROME	0.01287403	0.1966624684862457
ADENYLOSUCCINASE DEFICIENCY	0.012847934	0.19626382845063778
GRANULOMATOSIS WITH POLYANGIITIS	0.01284706	0.19625047730904055
1Q41Q42 MICRODELETION SYNDROME	0.0128382	0.1961151327843821
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.0128382	0.1961151327843821
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0128326	0.19602958771236328
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.01281651	0.19578379838936624
BRANCHIOOTIC SYNDROME	0.012768390000000001	0.19504872180623273
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.012740654	0.19462502928524789
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.012740654	0.19462502928524789
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012740654	0.19462502928524789
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.012740654	0.19462502928524789
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.19462502928524789
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.012740654	0.19462502928524789
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.19462502928524789
ELEJALDE DISEASE	0.012740654	0.19462502928524789
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.012716083999999999	0.1942497002817651
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.012710174000000001	0.19415941967897382
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01269532	0.19393251137544376
EMANUEL SYNDROME	0.012685954	0.19378943724249223
CHROMOSOME 5Q12 DELETION SYNDROME	0.012669774000000002	0.1935422730879806
PRADER-WILLI SYNDROME; PWS	0.012639384	0.1930780383132211
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	0.19291253915067602
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.01261486	0.19270341200140134
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.01261486	0.19270341200140134
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.01260988	0.19262733799092743
NEONATAL ADRENOLEUKODYSTROPHY	0.01259092	0.19233770681852072
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01252663	0.19135561883993277
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.012510964	0.19111630650095998
OTOFACIOCERVICAL SYNDROME	0.012462074	0.1903694674704239
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.012452384	0.19022144394401982
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.012433444	0.18993211828972748
EBOLA HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
LUJO HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
SCRUB TYPHUS	0.01242428	0.1897921298897309
CENTRAL NEUROCYTOMA	0.01242428	0.1897921298897309
DENGUE FEVER	0.01242428	0.1897921298897309
YELLOW FEVER	0.01242428	0.1897921298897309
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01241942	0.1897178889879431
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01241942	0.1897178889879431
ACROOTOOCULAR SYNDROME	0.012357610000000002	0.18877368525553495
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.012354684	0.18872898795540505
CODAS SYNDROME	0.012308013999999999	0.18801606143556215
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.012298799999999999	0.1878753092402797
COFFIN-SIRIS SYNDROME	0.012243684000000001	0.18703336242074553
SUMMITT SYNDROME	0.01223433	0.18689047159866257
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01219674	0.18631625030273596
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.186291197817359
FACIOCARDIOMELIC SYNDROME	0.0121951	0.186291197817359
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.186291197817359
CATARACT 48; CTRCT48	0.0121951	0.186291197817359
ACHROMATOPSIA	0.0121951	0.186291197817359
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.186291197817359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.186291197817359
TONNE-KALSCHEUER SYNDROME; TOKAS	0.012186444000000001	0.18615896957746703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012182454	0.18609801871365358
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.012170529999999999	0.18591586881387623
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.012153014	0.18564829604932584
CLASSIC PHENYLKETONURIA	0.012112694	0.18503237153079005
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012109734	0.18498715484986578
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.012096254	0.18478123564079182
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.012096254	0.18478123564079182
LARSEN SYNDROME	0.01208521	0.18461252853804608
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0120574	0.18418770560003808
BIOTINIDASE DEFICIENCY	0.012001954	0.18334071773161706
FONTAINE PROGEROID SYNDROME; FPS	0.01199977	0.18330735515352972
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01195799	0.18266912781264613
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01193903	0.18237949664023942
DISTAL MONOSOMY 19P13.3	0.011928814	0.18222343798742785
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0119243	0.1821544825490184
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0119173	0.18204755120899482
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.01188789	0.18159828682183862
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.01188789	0.18159828682183862
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.01188789	0.18159828682183862
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.01188789	0.18159828682183862
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011859994	0.18117215015593896
OCULOECTODERMAL SYNDROME; OES	0.011850784	0.18103145906427934
3Q27.3 MICRODELETION SYNDROME	0.0118411	0.1808835271933096
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.011822820000000001	0.1806042836367909
ZTTK SYNDROME; ZTTKS	0.011820394	0.18056722428951985
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.011817964	0.18053010383862597
BARDET-BIEDL SYNDROME 17; BBS17	0.011781554	0.17997390811144617
JOUBERT SYNDROME 7	0.011781554	0.17997390811144617
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.011781554	0.17997390811144617
JOUBERT SYNDROME 1	0.011781554	0.17997390811144617
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.011781554	0.17997390811144617
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.011762990000000001	0.17969032619770367
MUCOPOLYSACCHARIDOSIS TYPE IX	0.011762990000000001	0.17969032619770367
MARSHALL SYNDROME	0.011762459999999999	0.17968222996767327
CAMPOMELIC DYSPLASIA	0.011715650000000001	0.17896716482102995
SHELDON-HALL SYNDROME	0.011640890000000001	0.17782513810957815
BANGSTAD SYNDROME	0.011640890000000001	0.17782513810957815
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01160408	0.1772628320201113
TEMPLE-BARAITSER SYNDROME	0.01159287	0.1770915891170164
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.01158961	0.17704178966437686
8Q21.11 MICRODELETION SYNDROME	0.01158756	0.17701047405765566
SHPRINTZEN-GOLDBERG SYNDROME	0.01156418	0.17665332338197692
13Q12.3 MICRODELETION SYNDROME	0.01153299	0.1761768678826433
PROPIONIC ACIDEMIA	0.011502814	0.17571590215170738
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.011480404	0.17537356910457474
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.011463959999999999	0.17512237211095366
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.011441940000000001	0.17478599666705094
ADAMS-OLIVER SYNDROME	0.011431219999999999	0.17462223895775766
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.011357624	0.17349799340056124
COFS SYNDROME	0.01134559	0.17331416315115497
PFAPA SYNDROME	0.0113433	0.17327918132706158
STEVENS-JOHNSON SYNDROME	0.0113433	0.17327918132706158
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0113433	0.17327918132706158
ACUTE ADRENAL INSUFFICIENCY	0.0113433	0.17327918132706158
NODULAR NON-SUPPURATIVE PANNICULITIS	0.0113433	0.17327918132706158
TOXIC EPIDERMAL NECROLYSIS	0.0113433	0.17327918132706158
ERDHEIM-CHESTER DISEASE	0.0113433	0.17327918132706158
CASTLEMAN DISEASE	0.0113433	0.17327918132706158
PSEUDOMYXOMA PERITONEI	0.0113433	0.17327918132706158
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0113433	0.17327918132706158
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.011264630000000001	0.17207742582425375
MULTIPLE SYNOSTOSES SYNDROME	0.011264630000000001	0.17207742582425375
JOHNSON NEUROECTODERMAL SYNDROME	0.011264630000000001	0.17207742582425375
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.011264630000000001	0.17207742582425375
BARDET-BIEDL SYNDROME 6; BBS6	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 4; BBS4	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 10; MKS10	0.011236	0.17164007664355732
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.011236	0.17164007664355732
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.011236	0.17164007664355732
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3	0.011236	0.17164007664355732
NEPHRONOPHTHISIS 20	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 6; MKS6	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 10; BBS10	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.011236	0.17164007664355732
AXIAL OSTEOMALACIA	0.011236	0.17164007664355732
GENITOPALATOCARDIAC SYNDROME	0.011236	0.17164007664355732
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.011236	0.17164007664355732
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 4; MKS4	0.011236	0.17164007664355732
CONGENITAL MEGACALYCOSIS	0.011236	0.17164007664355732
ADAMS-OLIVER SYNDROME 2; AOS2	0.011224844	0.17146965863937116
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.011219014	0.17138060010903725
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.011177124	0.17074069241852474
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.011168504	0.17060901411123855
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011118254000000001	0.1698413998489265
19P13.12 MICRODELETION SYNDROME	0.011116374	0.16981268114617729
LICHEN PLANUS, FAMILIAL	0.0111111	0.1697321160194224
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.1697321160194224
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.1697321160194224
PRENATAL BOWING	0.0111111	0.1697321160194224
131600 EPIDERMOID CYSTS	0.0111111	0.1697321160194224
PARANA HARD-SKIN SYNDROME	0.0111111	0.1697321160194224
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.1697321160194224
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.1697321160194224
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.1697321160194224
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.1697321160194224
PILONIDAL SINUS	0.0111111	0.1697321160194224
LENTIGINES	0.0111111	0.1697321160194224
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	0.1697321160194224
HYPOPLASMINOGENEMIA	0.0111111	0.1697321160194224
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.1697321160194224
PIGMENTED PURPURIC ERUPTION	0.0111111	0.1697321160194224
DERMAL RIDGES, PATTERNLESS	0.0111111	0.1697321160194224
CAROTENEMIA, FAMILIAL	0.0111111	0.1697321160194224
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.1697321160194224
PSEUDOATROPHODERMA COLLI	0.0111111	0.1697321160194224
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.1697321160194224
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.1697321160194224
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.1697321160194224
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.1697321160194224
ACROMIAL DIMPLES	0.0111111	0.1697321160194224
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.1697321160194224
SYRINGOMAS, MULTIPLE	0.0111111	0.1697321160194224
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.1697321160194224
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.1697321160194224
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.1697321160194224
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.1697321160194224
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.1697321160194224
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.1697321160194224
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.1697321160194224
FUTCHER LINE	0.0111111	0.1697321160194224
GLOMUVENOUS MALFORMATIONS	0.0111111	0.1697321160194224
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.1697321160194224
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.1697321160194224
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.1697321160194224
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.1697321160194224
CAMOS SYNDROME	0.0111111	0.1697321160194224
TRICHILEMMAL CYST 1	0.0111111	0.1697321160194224
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.1697321160194224
STICKLER SYNDROME, TYPE I	0.01110802	0.169685066229812
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	0.16952359990637642
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01109745	0.16952359990637642
MUCOPOLYSACCHARIDOSIS TYPE 2	0.011089144	0.16939671823348557
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.011046544	0.1687459646499135
MAN1B1-CDG	0.011035164	0.16857212484284662
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.01102461	0.1684109029339025
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.010989	0.16786692793129687
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.010989	0.16786692793129687
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.010989	0.16786692793129687
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.010989	0.16786692793129687
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.010989	0.16786692793129687
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.010989	0.16786692793129687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.01093772	0.16708357948609556
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.01093772	0.16708357948609556
BARATELA-SCOTT SYNDROME	0.010864404000000001	0.16596361118250008
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01085385	0.16580238927355595
KLEEFSTRA SYNDROME 2; KLEFS2	0.010852594	0.16578320273597458
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010850924000000001	0.16575769197342613
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010850924000000001	0.16575769197342613
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.010850924000000001	0.16575769197342613
ARGININOSUCCINIC ACIDURIA	0.010850924000000001	0.16575769197342613
CITRULLINEMIA, CLASSIC	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.010850924000000001	0.16575769197342613
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.010850924000000001	0.16575769197342613
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010850924000000001	0.16575769197342613
19P13.13 MICRODELETION SYNDROME	0.010832074	0.16546974115064833
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010828514000000001	0.1654153589262935
DISTAL MONOSOMY 10P	0.01082208	0.16531707374890608
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01081207	0.16516416193267236
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.01074158	0.164087363338635
LISSENCEPHALY 5; LIS5	0.01070739	0.16356508012214838
BARTH SYNDROME; BTHS	0.010691889999999999	0.16332830358352474
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.010688704	0.1632796345479083
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.010645854	0.16262506198790683
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.010631404	0.16240432515028674
FRIED SYNDROME	0.010621704000000001	0.1622561488648255
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.01057582	0.16155522920687668
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010523894	0.16076201252658182
BILATERAL POLYMICROGYRIA	0.010523894	0.16076201252658182
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.01051713	0.16065868630030758
MICROPHTHALMIA, SYNDROMIC 1	0.01051468	0.16062126033129934
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.01048961	0.16023829337495776
ARTERIAL TORTUOSITY SYNDROME	0.01048961	0.16023829337495776
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.010484504	0.16016029460036343
CONGENITAL TOXOPLASMOSIS	0.010466364	0.1598831896706452
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.01043911	0.15946686013621625
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.01043527	0.15940820065826045
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.010435264	0.15940810900282612
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.010424484000000001	0.15924343473918987
OGDEN SYNDROME	0.010368434000000001	0.15838722022371535
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010349584	0.15809926940093758
ALPHA-MANNOSIDOSIS	0.010346464	0.15805160857509848
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.010305370000000001	0.15742386050553725
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.010305370000000001	0.15742386050553725
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.010305370000000001	0.15742386050553725
INFANTILE LIVER FAILURE SYNDROME 2	0.010305370000000001	0.15742386050553725
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.010305370000000001	0.15742386050553725
LYSINURIC PROTEIN INTOLERANCE	0.010305370000000001	0.15742386050553725
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553725
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553725
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553725
CITRULLINEMIA TYPE I	0.010305370000000001	0.15742386050553725
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.010305370000000001	0.15742386050553725
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.010305370000000001	0.15742386050553725
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.010305370000000001	0.15742386050553725
LATHOSTEROLOSIS	0.01028654	0.1571362152008738
GAUCHER DISEASE, TYPE II	0.010265464	0.15681426021196854
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.01025711	0.15668664529560325
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.01025711	0.15668664529560325
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.010256150000000002	0.15667198042611435
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.010235074	0.15635002543720905
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.010235074	0.15635002543720905
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.010235074	0.15635002543720905
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.010235074	0.15635002543720905
CLASSIC HOMOCYSTINURIA	0.01021437	0.15603375308523074
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.01018589	0.15559869529039194
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.010156499999999999	0.1551497364213501
20Q13.33 MICRODELETION SYNDROME	0.01014315	0.15494580308001946
3M SYNDROME	0.01011276	0.15448156830525994
COLE-CARPENTER SYNDROME 2; CLCRP2	0.01011276	0.15448156830525994
BRUCK SYNDROME	0.01011276	0.15448156830525994
MUCOPOLYSACCHARIDOSIS TYPE 7	0.01011252	0.1544779020878877
TORIELLO-LACASSIE-DROSTE SYNDROME	0.01010246	0.15432422647636812
RIDDLE SYNDROME	0.010095814	0.1542227028069686
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.01008585	0.1540704936823979
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.01008585	0.1540704936823979
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.01007615	0.15392231739693665
GIANT CELL ARTERITIS	0.0100627	0.15371685646503422
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.01002708	0.1531727287033714
DESBUQUOIS DYSPLASIA 1	0.01000961	0.15290585863048398
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.01000961	0.15290585863048398
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.01000961	0.15290585863048398
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.01000961	0.15290585863048398
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01000777	0.15287775096396344
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01000777	0.15287775096396344
SCLEROSTEOSIS 1; SOST1	0.00999203	0.15263730820796764
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00999203	0.15263730820796764
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.009979514	0.15244611497200547
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.009979514	0.15244611497200547
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.009979514	0.15244611497200547
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.009979514	0.15244611497200547
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00997935	0.15244360972346777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00994929	0.1519844159975951
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00993895	0.15182646313247455
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00993895	0.15182646313247455
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00993895	0.15182646313247455
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00993895	0.15182646313247455
CORNEODERMATOOSSEOUS SYNDROME	0.00992081	0.15154935820275633
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00990712	0.15134023105348166
OTOFACIOCERVICAL SYNDROME	0.0098795	0.15091831053756002
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009873594	0.15082809103839157
CROUZON DISEASE	0.00978974	0.14954714524034343
CEREBROFACIOARTICULAR SYNDROME	0.009741854000000001	0.1488156432191479
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.009718594	0.14846032565215525
ISOLATED PLAGIOCEPHALY	0.009718594	0.14846032565215525
DUANE RETRACTION SYNDROME	0.009704904	0.14825119850288057
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.009677169999999999	0.14782753653370714
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009672024000000001	0.14774892672288412
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.009672024000000001	0.14774892672288412
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009672024000000001	0.14774892672288412
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.009667764	0.1476838513645269
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.009659674	0.1475602692872711
PRADER-WILLI SYNDROME	0.00960332	0.14669941089645844
ROIFMAN SYNDROME; RFMN	0.009600804000000001	0.1466609767176728
TYSHCHENKO SYNDROME	0.009600804000000001	0.1466609767176728
GALLOWAY-MOWAT SYNDROME	0.009600804000000001	0.1466609767176728
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00958929	0.14648508993923975
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00957675	0.14629353008154036
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.009543604	0.14578719491062303
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.009543604	0.14578719491062303
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.009511294	0.14529363039688564
SSR4-CDG	0.009496984	0.14507503218606602
6Q16 MICRODELETION SYNDROME	0.009485024	0.14489233235368285
AARSKOG-SCOTT SYNDROME	0.009485024	0.14489233235368285
MEVALONIC ACIDURIA	0.009473484	0.14471604840170113
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009456724	0.14446002422187326
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00943396	0.1441122835041166
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00943396	0.1441122835041166
CATARACT 45	0.00943396	0.1441122835041166
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00943396	0.1441122835041166
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.1441122835041166
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.1441122835041166
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.1441122835041166
EDICT SYNDROME	0.00943396	0.1441122835041166
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00943396	0.1441122835041166
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.00943396	0.1441122835041166
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.1441122835041166
KNOBLOCH SYNDROME 1; KNO1	0.00943396	0.1441122835041166
SUPERNUMERARY NOSTRIL	0.00943396	0.1441122835041166
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.1441122835041166
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.1441122835041166
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.1441122835041166
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.1441122835041166
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.1441122835041166
CATARACT 7; CTRCT7	0.00943396	0.1441122835041166
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.1441122835041166
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.1441122835041166
CATARACT 44; CTRCT44	0.00943396	0.1441122835041166
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.1441122835041166
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00943396	0.1441122835041166
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00943396	0.1441122835041166
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009426714000000001	0.1440015942912865
ACRO-RENAL-OCULAR SYNDROME	0.00938599	0.14337949830684074
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009294124	0.14197616195218277
EOSINOPHILIC GASTROENTERITIS	0.009224389999999999	0.1409109119428679
RAT-BITE FEVER	0.009224389999999999	0.1409109119428679
PANCREATOBLASTOMA	0.009224389999999999	0.1409109119428679
TSH-SECRETING PITUITARY ADENOMA	0.009224389999999999	0.1409109119428679
BETA-KETOTHIOLASE DEFICIENCY	0.009224389999999999	0.1409109119428679
HURLER SYNDROME	0.009215824000000001	0.1407800585344905
17P11.2 MICRODUPLICATION SYNDROME	0.009208404	0.1406667113140655
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.009208404	0.1406667113140655
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.009194714	0.1404575841647908
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00918994	0.14038465699089472
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00918994	0.14038465699089472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00918994	0.14038465699089472
15Q14 MICRODELETION SYNDROME	0.009189934	0.14038456533546043
CONGENITAL HYDROCEPHALUS	0.00915935	0.1399173670349917
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00915452	0.13984358441037542
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00915452	0.13984358441037542
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009126470000000001	0.13941509525499526
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.009126470000000001	0.13941509525499526
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.009104254	0.13907572573357185
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.009100174	0.13901340003824383
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.009100174	0.13901340003824383
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.009091564	0.13888187449001482
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00908373	0.13876220304462272
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00908373	0.13876220304462272
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00905525	0.13832714524978396
GMS SYNDROME	0.00905525	0.13832714524978396
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00905525	0.13832714524978396
FATCO SYNDROME	0.00905525	0.13832714524978396
DISTAL MONOSOMY 17Q	0.00905525	0.13832714524978396
CORNEODERMATOOSSEOUS SYNDROME	0.00905525	0.13832714524978396
TEMPLE SYNDROME	0.00905525	0.13832714524978396
TEMPLE SYNDROME	0.00905525	0.13832714524978396
CRANIODIAPHYSEAL DYSPLASIA	0.00903983	0.1380915907836177
MARINESCO-SJÖGREN SYNDROME	0.009037894000000001	0.13806201663014836
INCONTINENTIA PIGMENTI; IP	0.00902734	0.13790079472120423
WIEDEMANN-STEINER SYNDROME; WDSTS	0.009021724	0.1378150052346939
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009020690000000001	0.13779920994818187
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	0.13779071654460281
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.009020134	0.13779071654460281
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009020134	0.13779071654460281
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.009020134	0.13779071654460281
ADAMS-OLIVER SYNDROME 1; AOS1	0.009020134	0.13779071654460281
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.13779071654460281
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.009020134	0.13779071654460281
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.009020134	0.13779071654460281
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009020134	0.13779071654460281
XIA-GIBBS SYNDROME	0.009020134	0.13779071654460281
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009020134	0.13779071654460281
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009020134	0.13779071654460281
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	0.13779071654460281
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009020134	0.13779071654460281
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009020134	0.13779071654460281
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009020134	0.13779071654460281
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00901337	0.1376873903183286
JABERI-ELAHI SYNDROME; JABELS	0.008985484	0.13726140641148613
SRD5A3-CDG	0.008985484	0.13726140641148613
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008977394	0.1371378243342303
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.008977394	0.1371378243342303
RUVALCABA SYNDROME	0.008977394	0.1371378243342303
X SMALL RINGS	0.008974094	0.13708741384536205
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.13670276653939153
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.13670276653939153
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	0.13670276653939153
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.13670276653939153
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.13670276653939153
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.13670276653939153
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.13670276653939153
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	0.13670276653939153
TRISOMY 4P	0.00893947	0.136558500885794
FLOATING-HARBOR SYNDROME	0.008936284	0.13650983185017754
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00892486	0.1363353199032591
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00892486	0.1363353199032591
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.008853034000000001	0.1352381126991829
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008833134	0.13493412217540154
WILLIAMS-BEUREN SYNDROME; WBS	0.00874857	0.13364233048429391
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00874829	0.13363805323069297
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0087346	0.13342892608141826
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0087346	0.13342892608141826
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00867477	0.13251496864233106
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00867477	0.13251496864233106
DISTAL MONOSOMY 3P	0.00866285	0.13233287984617662
MESOMELIA-SYNOSTOSES SYNDROME	0.00866285	0.13233287984617662
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.008652739999999999	0.13217844043937113
QAZI-MARKOUIZOS SYNDROME	0.008652739999999999	0.13217844043937113
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.008652739999999999	0.13217844043937113
PEROXISOME BIOGENESIS DISORDER 3B	0.008628264	0.13180454737102587
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.008624434	0.13174604065212725
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008604854	0.1314469384181756
DUPLICATION/INVERSION 15Q11	0.00858501	0.13114380334511447
MELNICK-NEEDLES SYNDROME	0.0085796	0.13106116069518195
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0085796	0.13106116069518195
GOLDENHAR SYNDROME	0.0085796	0.13106116069518195
GORDON SYNDROME	0.0085796	0.13106116069518195
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00856591	0.13085203354590727
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00856591	0.13085203354590727
FUCOSIDOSIS	0.008563934	0.1308218483562092
FRAGILE X MENTAL RETARDATION SYNDROME	0.0085587	0.130741894265683
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008556514000000001	0.13070850113578422
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00854601	0.13054804302212597
WAARDENBURG SYNDROME	0.00854441	0.13052360157297774
SHASHI-PENA SYNDROME; SHAPNS	0.008538044	0.13042635515717912
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.12945688507671396
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.12945688507671396
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.12945688507671396
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.12945688507671396
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.12945688507671396
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.12945688507671396
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00847458	0.12945688507671396
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00847458	0.12945688507671396
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.12945688507671396
PACHYGYRIA, FRONTOTEMPORAL	0.00847458	0.12945688507671396
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.008444960000000001	0.1290044127493571
SAUL-WILSON SYNDROME; SWILS	0.008444454	0.12899668314106394
MOSAIC TRISOMY 8	0.0084398	0.12892558907585397
OSTEOGENESIS IMPERFECTA, TYPE IX	0.00843184	0.12880399286634142
OMPHALOCELE	0.00840336	0.12836893507150265
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.12836893507150265
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.12836893507150265
HYDROLETHALUS	0.00840336	0.12836893507150265
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.12836893507150265
SCHISIS ASSOCIATION	0.00840336	0.12836893507150265
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.12836893507150265
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.12836893507150265
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.12836893507150265
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.12836893507150265
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.12836893507150265
EBSTEIN MALFORMATION	0.00840336	0.12836893507150265
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.12836893507150265
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.12836893507150265
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.12836893507150265
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.12836893507150265
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.12836893507150265
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.12836893507150265
RETINOPATHY OF PREMATURITY	0.00840336	0.12836893507150265
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.12836893507150265
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.12836893507150265
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.12836893507150265
PEMPHIGOID GESTATIONIS	0.00840336	0.12836893507150265
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.12836893507150265
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.12836893507150265
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.12836893507150265
NEMALINE MYOPATHY 10	0.00840336	0.12836893507150265
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.12836893507150265
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.12836893507150265
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.12836893507150265
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.12836893507150265
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.008361480000000001	0.12772918014004733
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.008361480000000001	0.12772918014004733
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00835799	0.1276758672290927
SEVERE CANAVAN DISEASE	0.008352314	0.1275891611882393
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008352314	0.1275891611882393
DESANTO-SHINAWI SYNDROME	0.008345664000000001	0.12748757641521694
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00830748	0.12690428123129405
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00830748	0.12690428123129405
HYPERTELORISM, TEEBI TYPE	0.00828758	0.1266002907075127
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.008284394	0.1265516216718963
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.008284394	0.1265516216718963
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00827604	0.12642400675553098
KABUKI SYNDROME	0.00825535	0.12610794826623273
CHROMOSOME 18Q DELETION SYNDROME	0.00825535	0.12610794826623273
DISTAL MONOSOMY 1Q	0.008239694	0.12586878868631715
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.008239694	0.12586878868631715
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.008239694	0.12586878868631715
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.008239694	0.12586878868631715
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.008239694	0.12586878868631715
CHROMOSOME 18P DELETION SYNDROME	0.008239694	0.12586878868631715
MEIER-GORLIN SYNDROME 1; MGORS1	0.00822726	0.12567884807462384
48,XXXY SYNDROME	0.008201144	0.1252799025209016
GABRIELE-DE VRIES SYNDROME; GADEVS	0.008201144	0.1252799025209016
RETINITIS PIGMENTOSA	0.008140660000000001	0.12435595463947503
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00808271	0.12347071590313699
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.008080194	0.12343228172435139
ADRENOMYODYSTROPHY	0.0080593	0.12311310695028671
TRISOMY XQ28	0.0080593	0.12311310695028671
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0080593	0.12311310695028671
BOWEN-CONRADI SYNDROME	0.0080593	0.12311310695028671
NANCE-HORAN SYNDROME	0.00805299	0.1230167159852083
CONGENITAL HYPOTHYROIDISM	0.008030994	0.1226807071630428
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00801838	0.12248801688832033
MULTIPLE SULFATASE DEFICIENCY	0.008017304000000001	0.12247158001376815
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.008010960000000001	0.12237466966789534
WOODHOUSE-SAKATI SYNDROME	0.00799727	0.12216554251862066
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00799157	0.12207846985603002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.12148872823989428
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.12148872823989428
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.007952964	0.12148872823989428
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.12148872823989428
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.12148872823989428
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.12148872823989428
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.12148872823989428
ISOLATED KLIPPEL-FEIL SYNDROME	0.007927710000000001	0.12110295051690069
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.007927710000000001	0.12110295051690069
SCLEROSTEOSIS 2; SOST2	0.007927710000000001	0.12110295051690069
WILDERVANCK SYNDROME	0.007927710000000001	0.12110295051690069
DEAFNESS-CRANIOFACIAL SYNDROME	0.007927710000000001	0.12110295051690069
DEAFNESS-CRANIOFACIAL SYNDROME	0.00791402	0.12089382336762598
CRANIOFRONTONASAL DYSPLASIA	0.00791402	0.12089382336762598
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00791402	0.12089382336762598
MARTSOLF SYNDROME	0.0078989	0.12066285167317506
MONOSOMY 13Q34	0.007885234	0.12045409114563758
ROBINOW-SORAUF SYNDROME	0.00782428	0.11952296358852371
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00782428	0.11952296358852371
ACHONDROPLASIA	0.00782173	0.11948401002894374
CRIGLER-NAJJAR SYNDROME	0.00780676	0.11925532972035045
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.007792564	0.11903847296278264
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00778201	0.1188772510538385
ICF SYNDROME	0.007776394000000001	0.11879146156732819
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.007776394000000001	0.11879146156732819
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00777422	0.11875825174829799
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007740024	0.1182358768763771
KEUTEL SYNDROME	0.007740024	0.1182358768763771
CHROMOSOME 1P35 DELETION SYNDROME	0.007740024	0.1182358768763771
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00773884	0.11821779020400741
THYROID HEMIAGENESIS	0.007728764000000001	0.11806387017799633
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.007728764000000001	0.11806387017799633
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.007728764000000001	0.11806387017799633
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.007728764000000001	0.11806387017799633
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.007728764000000001	0.11806387017799633
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007728764000000001	0.11806387017799633
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0077061000000000004	0.11771765705081143
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0077061000000000004	0.11771765705081143
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0077061000000000004	0.11771765705081143
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00769414	0.11753495721842828
TRISOMY 5P	0.00769414	0.11753495721842828
SONODA SYNDROME	0.00769414	0.11753495721842828
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00769414	0.11753495721842828
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00769414	0.11753495721842828
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00769414	0.11753495721842828
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00769414	0.11753495721842828
NEURALGIC AMYOTROPHY	0.00769414	0.11753495721842828
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00769414	0.11753495721842828
%300712 CRANIOFACIOSKELETAL SYNDROME	0.007690954	0.11748628818281184
POPOV-CHANG SYNDROME; POPCHAS	0.007690954	0.11748628818281184
12Q14 MICRODELETION SYNDROME	0.007690954	0.11748628818281184
CHYLOMICRON RETENTION DISEASE	0.0076657	0.1171005104598182
CHYLOMICRON RETENTION DISEASE	0.0076657	0.1171005104598182
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.0076657	0.1171005104598182
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0076657	0.1171005104598182
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.0076657	0.1171005104598182
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0076657	0.1171005104598182
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0076657	0.1171005104598182
SPINOCEREBELLAR ATAXIA TYPE 34	0.00765559	0.11694607105301273
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00765559	0.11694607105301273
BENCZE SYNDROME	0.00765559	0.11694607105301273
SECKEL SYNDROME 1; SCKL1	0.00765559	0.11694607105301273
8P23.1 MICRODELETION SYNDROME	0.007651104	0.11687754333996332
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00764191	0.11673709666279522
FAMILIAL COLD URTICARIA	0.00763873	0.11668851928261308
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.007636574	0.11665558442988584
JUVENILE PAGET DISEASE	0.0076338199999999995	0.1166135145855394
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0076338199999999995	0.1166135145855394
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007607704	0.11621456903181716
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.007587804	0.11591057850803585
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.007587804	0.11591057850803585
TIMOTHY SYNDROME; TS	0.007587804	0.11591057850803585
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.007587804	0.11591057850803585
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.007587804	0.11591057850803585
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.007535574	0.11511271795240278
OPITZ G/BBB SYNDROME	0.007513794	0.11478000872587231
COCKAYNE SYNDROME A; CSA	0.00749898	0.11455371145857098
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007495174	0.1144955713614096
COFFIN-SIRIS SYNDROME 7; CSS7	0.007493794	0.11447449061151922
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.007486754	0.11436694823526694
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007486754	0.11436694823526694
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0074854399999999995	0.11434687569515394
NEURAMINIDASE DEFICIENCY	0.007471750000000001	0.11413774854587928
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007467904	0.11407899741248918
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.007451094	0.11382220943737542
SECKEL SYNDROME 7; SCKL7	0.00740741	0.11315489677200542
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00740741	0.11315489677200542
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.11315489677200542
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.11315489677200542
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.11315489677200542
DPM1-CDG	0.00740741	0.11315489677200542
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.11315489677200542
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.11315489677200542
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.11315489677200542
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.11315489677200542
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00740741	0.11315489677200542
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.11315489677200542
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00740741	0.11315489677200542
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.11315489677200542
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.11315489677200542
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.11315489677200542
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.11315489677200542
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.11315489677200542
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.11315489677200542
AMISH LETHAL MICROCEPHALY	0.00740741	0.11315489677200542
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00740741	0.11315489677200542
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.11315489677200542
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.11315489677200542
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.11315489677200542
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.11315489677200542
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00740741	0.11315489677200542
NEPHROGENIC DIABETES INSIPIDUS	0.007332414000000001	0.11200926494680427
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.007310704	0.11167762503367401
PERMANENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
TRANSIENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
KRABBE DISEASE	0.007257644	0.11086708547629529
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0072308400000000005	0.11045763009943932
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0072308400000000005	0.11045763009943932
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0072308400000000005	0.11045763009943932
DISTAL TRISOMY 5Q	0.0072308400000000005	0.11045763009943932
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0072308400000000005	0.11045763009943932
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007202954	0.11003164619259682
RAPADILINO SYNDROME	0.00719447	0.10990204540848823
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0071926640000000005	0.10987445712276217
FRANK-TER HAAR SYNDROME; FTHS	0.007183210000000001	0.10973003871010747
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007152820000000001	0.10926580393534797
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.007152820000000001	0.10926580393534797
ATKIN-FLAITZ SYNDROME	0.007152820000000001	0.10926580393534797
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0071454	0.10915245671492296
SHORT STATURE, BRUSSELS TYPE	0.0071454	0.10915245671492296
OSTEOGENESIS IMPERFECTA, TYPE X	0.0071454	0.10915245671492296
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.0071454	0.10915245671492296
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0071454	0.10915245671492296
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0071384740000000006	0.10904665579192252
RAHMAN SYNDROME	0.0071384740000000006	0.10904665579192252
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.007124504	0.10883325138904688
AL-RAQAD SYNDROME; ARS	0.007124504	0.10883325138904688
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.007124504	0.10883325138904688
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.007124504	0.10883325138904688
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00706215	0.1078807375639283
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00704225	0.10757674704014698
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00704225	0.10757674704014698
BRACHYDACTYLY, TYPE E	0.00704225	0.10757674704014698
RING CHROMOSOME 1 SYNDROME	0.00704225	0.10757674704014698
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00704225	0.10757674704014698
FAMILIAL VISCERAL MYOPATHY	0.00704225	0.10757674704014698
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00704225	0.10757674704014698
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00704225	0.10757674704014698
2Q37 MONOSOMY	0.00704225	0.10757674704014698
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00704225	0.10757674704014698
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00704225	0.10757674704014698
ACTH-INDEPENDENT CUSHING SYNDROME	0.00704225	0.10757674704014698
CHERUBISM	0.00704225	0.10757674704014698
ACROMICRIC DYSPLASIA	0.00704225	0.10757674704014698
JUNG SYNDROME	0.00704225	0.10757674704014698
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00704225	0.10757674704014698
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00704225	0.10757674704014698
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00704225	0.10757674704014698
ACROMICRIC DYSPLASIA	0.00704225	0.10757674704014698
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007039064	0.10752807800453056
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007039064	0.10752807800453056
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.007039064	0.10752807800453056
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.007039064	0.10752807800453056
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007039064	0.10752807800453056
CREE MENTAL RETARDATION SYNDROME	0.007039064	0.10752807800453056
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.0070100200000000005	0.10708440459886702
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0070100200000000005	0.10708440459886702
ACROCRANIOFACIAL DYSOSTOSIS	0.0070100200000000005	0.10708440459886702
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006998374	0.1069065014008792
SARCOIDOSIS	0.00699086	0.10679171824531676
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.006984684	0.10669737425160453
POSTENCEPHALITIC PARKINSONISM	0.006983420000000001	0.10667806550677744
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.006955814	0.10625635885353588
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0069412	0.10603311676737807
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.0069412	0.10603311676737807
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00693593	0.10595261274424603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00693593	0.10595261274424603
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00693593	0.10595261274424603
MICROPHTHALMIA, LENZ TYPE	0.00691923	0.10569750511876122
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.006913894	0.10561599288585184
COHEN SYNDROME	0.006913894	0.10561599288585184
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.006903684	0.10546002588847458
IMMUNODEFICIENCY 23; IMD23	0.006903684	0.10546002588847458
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.006903684	0.10546002588847458
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00686504	0.10486970378792157
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00686504	0.10486970378792157
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00685135	0.10466057663864689
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00685135	0.10466057663864689
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00685135	0.10466057663864689
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00685135	0.10466057663864689
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006834864	0.10440873805698567
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.006834864	0.10440873805698567
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.006834864	0.10440873805698567
EARLY MYOCLONIC ENCEPHALOPATHY	0.006834864	0.10440873805698567
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.006834864	0.10440873805698567
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006834864	0.10440873805698567
GABA-TRANSAMINASE DEFICIENCY	0.006834864	0.10440873805698567
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006834864	0.10440873805698567
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.006834864	0.10440873805698567
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.006828214000000001	0.10430715328396327
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0068160140000000004	0.1041207872342079
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0068160140000000004	0.1041207872342079
ARTERIAL TORTUOSITY SYNDROME	0.0068160140000000004	0.1041207872342079
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0068160140000000004	0.1041207872342079
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME WITH RENAL DEFECT	0.0068160140000000004	0.1041207872342079
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0068160140000000004	0.1041207872342079
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0068160140000000004	0.1041207872342079
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0068160140000000004	0.1041207872342079
JOUBERT SYNDROME	0.0068160140000000004	0.1041207872342079
MEHMO SYNDROME; MEHMO	0.0068160140000000004	0.1041207872342079
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0068160140000000004	0.1041207872342079
PSEUDOHYPOALDOSTERONISM TYPE 2	0.0067868600000000005	0.1036754334789154
COOPER-JABS SYNDROME	0.00675159	0.10313665228425377
RETICULAR DYSGENESIS	0.00672578	0.10274238115768111
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0067120899999999995	0.10253325400840642
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00670981	0.10249842494337018
SCARF SYNDROME	0.00670981	0.10249842494337018
L1 SYNDROME	0.006680524	0.10205105476852297
HEREDITARY FOLATE MALABSORPTION	0.006680524	0.10205105476852297
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.006670014	0.10189050499943043
20P12.3 MICRODELETION SYNDROME	0.006661924	0.10176692292217461
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006661924	0.10176692292217461
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.006661924	0.10176692292217461
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006661924	0.10176692292217461
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00664711	0.10154062565487329
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0066369	0.10138465865749606
14Q12 MICRODELETION SYNDROME	0.006617	0.10108066813371472
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00657895	0.10049941992115802
ACHONDROGENESIS TYPE 2	0.00657895	0.10049941992115802
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00657895	0.10049941992115802
ACHONDROGENESIS	0.00657895	0.10049941992115802
FIBROCHONDROGENESIS 1; FBCG1	0.00657895	0.10049941992115802
EMERY-NELSON SYNDROME	0.00657895	0.10049941992115802
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00657895	0.10049941992115802
OROFACIODIGITAL SYNDROME TYPE 10	0.00657895	0.10049941992115802
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00657895	0.10049941992115802
MAXILLONASAL DYSPLASIA	0.00657895	0.10049941992115802
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00657895	0.10049941992115802
OROFACIODIGITAL SYNDROME XV; OFD15	0.00657895	0.10049941992115802
LETHAL KNIEST-LIKE DYSPLASIA	0.00657895	0.10049941992115802
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00657895	0.10049941992115802
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00657895	0.10049941992115802
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00657895	0.10049941992115802
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00657895	0.10049941992115802
ACHONDROGENESIS TYPE 1A	0.00657895	0.10049941992115802
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00657895	0.10049941992115802
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00657895	0.10049941992115802
MONOSOMY 18P	0.006545034	0.09998132230283807
WRINKLY SKIN SYNDROME	0.006545034	0.09998132230283807
SECKEL SYNDROME 8; SCKL8	0.006545034	0.09998132230283807
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.006545034	0.09998132230283807
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006540774	0.09991624694448085
OTODENTAL DYSPLASIA	0.00652889	0.09973470808093228
FRANK-TER HAAR SYNDROME	0.00650093	0.09930759375706667
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00650093	0.09930759375706667
CLARK-BARAITSER SYNDROME	0.00650093	0.09930759375706667
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00649351	0.09919424653664169
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00649351	0.09919424653664169
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00649351	0.09919424653664169
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00649351	0.09919424653664169
PARTINGTON SYNDROME	0.00649351	0.09919424653664169
TRANSALDOLASE DEFICIENCY	0.00649351	0.09919424653664169
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00649351	0.09919424653664169
3-HYDROXYISOBUTYRIC ACIDURIA	0.00649351	0.09919424653664169
MEIER-GORLIN SYNDROME 3; MGORS3	0.00649351	0.09919424653664169
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00649351	0.09919424653664169
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00649351	0.09919424653664169
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00649351	0.09919424653664169
RUSSELL-SILVER SYNDROME, X-LINKED	0.00649351	0.09919424653664169
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00649351	0.09919424653664169
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00649351	0.09919424653664169
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006458834	0.09866453922997631
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00645282	0.09857266993299034
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00645282	0.09857266993299034
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00645048	0.09853692431361102
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0064391299999999995	0.09836354278371566
ACROCALLOSAL SYNDROME; ACLS	0.00641242	0.09795552334199716
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	0.09792252738564701
CURRY-JONES SYNDROME	0.00641026	0.09792252738564701
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	0.09792252738564701
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	0.09792252738564701
HEMIFACIAL HYPERPLASIA	0.00641026	0.09792252738564701
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	0.09792252738564701
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	0.09792252738564701
TORTICOLLIS	0.00641026	0.09792252738564701
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	0.09792252738564701
DISTAL TRISOMY 15Q	0.00641026	0.09792252738564701
CAFFEY DISEASE	0.00641026	0.09792252738564701
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	0.09792252738564701
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	0.09792252738564701
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	0.09792252738564701
SPINOCEREBELLAR ATAXIA TYPE 13	0.006404934	0.09784116791179479
BRAIN-LUNG-THYROID SYNDROME	0.006391244000000001	0.09763204076252012
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.0973353215698604
CRANIOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058572
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00635813	0.09712619442058572
BRITTLE CORNEA SYNDROME	0.00635813	0.09712619442058572
FRONTOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058572
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00635813	0.09712619442058572
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.09712619442058572
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00628931	0.09607490658909679
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00628931	0.09607490658909679
TYPHOID	0.00628931	0.09607490658909679
GLYCINE ENCEPHALOPATHY; GCE	0.00628931	0.09607490658909679
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00628931	0.09607490658909679
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00628931	0.09607490658909679
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00628931	0.09607490658909679
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.00628931	0.09607490658909679
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.00628931	0.09607490658909679
HEMOCHROMATOSIS TYPE 2	0.00628931	0.09607490658909679
EVANS SYNDROME	0.00628931	0.09607490658909679
PSEUDO-TORCH SYNDROME 2	0.00628931	0.09607490658909679
CIRRHOSIS, FAMILIAL	0.00628931	0.09607490658909679
KUFOR-RAKEB SYNDROME	0.00628931	0.09607490658909679
HEMOCHROMATOSIS, TYPE 2A	0.00628931	0.09607490658909679
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00628931	0.09607490658909679
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00628931	0.09607490658909679
EISENMENGER SYNDROME	0.00628931	0.09607490658909679
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00628931	0.09607490658909679
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00628931	0.09607490658909679
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00628931	0.09607490658909679
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00628931	0.09607490658909679
POSTERIOR URETHRAL VALVE	0.00628931	0.09607490658909679
MYXEDEMA	0.00628931	0.09607490658909679
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00628931	0.09607490658909679
ENCEPHALITIS LETHARGICA	0.00628931	0.09607490658909679
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00628931	0.09607490658909679
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.00628931	0.09607490658909679
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00628931	0.09607490658909679
GLYCINE ENCEPHALOPATHY	0.00628931	0.09607490658909679
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00628931	0.09607490658909679
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00627046	0.09578695576631903
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00626734	0.09573929494047993
COFFIN-SIRIS SYNDROME 4; CSS4	0.0062484640000000004	0.09545094694415351
COFFIN-SIRIS SYNDROME 3; CSS3	0.0062484640000000004	0.09545094694415351
LUSCAN-LUMISH SYNDROME; LLS	0.006222574	0.09505545374512345
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.006222574	0.09505545374512345
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.006222574	0.09505545374512345
GLASS SYNDROME	0.006222574	0.09505545374512345
PAROXYSMAL COLD HEMOGLOBINURIA	0.00613497	0.09371722330063412
HYDATIDIFORM MOLE	0.00613497	0.09371722330063412
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00613497	0.09371722330063412
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.09371722330063412
LYME DISEASE	0.00613497	0.09371722330063412
IMMUNOGLOBULIN A VASCULITIS	0.00613497	0.09371722330063412
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00613497	0.09371722330063412
FAMILIAL MEDITERRANEAN FEVER	0.00613497	0.09371722330063412
NIPAH VIRUS DISEASE	0.00613497	0.09371722330063412
INHALATIONAL BOTULISM	0.00613497	0.09371722330063412
LEPTOSPIROSIS	0.00613497	0.09371722330063412
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00613497	0.09371722330063412
HUGHES-STOVIN SYNDROME	0.00613497	0.09371722330063412
INTESTINAL BOTULISM	0.00613497	0.09371722330063412
COLD AGGLUTININ DISEASE	0.00613497	0.09371722330063412
RHEUMATIC FEVER	0.00613497	0.09371722330063412
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00613497	0.09371722330063412
MICROSCOPIC POLYANGIITIS	0.00613497	0.09371722330063412
KAWASAKI DISEASE	0.00613497	0.09371722330063412
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.09371722330063412
DRACUNCULIASIS	0.00613497	0.09371722330063412
FOODBORNE BOTULISM	0.00613497	0.09371722330063412
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00613497	0.09371722330063412
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00613497	0.09371722330063412
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00613497	0.09371722330063412
PAROXYSMAL HEMICRANIA	0.00613497	0.09371722330063412
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00613497	0.09371722330063412
CREST SYNDROME	0.00613497	0.09371722330063412
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
PORPHYRIA	0.00613497	0.09371722330063412
AMYOTROPHIC LATERAL SCLEROSIS	0.00613497	0.09371722330063412
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.09371722330063412
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
PRIMARY PARATHYROID HYPERPLASIA	0.00613497	0.09371722330063412
HEREDITARY COPROPORPHYRIA	0.00613497	0.09371722330063412
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.09371722330063412
GRISCELLI SYNDROME TYPE 2	0.00613497	0.09371722330063412
BABESIOSIS	0.00613497	0.09371722330063412
BOTULISM	0.00613497	0.09371722330063412
EPISODIC ATAXIA TYPE 6	0.00613497	0.09371722330063412
PORPHYRIA VARIEGATA	0.00613497	0.09371722330063412
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006132814	0.09368428844790685
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006132814	0.09368428844790685
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0061163699999999994	0.09343309145428574
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.0061163699999999994	0.09343309145428574
TEEBI-SHALTOUT SYNDROME; TBSH	0.0061163699999999994	0.09343309145428574
BRUCK SYNDROME 2	0.0061163699999999994	0.09343309145428574
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0061163699999999994	0.09343309145428574
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.0061163699999999994	0.09343309145428574
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0061163699999999994	0.09343309145428574
ACROCAPITOFEMORAL DYSPLASIA	0.0061163699999999994	0.09343309145428574
ULNAR-MAMMARY SYNDROME	0.0061163699999999994	0.09343309145428574
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0060997000000000004	0.09317844210597247
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0060997000000000004	0.09317844210597247
MEIER-GORLIN SYNDROME 6; MGORS6	0.0060997000000000004	0.09317844210597247
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0060997000000000004	0.09317844210597247
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0060997000000000004	0.09317844210597247
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.006079064	0.09286320851558297
SALT-AND-PEPPER SYNDROME	0.006065374	0.09265408136630829
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.006065374	0.09265408136630829
GALACTOSE EPIMERASE DEFICIENCY	0.006065374	0.09265408136630829
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.006051814000000001	0.09244694008477691
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.006051814000000001	0.09244694008477691
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.006051814000000001	0.09244694008477691
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.006018124	0.09193229482114915
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.006018124	0.09193229482114915
CATEL-MANZKE SYNDROME; CATMANS	0.006010034	0.09180871274389332
GERODERMA OSTEODYSPLASTICA	0.006010034	0.09180871274389332
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00599948	0.0916474908349492
ANE SYNDROME	0.00599948	0.0916474908349492
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00599948	0.0916474908349492
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00599948	0.0916474908349492
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00599948	0.0916474908349492
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00599948	0.0916474908349492
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00599948	0.0916474908349492
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00599948	0.0916474908349492
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00599948	0.0916474908349492
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00599948	0.0916474908349492
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00599522	0.091582415476592
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.005977724	0.09131514823015593
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.005977724	0.09131514823015593
HELSMOORTEL-VAN DER AA SYNDROME	0.005976344	0.09129406748026557
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.005976344	0.09129406748026557
MICRO SYNDROME	0.005947334	0.09085091345539643
MEND SYNDROME; MEND	0.005947334	0.09085091345539643
MEND SYNDROME	0.005947334	0.09085091345539643
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.005893144	0.09002311212455678
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.005893144	0.09002311212455678
HYPEREKPLEXIA 4; HKPX4	0.005893144	0.09002311212455678
ACRODERMATITIS ENTEROPATHICA	0.005860219999999999	0.08952016820470875
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00585938	0.08950733644390592
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.005845690000000001	0.08929820929463125
3MC SYNDROME 3	0.00581898	0.08889018985291271
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.005806944	0.08870632905169502
CHROMOSOME 19P13.13 DELETION SYNDROME	0.005806944	0.08870632905169502
2Q23.1 MICRODUPLICATION SYNDROME	0.005806944	0.08870632905169502
GALACTOSEMIA	0.00579859	0.08857871413532975
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.005753884	0.08789578949431631
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005753884	0.08789578949431631
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0057530440000000006	0.0878829577335135
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0057530440000000006	0.0878829577335135
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.005753044	0.0878829577335135
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.005753044	0.0878829577335135
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.005753044	0.0878829577335135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.005753044	0.0878829577335135
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.005753044	0.0878829577335135
MYHRE SYNDROME	0.005742754000000001	0.08772576866367886
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.005739354	0.08767383058423882
1Q21.1 MICRODELETION SYNDROME	0.005729064	0.08751664151440415
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.005712644	0.08726581114252029
ABLEPHARON MACROSTOMIA SYNDROME	0.005712644	0.08726581114252029
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.005712644	0.08726581114252029
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.005712644	0.08726581114252029
MICROTRIPLICATION 11Q24.1	0.00570291	0.08711711547626463
SIFRIM-HITZ-WEISS SYNDROME	0.00570291	0.08711711547626463
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.005698954	0.08705668399324559
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.005698954	0.08705668399324559
FOUNTAIN SYNDROME	0.00568922	0.08690798832698997
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00568922	0.08690798832698997
HURLER-SCHEIE SYNDROME	0.00568922	0.08690798832698997
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.005668564	0.0865924492184861
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00558726	0.08535045698001799
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.005570684	0.08509724356684216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.005570684	0.08509724356684216
MENTAL RETARDATION, X-LINKED 72	0.005570684	0.08509724356684216
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.005570684	0.08509724356684216
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.005570684	0.08509724356684216
AU-KLINE SYNDROME; AUKS	0.005570684	0.08509724356684216
TEMTAMY SYNDROME; TEMTYS	0.005570684	0.08509724356684216
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.005570684	0.08509724356684216
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.005570684	0.08509724356684216
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00553351	0.0845293770476941
PLAGUE	0.00553351	0.0845293770476941
KRABBE DISEASE	0.00553351	0.0845293770476941
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00553351	0.0845293770476941
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00551982	0.08432024989841942
DIAMOND-BLACKFAN ANEMIA 10	0.005506260000000001	0.08411310861688805
ALOPECIA ANTIBODY DEFICIENCY	0.005506260000000001	0.08411310861688805
FRONTONASAL DYSPLASIA	0.005506260000000001	0.08411310861688805
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.005506260000000001	0.08411310861688805
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.005506260000000001	0.08411310861688805
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.005506260000000001	0.08411310861688805
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.005506260000000001	0.08411310861688805
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.005506260000000001	0.08411310861688805
GORLIN-CHAUDHRY-MOSS SYNDROME	0.005506260000000001	0.08411310861688805
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.005480924	0.08372607826962557
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.005480924	0.08372607826962557
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.005480924	0.08372607826962557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005480924	0.08372607826962557
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005480924	0.08372607826962557
6Q TERMINAL DELETION SYNDROME	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005480924	0.08372607826962557
CHROMOSOME 16P13.2 DELETION SYNDROME	0.005480924	0.08372607826962557
PENOSCROTAL TRANSPOSITION	0.00546448	0.08347488127600446
NEONATAL MARFAN SYNDROME	0.00546448	0.08347488127600446
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00546448	0.08347488127600446
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00546448	0.08347488127600446
AMISH NEMALINE MYOPATHY	0.00546448	0.08347488127600446
LOEYS-DIETZ SYNDROME	0.00546448	0.08347488127600446
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00546448	0.08347488127600446
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00546448	0.08347488127600446
SPINOCEREBELLAR ATAXIA TYPE 43	0.00546448	0.08347488127600446
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00546448	0.08347488127600446
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00546448	0.08347488127600446
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00546448	0.08347488127600446
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00546448	0.08347488127600446
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00546448	0.08347488127600446
ELLIS-VAN CREVELD SYNDROME	0.00546448	0.08347488127600446
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00546448	0.08347488127600446
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.005440524	0.08310893167863236
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005440524	0.08310893167863236
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005440524	0.08310893167863236
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005440524	0.08310893167863236
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.005440524	0.08310893167863236
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.005440524	0.08310893167863236
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00543217	0.08298131676226707
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00543217	0.08298131676226707
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0054101340000000005	0.08264469690387286
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005399924	0.08248872990649561
ZECHI-CEIDE SYNDROME	0.005399924	0.08248872990649561
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.005399924	0.08248872990649561
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.08168928065666792
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.08168928065666792
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.08168928065666792
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.08168928065666792
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.08168928065666792
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00534759	0.08168928065666792
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00534759	0.08168928065666792
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.08168928065666792
MENTAL RETARDATION, X-LINKED 19	0.00534759	0.08168928065666792
SCHOLTE SYNDROME; SHLTS	0.00534759	0.08168928065666792
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.08168928065666792
NEMALINE MYOPATHY 4	0.00534759	0.08168928065666792
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00534759	0.08168928065666792
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00534759	0.08168928065666792
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00534759	0.08168928065666792
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.08168928065666792
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.08168928065666792
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00534759	0.08168928065666792
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.08168928065666792
PRIMARY DYSTONIA, DYT4 TYPE	0.00534759	0.08168928065666792
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00534759	0.08168928065666792
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00534759	0.08168928065666792
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.08168928065666792
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00534759	0.08168928065666792
GERODERMA OSTEODYSPLASTICUM; GO	0.00534759	0.08168928065666792
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.08168928065666792
CENTRAL CORE DISEASE	0.00534759	0.08168928065666792
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00534759	0.08168928065666792
CARPENTER SYNDROME	0.00534759	0.08168928065666792
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.08168928065666792
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.00534759	0.08168928065666792
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00534759	0.08168928065666792
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.005324454	0.08133585730198428
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.005324454	0.08133585730198428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005324454	0.08133585730198428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.005324454	0.08133585730198428
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00526139	0.08037249758380617
SPINOCEREBELLAR ATAXIA TYPE 25	0.00526139	0.08037249758380617
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.005213504000000001	0.07964099556261062
NAVAJO NEUROHEPATOPATHY	0.005213504	0.0796409955626106
NIEMANN-PICK DISEASE, TYPE A	0.005213504	0.0796409955626106
FOCAL MYOSITIS	0.00520833	0.07956195802642746
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.07956195802642746
PLEURAL MESOTHELIOMA	0.00520833	0.07956195802642746
PEMPHIGUS VULGARIS	0.00520833	0.07956195802642746
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.07956195802642746
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.07956195802642746
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.07956195802642746
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.07956195802642746
REACTIVE ARTHRITIS	0.00520833	0.07956195802642746
TUBERCULOSIS	0.00520833	0.07956195802642746
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.07956195802642746
YAO SYNDROME	0.00520833	0.07956195802642746
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.07956195802642746
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.07956195802642746
OROMANDIBULAR DYSTONIA	0.00520833	0.07956195802642746
ATTRV30M AMYLOIDOSIS	0.00520833	0.07956195802642746
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.07956195802642746
EOSINOPHILIC FASCIITIS	0.00520833	0.07956195802642746
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.07956195802642746
OSTEOSARCOMA	0.00520833	0.07956195802642746
HUNTINGTON DISEASE-LIKE 1	0.00520833	0.07956195802642746
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.07956195802642746
THYROTOXIC PERIODIC PARALYSIS	0.00520833	0.07956195802642746
JUVENILE HUNTINGTON DISEASE	0.00520833	0.07956195802642746
MU-HEAVY CHAIN DISEASE	0.00520833	0.07956195802642746
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.07956195802642746
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.07956195802642746
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.07956195802642746
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.07956195802642746
BULLOUS PEMPHIGOID	0.00520833	0.07956195802642746
ISAAC SYNDROME	0.00520833	0.07956195802642746
JUVENILE DERMATOMYOSITIS	0.00520833	0.07956195802642746
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.07956195802642746
CHRONIC HICCUP	0.00520833	0.07956195802642746
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.07956195802642746
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.07956195802642746
PERRY SYNDROME	0.00520833	0.07956195802642746
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.07956195802642746
LEISHMANIASIS	0.00520833	0.07956195802642746
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00520833	0.07956195802642746
MULTIPLE MYELOMA	0.00520833	0.07956195802642746
PERRY SYNDROME	0.00520833	0.07956195802642746
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.07956195802642746
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.07956195802642746
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.07956195802642746
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642746
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642746
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.07956195802642746
BUDD-CHIARI SYNDROME	0.00520833	0.07956195802642746
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00520749	0.07954912626562463
BETA-MANNOSIDOSIS	0.00520749	0.07954912626562463
PROLIDASE DEFICIENCY	0.00520749	0.07954912626562463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0051938	0.07933999911634995
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0051938	0.07933999911634995
LAURENCE-MOON SYNDROME	0.0051835100000000005	0.0791828100465153
CONGENITAL RUBELLA SYNDROME	0.0051835100000000005	0.0791828100465153
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00516709	0.07893197967463142
AXENFELD-RIEGER SYNDROME	0.00516709	0.07893197967463142
OSTEOPETROSIS AND RELATED DISORDERS	0.00516709	0.07893197967463142
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00516709	0.07893197967463142
HARDIKAR SYNDROME	0.00516709	0.07893197967463142
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00516709	0.07893197967463142
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00516709	0.07893197967463142
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0051367	0.07846774489987192
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0051367	0.07846774489987192
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00512301	0.07825861775059724
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00512301	0.07825861775059724
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00512301	0.07825861775059724
GALACTOSIALIDOSIS	0.00505102	0.07715890529798335
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00505102	0.07715890529798335
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00505102	0.07715890529798335
SCHEIE SYNDROME	0.0050373300000000005	0.07694977814870868
FRONTOMETAPHYSEAL DYSPLASIA	0.0050373300000000005	0.07694977814870868
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.005030364	0.0768433661894795
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00502513	0.0767634120989533
CAP MYOPATHY	0.00502513	0.0767634120989533
MENTAL RETARDATION, X-LINKED 93	0.00502513	0.0767634120989533
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00502513	0.0767634120989533
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00502513	0.0767634120989533
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00502513	0.0767634120989533
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.00502513	0.0767634120989533
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00502513	0.0767634120989533
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00502513	0.0767634120989533
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00502513	0.0767634120989533
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00502513	0.0767634120989533
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502513	0.0767634120989533
SOTOS SYNDROME 3	0.00502513	0.0767634120989533
CDAGS SYNDROME	0.0050166740000000005	0.07663423904020482
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00493537	0.07539224680173669
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00493537	0.07539224680173669
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00493537	0.07539224680173669
GAPO SYNDROME; GAPOS	0.00489497	0.07477510021074349
HOLMES-GANG SYNDROME	0.004887484	0.07466074478054113
SAY-BARBER-MILLER SYNDROME	0.004887484	0.07466074478054113
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004887484	0.07466074478054113
WILSON-TURNER SYNDROME	0.004887484	0.07466074478054113
URBAN-ROGERS-MEYER SYNDROME	0.00486458	0.07431086543598399
MASA SYNDROME	0.00486458	0.07431086543598399
CLEFT LIP/PALATE	0.00485437	0.07415489843860675
ISOLATED CLEFT LIP	0.00485437	0.07415489843860675
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00485437	0.07415489843860675
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.00485437	0.07415489843860675
TREACHER COLLINS SYNDROME 3; TCS3	0.00485437	0.07415489843860675
%608572 BURN-MCKEOWN SYNDROME	0.00485437	0.07415489843860675
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00485437	0.07415489843860675
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00485437	0.07415489843860675
MARSHALL-SMITH SYNDROME	0.00485437	0.07415489843860675
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.07415489843860675
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.07415489843860675
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.07415489843860675
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.07415489843860675
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.07415489843860675
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.07415489843860675
PHAVER SYNDROME	0.00485437	0.07415489843860675
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.07415489843860675
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00485437	0.07415489843860675
PRIMARY CILIARY DYSKINESIA	0.00485437	0.07415489843860675
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00485437	0.07415489843860675
TREACHER COLLINS SYNDROME 2; TCS2	0.00485437	0.07415489843860675
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.07415489843860675
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00485437	0.07415489843860675
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00485437	0.07415489843860675
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00485437	0.07415489843860675
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.00485437	0.07415489843860675
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00485437	0.07415489843860675
OTOSCLEROSIS	0.00485437	0.07415489843860675
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.07415489843860675
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.07415489843860675
RICHARDS-RUNDLE SYNDROME; RRNS	0.004812094	0.07350909424848721
MUENKE SYNDROME	0.004812094	0.07350909424848721
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.0047789	0.07300202583409542
PITT-HOPKINS SYNDROME	0.0047789	0.07300202583409542
16P12.1P12.3 TRIPLICATION SYNDROME	0.0047789	0.07300202583409542
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.0047789	0.07300202583409542
MUCOLIPIDOSIS TYPE IV	0.0047789	0.07300202583409542
PELGER-HUET ANOMALY; PHA	0.004758244	0.07268648672559157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.004758244	0.07268648672559157
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.004758244	0.07268648672559157
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.00474989	0.07255887180922627
SPONASTRIME DYSPLASIA	0.00474989	0.07255887180922627
METATROPIC DYSPLASIA	0.00474989	0.07255887180922627
FAMILIAL THYROID DYSHORMONOGENESIS	0.004731014	0.07227052381289985
ATHYREOSIS	0.004731014	0.07227052381289985
THYROID ECTOPIA	0.004731014	0.07227052381289985
COFFIN-SIRIS SYNDROME 5	0.004731014	0.07227052381289985
THYROID HYPOPLASIA	0.004731014	0.07227052381289985
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.004731014	0.07227052381289985
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004731014	0.07227052381289985
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004731014	0.07227052381289985
OGDEN SYNDROME; OGDNS	0.004731014	0.07227052381289985
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004731014	0.07227052381289985
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004731014	0.07227052381289985
COFFIN-SIRIS SYNDROME 2; CSS2	0.004731014	0.07227052381289985
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004731014	0.07227052381289985
RABSON-MENDENHALL SYNDROME	0.004731014	0.07227052381289985
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004731014	0.07227052381289985
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004667950000000001	0.07130716409472174
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004667950000000001	0.07130716409472174
ATRESIA OF SMALL INTESTINE	0.004667950000000001	0.07130716409472174
LYSINURIC PROTEIN INTOLERANCE; LPI	0.004667950000000001	0.07130716409472174
LESCH-NYHAN SYNDROME; LNS	0.004667950000000001	0.07130716409472174
CYSTINOSIS	0.004667950000000001	0.07130716409472174
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004561614	0.0696827853843293
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004561614	0.0696827853843293
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.004561614	0.0696827853843293
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.004561614	0.0696827853843293
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00453162	0.069224599868234
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.004497424	0.06870222499631312
YUNIS-VARON SYNDROME	0.004497424	0.06870222499631312
SANDHOFF DISEASE	0.0044848100000000005	0.06850953472159063
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0044848100000000005	0.06850953472159063
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0044848100000000005	0.06850953472159063
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0044848100000000005	0.06850953472159063
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0044848100000000005	0.06850953472159063
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0044848100000000005	0.06850953472159063
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0044848100000000005	0.06850953472159063
CLEIDOCRANIAL DYSPLASIA; CCD	0.0044848100000000005	0.06850953472159063
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0044848100000000005	0.06850953472159063
INFANTILE REFSUM DISEASE	0.0044837340000000005	0.06849309784703844
VICI SYNDROME	0.0044837340000000005	0.06849309784703844
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00447112	0.06830040757231595
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00447112	0.06830040757231595
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00447112	0.06830040757231595
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00434193	0.06632691331265227
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00434193	0.06632691331265227
KENNERKNECHT SYNDROME	0.00434193	0.06632691331265227
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00434193	0.06632691331265227
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00434193	0.06632691331265227
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00434193	0.06632691331265227
ISOLATED AGAMMAGLOBULINEMIA	0.00434193	0.06632691331265227
RODRIGUES BLINDNESS	0.00434193	0.06632691331265227
DIAMOND-BLACKFAN ANEMIA 4	0.00434193	0.06632691331265227
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00434193	0.06632691331265227
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00434193	0.06632691331265227
HAIRY ELBOWS	0.00434193	0.06632691331265227
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00434193	0.06632691331265227
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00430153	0.06570976672165905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.06470253460225983
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.004235594	0.06470253460225983
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.06470253460225983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.06470253460225983
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.06470253460225983
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004235594	0.06470253460225983
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.004235594	0.06470253460225983
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.004235594	0.06470253460225983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004235594	0.06470253460225983
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.06470253460225983
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.06470253460225983
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.06470253460225983
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.06470253460225983
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.06470253460225983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004235594	0.06470253460225983
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.06470253460225983
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.004235594	0.06470253460225983
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004235594	0.06470253460225983
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.06470253460225983
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004235594	0.06470253460225983
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004235594	0.06470253460225983
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004235594	0.06470253460225983
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.06470253460225983
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.06470253460225983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.06470253460225983
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.004235594	0.06470253460225983
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.06470253460225983
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.06470253460225983
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004225304	0.06454534553242518
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004225304	0.06454534553242518
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004225304	0.06454534553242518
DISTAL TRISOMY 6P	0.004225304	0.06454534553242518
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.004225304	0.06454534553242518
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00421269	0.0643526552577027
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00421269	0.0643526552577027
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00421269	0.0643526552577027
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00421269	0.0643526552577027
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00421269	0.0643526552577027
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00421269	0.0643526552577027
JOUBERT SYNDROME 10	0.004195194	0.06408538801126663
2P21 MICRODELETION SYNDROME	0.004195194	0.06408538801126663
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	0.06408538801126663
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004195194	0.06408538801126663
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004195194	0.06408538801126663
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	0.06408538801126663
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004195194	0.06408538801126663
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004195194	0.06408538801126663
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004195194	0.06408538801126663
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004195194	0.06408538801126663
COG4-CDG	0.004195194	0.06408538801126663
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.004195194	0.06408538801126663
HEART AND BRAIN MALFORMATION SYNDROME	0.004195194	0.06408538801126663
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	0.06408538801126663
RING CHROMOSOME 14 SYNDROME	0.004195194	0.06408538801126663
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.004195194	0.06408538801126663
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004195194	0.06408538801126663
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	0.06408538801126663
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.004195194	0.06408538801126663
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.004195194	0.06408538801126663
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.004195194	0.06408538801126663
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.004195194	0.06408538801126663
MUCOLIPIDOSIS III ALPHA/BETA	0.00418546	0.063936692345011
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00418546	0.063936692345011
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00418546	0.063936692345011
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00418546	0.063936692345011
CARPENTER-WAZIRI SYNDROME	0.00418546	0.063936692345011
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00418546	0.063936692345011
ATKIN-FLAITZ SYNDROME	0.00418546	0.063936692345011
2Q23.1 MICRODELETION SYNDROME	0.00418546	0.063936692345011
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00418546	0.063936692345011
COLE-CARPENTER SYNDROME	0.004164804	0.06362115323650713
FARBER DISEASE	0.004164804	0.06362115323650713
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.004164804	0.06362115323650713
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004164804	0.06362115323650713
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.004164804	0.06362115323650713
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.004164804	0.06362115323650713
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.06231231363461856
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.004079124	0.06231231363461856
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.004079124	0.06231231363461856
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.004079124	0.06231231363461856
SIALURIA	0.004079124	0.06231231363461856
PERIPHERAL HYPOTHYROIDISM	0.004079124	0.06231231363461856
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004079124	0.06231231363461856
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.06231231363461856
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.06231231363461856
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.004079124	0.06231231363461856
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.06134895391644045
AA AMYLOIDOSIS	0.00401606	0.06134895391644045
EPISODIC ATAXIA, TYPE 3	0.00401606	0.06134895391644045
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00401606	0.06134895391644045
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.06134895391644045
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.06134895391644045
ENTERIC ANENDOCRINOSIS	0.00401606	0.06134895391644045
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00401606	0.06134895391644045
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.06134895391644045
INHALATIONAL ANTHRAX	0.00401606	0.06134895391644045
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00401606	0.06134895391644045
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.06134895391644045
HELLP SYNDROME	0.00401606	0.06134895391644045
PROLACTINOMA	0.00401606	0.06134895391644045
EPISODIC ATAXIA, TYPE 6	0.00401606	0.06134895391644045
GRAFT VERSUS HOST DISEASE	0.00401606	0.06134895391644045
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.06134895391644045
NEUROLEPTIC MALIGNANT SYNDROME	0.00401606	0.06134895391644045
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00401606	0.06134895391644045
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.06134895391644045
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.06134895391644045
GITELMAN SYNDROME	0.00401606	0.06134895391644045
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00401606	0.06134895391644045
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.06134895391644045
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.06134895391644045
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00401606	0.06134895391644045
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.06134895391644045
HYPER-IGD SYNDROME	0.00401606	0.06134895391644045
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.06134895391644045
RELAPSING FEVER	0.00401606	0.06134895391644045
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00401606	0.06134895391644045
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.06134895391644045
CAROLI DISEASE, ISOLATED	0.00401606	0.06134895391644045
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.06134895391644045
ACQUIRED METHEMOGLOBINEMIA	0.00401606	0.06134895391644045
NON-FUNCTIONING PITUITARY ADENOMA	0.00401606	0.06134895391644045
HYPOADRENOCORTICISM, FAMILIAL	0.00401606	0.06134895391644045
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.06134895391644045
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.06134895391644045
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00401606	0.06134895391644045
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.06134895391644045
PORPHYRIA VARIEGATA	0.00401606	0.06134895391644045
VISCERAL MYOPATHY; VSCM	0.00401606	0.06134895391644045
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.06134895391644045
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00401606	0.06134895391644045
VALINEMIA	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.06134895391644045
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.06134895391644045
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.06134895391644045
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.06134895391644045
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.06134895391644045
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.06134895391644045
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.06134895391644045
CONGENITAL PANCREATIC CYST	0.00401606	0.06134895391644045
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.06134895391644045
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.06134895391644045
BENIGN OCCIPITAL EPILEPSY	0.00401606	0.06134895391644045
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00401606	0.06134895391644045
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.06134895391644045
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.06134895391644045
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.06134895391644045
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.06134895391644045
HYPOPHOSPHATASIA, INFANTILE	0.00401606	0.06134895391644045
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00401606	0.06134895391644045
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.06134895391644045
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.06134895391644045
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.06134895391644045
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.06134895391644045
OPTIC ATROPHY 11; OPA11	0.003960224	0.06049600844478953
KABUKI SYNDROME 1	0.003960224	0.06049600844478953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003960224	0.06049600844478953
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00395187	0.06036839352842425
SPASTIC PARAPARESIS AND DEAFNESS	0.00395187	0.06036839352842425
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00395187	0.06036839352842425
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.003946534	0.06028688129551485
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00393818	0.06015926637914958
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00393818	0.06015926637914958
NATHALIE SYNDROME	0.00393818	0.06015926637914958
NAIL-PATELLA SYNDROME	0.00393818	0.06015926637914958
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00393818	0.06015926637914958
VOGT-KOYANAGI-HARADA DISEASE	0.00393818	0.06015926637914958
LEBER CONGENITAL AMAUROSIS	0.0038455340000000003	0.05874401481803182
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0038455340000000003	0.05874401481803182
3Q29 MICRODUPLICATION SYNDROME	0.0038455340000000003	0.05874401481803182
LATHOSTEROLOSIS	0.0038455340000000003	0.05874401481803182
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0038455340000000003	0.05874401481803182
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0038455340000000003	0.05874401481803182
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0038455340000000003	0.05874401481803182
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0038455340000000003	0.05874401481803182
OTOPALATODIGITAL SYNDROME TYPE 2	0.0038455340000000003	0.05874401481803182
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003831844	0.05853488766875715
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.003831844	0.05853488766875715
USHER SYNDROME TYPE 1	0.003831844	0.05853488766875715
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.003831844	0.05853488766875715
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.05636870313437097
LICHTENSTEIN SYNDROME	0.00369004	0.05636870313437097
ZECHI-CEIDE SYNDROME	0.00369004	0.05636870313437097
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.05636870313437097
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.05636870313437097
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.05636870313437097
ISOLATED BILIARY ATRESIA	0.00369004	0.05636870313437097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.05636870313437097
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.05636870313437097
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.05636870313437097
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.05636870313437097
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.05636870313437097
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.05636870313437097
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.05636870313437097
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.05636870313437097
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.05636870313437097
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.05636870313437097
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.05636870313437097
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.05636870313437097
EPILEPSY-TELANGIECTASIA	0.00369004	0.05636870313437097
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.05636870313437097
UROFACIAL SYNDROME	0.00369004	0.05636870313437097
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.05636870313437097
LARON SYNDROME	0.00369004	0.05636870313437097
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.05636870313437097
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.05636870313437097
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.05636870313437097
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.05636870313437097
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.05636870313437097
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.05636870313437097
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.05636870313437097
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.05636870313437097
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.05636870313437097
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.05636870313437097
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00367975	0.05621151406453632
HIDROTIC ECTODERMAL DYSPLASIA	0.00367975	0.05621151406453632
DYSEQUILIBRIUM SYNDROME	0.00367975	0.05621151406453632
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.05575155654337777
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.05575155654337777
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00364964	0.05575155654337777
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00364964	0.05575155654337777
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.05575155654337777
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.05575155654337777
MILLER-DIEKER SYNDROME	0.00364964	0.05575155654337777
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.05575155654337777
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.05575155654337777
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.05575155654337777
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.05575155654337777
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.05575155654337777
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00364964	0.05575155654337777
T-SUBSTANCE ANOMALY	0.00364964	0.05575155654337777
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.05575155654337777
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.05575155654337777
LYSINE MALABSORPTION SYNDROME	0.00364964	0.05575155654337777
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.05575155654337777
AROMATASE DEFICIENCY	0.00364964	0.05575155654337777
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.05575155654337777
FAMILIAL DYSAUTONOMIA	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.05575155654337777
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.05575155654337777
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.05575155654337777
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.05575155654337777
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.05575155654337777
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.05575155654337777
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.05575155654337777
ROWLEY-ROSENBERG SYNDROME	0.00364964	0.05575155654337777
SERKAL SYNDROME	0.00364964	0.05575155654337777
CITRULLINE TRANSPORT DEFECT	0.00364964	0.05575155654337777
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.05575155654337777
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00364964	0.05575155654337777
HEREDITARY SPHEROCYTOSIS	0.00364964	0.05575155654337777
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.05575155654337777
GLYCOGEN STORAGE DISEASE IXC	0.00364964	0.05575155654337777
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.05575155654337777
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00364964	0.05575155654337777
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.05575155654337777
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.05575155654337777
HYPOTONIA-CYSTINURIA SYNDROME	0.00364964	0.05575155654337777
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00364964	0.05575155654337777
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.05575155654337777
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.05575155654337777
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00364964	0.05575155654337777
COLOBOMA, OCULAR	0.00364964	0.05575155654337777
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.05575155654337777
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.05575155654337777
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.05575155654337777
MAJEED SYNDROME	0.00364964	0.05575155654337777
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00364964	0.05575155654337777
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.05575155654337777
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.05575155654337777
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.05575155654337777
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.05575155654337777
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00364964	0.05575155654337777
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.05575155654337777
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.05575155654337777
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.05575155654337777
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.05575155654337777
THREONINEMIA	0.00364964	0.05575155654337777
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00361925	0.055287321768618274
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00361925	0.055287321768618274
SJÖGREN-LARSSON SYNDROME	0.00361925	0.055287321768618274
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00361925	0.055287321768618274
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00361925	0.055287321768618274
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00361925	0.055287321768618274
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00361925	0.055287321768618274
RUVALCABA SYNDROME	0.00361925	0.055287321768618274
HURLER-SCHEIE SYNDROME	0.00361925	0.055287321768618274
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00361925	0.055287321768618274
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0035734140000000005	0.05458713535414389
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0035734140000000005	0.05458713535414389
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003573414	0.05458713535414389
1Q21.1 MICRODUPLICATION SYNDROME	0.003573414	0.05458713535414389
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.003573414	0.05458713535414389
MIETENS SYNDROME	0.003573414	0.05458713535414389
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003573414	0.05458713535414389
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.003573414	0.05458713535414389
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00353357	0.0539784821667297
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.0539784821667297
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0539784821667297
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.0539784821667297
268650 RUDIGER SYNDROME	0.00353357	0.0539784821667297
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.0539784821667297
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00353357	0.0539784821667297
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.0539784821667297
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00353357	0.0539784821667297
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0539784821667297
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.0539784821667297
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00353357	0.0539784821667297
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00353357	0.0539784821667297
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00353357	0.0539784821667297
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00353357	0.0539784821667297
SANDHOFF DISEASE	0.00353357	0.0539784821667297
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.0539784821667297
INFANTILE SYSTEMIC HYALINOSIS	0.00353357	0.0539784821667297
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.0539784821667297
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.0539784821667297
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00353357	0.0539784821667297
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003512914	0.05366294305822584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.003512914	0.05366294305822584
TRISOMY 9P	0.003512914	0.05366294305822584
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.003512914	0.05366294305822584
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003512914	0.05366294305822584
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003512914	0.05366294305822584
GAUCHER DISEASE	0.00341467	0.05216217697690067
PELVISCAPULAR DYSPLASIA	0.00341467	0.05216217697690067
FREEMAN-SHELDON SYNDROME	0.00341467	0.05216217697690067
STIFF SKIN SYNDROME	0.00340098	0.05195304982762599
COG5-CDG	0.00340098	0.05195304982762599
JOHANSON-BLIZZARD SYNDROME; JBS	0.00340098	0.05195304982762599
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00340098	0.05195304982762599
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0033083340000000004	0.05053779826650824
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.003308334	0.05053779826650824
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.003308334	0.05053779826650824
CHAR SYNDROME	0.003308334	0.05053779826650824
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003308334	0.05053779826650824
DISTAL MONOSOMY 6P	0.003308334	0.05053779826650824
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00329998	0.05041018335014296
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00329998	0.05041018335014296
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00329998	0.05041018335014296
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00329998	0.05041018335014296
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00329998	0.05041018335014296
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00329998	0.05041018335014296
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00329998	0.05041018335014296
AGEL AMYLOIDOSIS	0.00329998	0.05041018335014296
CENANI-LENZ SYNDROME	0.00329998	0.05041018335014296
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032946440000000002	0.050328671117233555
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0032946440000000002	0.050328671117233555
CRANIOSYNOSTOSIS 6; CRS6	0.0032946440000000002	0.050328671117233555
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0032946440000000002	0.050328671117233555
PONTINE TEGMENTAL CAP DYSPLASIA	0.0032946440000000002	0.050328671117233555
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0032946440000000002	0.050328671117233555
HYPERTRYPTOPHANEMIA; HYPTRP	0.0032946440000000002	0.050328671117233555
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0032946440000000002	0.050328671117233555
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0032946440000000002	0.050328671117233555
LEIGH SYNDROME; LS	0.0032946440000000002	0.050328671117233555
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00328629	0.050201056200868274
RELAPSING POLYCHONDRITIS	0.00328629	0.050201056200868274
REFSUM DISEASE	0.00328629	0.050201056200868274
STICKLER SYNDROME TYPE 2	0.00328629	0.050201056200868274
STICKLER SYNDROME TYPE 1	0.00328629	0.050201056200868274
REFSUM DISEASE	0.00328629	0.050201056200868274
USHER SYNDROME TYPE 3	0.00328629	0.050201056200868274
USHER SYNDROME TYPE 2	0.00328629	0.050201056200868274
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00328629	0.050201056200868274
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00328629	0.050201056200868274
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00328629	0.050201056200868274
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00328629	0.050201056200868274
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00328629	0.050201056200868274
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00328629	0.050201056200868274
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00328629	0.050201056200868274
USHER SYNDROME	0.00328629	0.050201056200868274
STICKLER SYNDROME, TYPE II	0.00328629	0.050201056200868274
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.0030278600000000003	0.04625330388625503
MUSCLE-EYE-BRAIN DISEASE	0.0030278600000000003	0.04625330388625503
GROENOUW TYPE I CORNEAL DYSTROPHY	0.0030278600000000003	0.04625330388625503
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0030278600000000003	0.04625330388625503
PRIMARY CUTIS VERTICIS GYRATA	0.0030278600000000003	0.04625330388625503
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0030278600000000003	0.04625330388625503
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0030278600000000003	0.04625330388625503
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.0030278600000000003	0.04625330388625503
LEBER CONGENITAL AMAUROSIS 16	0.0030278600000000003	0.04625330388625503
MORNING GLORY DISC ANOMALY	0.0030278600000000003	0.04625330388625503
COATS DISEASE	0.0030278600000000003	0.04625330388625503
WOOLLY HAIR	0.0030278600000000003	0.04625330388625503
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.0030278600000000003	0.04625330388625503
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.0030278600000000003	0.04625330388625503
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.046151719113232625
COWCHOCK SYNDROME; COWCK	0.00302121	0.046151719113232625
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.046151719113232625
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.046151719113232625
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.002979974	0.04552180186505946
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.002979974	0.04552180186505946
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.002979974	0.04552180186505946
OCULO-PALATO-CEREBRAL SYNDROME	0.002979974	0.04552180186505946
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.002979974	0.04552180186505946
SENIOR-LOKEN SYNDROME	0.002979974	0.04552180186505946
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00296736	0.04532911159033698
OSTEOMESOPYKNOSIS	0.00296736	0.04532911159033698
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00296736	0.04532911159033698
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00296736	0.04532911159033698
HIP DYSPLASIA, BEUKES TYPE	0.00296736	0.04532911159033698
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00296736	0.04532911159033698
HOLT-ORAM SYNDROME	0.00296736	0.04532911159033698
OROFACIODIGITAL SYNDROME III	0.00296736	0.04532911159033698
RHIZOMELIC SYNDROME, URBACH TYPE	0.00296736	0.04532911159033698
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00296736	0.04532911159033698
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.00296736	0.04532911159033698
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.04532911159033698
METATROPIC DYSPLASIA	0.00296736	0.04532911159033698
SCHEUERMANN DISEASE	0.00296736	0.04532911159033698
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00296736	0.04532911159033698
FAMILIAL SCHEUERMANN DISEASE	0.00296736	0.04532911159033698
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.04532911159033698
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00296736	0.04532911159033698
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.04532911159033698
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00296736	0.04532911159033698
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.00296736	0.04532911159033698
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00296736	0.04532911159033698
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00296736	0.04532911159033698
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00296736	0.04532911159033698
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00296736	0.04532911159033698
WEISMANN-NETTER SYNDROME	0.00296736	0.04532911159033698
MENTAL RETARDATION, X-LINKED 82	0.00296736	0.04532911159033698
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00296736	0.04532911159033698
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.04532911159033698
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.00296736	0.04532911159033698
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00296736	0.04532911159033698
PSEUDOACHONDROPLASIA	0.00296736	0.04532911159033698
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00296736	0.04532911159033698
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00296736	0.04532911159033698
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00296736	0.04532911159033698
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00296736	0.04532911159033698
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00296736	0.04532911159033698
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00296736	0.04532911159033698
SPONDYLOENCHONDRODYSPLASIA	0.00296736	0.04532911159033698
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00296736	0.04532911159033698
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.00296736	0.04532911159033698
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00296736	0.04532911159033698
EHLERS-DANLOS SYNDROME, TYPE VI	0.00296736	0.04532911159033698
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00296736	0.04532911159033698
GAUCHER DISEASE TYPE 1	0.00296736	0.04532911159033698
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00296736	0.04532911159033698
BETHLEM MYOPATHY 2; BTHLM2	0.00296736	0.04532911159033698
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00296736	0.04532911159033698
RETT SYNDROME, CONGENITAL VARIANT	0.00296736	0.04532911159033698
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00296736	0.04532911159033698
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00296736	0.04532911159033698
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00296736	0.04532911159033698
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00296736	0.04532911159033698
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00296736	0.04532911159033698
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00296736	0.04532911159033698
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00296736	0.04532911159033698
MOEBIUS SYNDROME	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0027627800000000003	0.04220396679861938
6P22 MICRODELETION SYNDROME	0.0027627800000000003	0.04220396679861938
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0027627800000000003	0.04220396679861938
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027627800000000003	0.04220396679861938
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00274909	0.041994839649344695
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.041994839649344695
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.041994839649344695
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00274909	0.041994839649344695
PROXIMAL SYMPHALANGISM	0.00274909	0.041994839649344695
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00274909	0.041994839649344695
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00274909	0.041994839649344695
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00274909	0.041994839649344695
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00274909	0.041994839649344695
FETAL IODINE SYNDROME	0.00274909	0.041994839649344695
14Q22Q23 MICRODELETION SYNDROME	0.002714894	0.041472464777423806
NARP SYNDROME	0.002714894	0.041472464777423806
PELIZAEUS-MERZBACHER DISEASE	0.002714894	0.041472464777423806
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.002714894	0.041472464777423806
RFT1-CDG	0.002714894	0.041472464777423806
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.002714894	0.041472464777423806
LYMPHEDEMA, HEREDITARY, III	0.002714894	0.041472464777423806
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.002714894	0.041472464777423806
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0027012040000000005	0.041263337628149134
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0027012040000000005	0.041263337628149134
NOONAN SYNDROME 11; NS11	0.0027012040000000005	0.041263337628149134
STEEL SYNDROME; STLS	0.0027012040000000005	0.041263337628149134
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.0027012040000000005	0.041263337628149134
6Q25 MICRODELETION SYNDROME	0.0027012040000000005	0.041263337628149134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027012040000000005	0.041263337628149134
16P13.11 MICRODELETION SYNDROME	0.0027012040000000005	0.041263337628149134
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027012040000000005	0.041263337628149134
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0027012040000000005	0.041263337628149134
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002442774	0.037315585313535876
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002442774	0.037315585313535876
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002442774	0.037315585313535876
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002442774	0.037315585313535876
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.002442774	0.037315585313535876
49,XXXXY SYNDROME	0.002442774	0.037315585313535876
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002442774	0.037315585313535876
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002442774	0.037315585313535876
TOLUENE EMBRYOPATHY	0.002442774	0.037315585313535876
PENTASOMY X	0.002442774	0.037315585313535876
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.002442774	0.037315585313535876
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.002442774	0.037315585313535876
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002442774	0.037315585313535876
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002442774	0.037315585313535876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002442774	0.037315585313535876
1Q44 MICRODELETION SYNDROME	0.002442774	0.037315585313535876
HADZISELIMOVIC SYNDROME	0.002442774	0.037315585313535876
HARTNUP DISEASE	0.002442774	0.037315585313535876
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.002442774	0.037315585313535876
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.002442774	0.037315585313535876
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00243442	0.0371879703971706
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00243442	0.0371879703971706
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00243442	0.0371879703971706
WEILL-MARCHESANI SYNDROME	0.00243442	0.0371879703971706
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00243442	0.0371879703971706
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00243442	0.0371879703971706
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00243442	0.0371879703971706
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00243442	0.0371879703971706
FRONTOFACIONASAL DYSPLASIA	0.00243442	0.0371879703971706
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00243442	0.0371879703971706
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00243442	0.0371879703971706
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00243442	0.0371879703971706
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00243442	0.0371879703971706
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0023280840000000002	0.03556359168677817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0023280840000000002	0.03556359168677817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0023280840000000002	0.03556359168677817
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0023280840000000002	0.03556359168677817
PEROXISOME BIOGENESIS DISORDER 10B	0.0023280840000000002	0.03556359168677817
WALKER-WARBURG SYNDROME	0.0023280840000000002	0.03556359168677817
PELLAGRA-LIKE SYNDROME	0.0023280840000000002	0.03556359168677817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0023280840000000002	0.03556359168677817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0023280840000000002	0.03556359168677817
CONGENITAL VARICELLA SYNDROME	0.0023280840000000002	0.03556359168677817
ALDH18A1-RELATED DE BARSY SYNDROME	0.0023280840000000002	0.03556359168677817
LISSENCEPHALY 8; LIS8	0.0023280840000000002	0.03556359168677817
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0023280840000000002	0.03556359168677817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0023280840000000002	0.03556359168677817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0023280840000000002	0.03556359168677817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0023280840000000002	0.03556359168677817
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00216934	0.03313863330953495
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00216934	0.03313863330953495
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00216934	0.03313863330953495
THALIDOMIDE EMBRYOPATHY	0.00216934	0.03313863330953495
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00216934	0.03313863330953495
CHARGE-LIKE SYNDROME, X-LINKED	0.00216934	0.03313863330953495
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00216934	0.03313863330953495
46,XX GONADAL DYSGENESIS	0.00216934	0.03313863330953495
COXOAURICULAR SYNDROME	0.00216934	0.03313863330953495
OHDO SYNDROME	0.00216934	0.03313863330953495
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00216934	0.03313863330953495
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00216934	0.03313863330953495
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00216934	0.03313863330953495
H SYNDROME	0.00216934	0.03313863330953495
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00216934	0.03313863330953495
FETAL METHYLMERCURY SYNDROME	0.00216934	0.03313863330953495
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00216934	0.03313863330953495
ACRODYSOSTOSIS	0.00216934	0.03313863330953495
CAT-EYE SYNDROME	0.00216934	0.03313863330953495
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00216934	0.03313863330953495
X-LINKED HYPOPHOSPHATEMIA	0.00216934	0.03313863330953495
DYSOSTEOSCLEROSIS	0.00216934	0.03313863330953495
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00216934	0.03313863330953495
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00216934	0.03313863330953495
COXOAURICULAR SYNDROME	0.00216934	0.03313863330953495
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00216934	0.03313863330953495
STICKLER SYNDROME, TYPE V; STL5	0.0021556500000000003	0.03292950616026027
KEIPERT SYNDROME	0.0021556500000000003	0.03292950616026027
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0021556500000000003	0.03292950616026027
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.0021556500000000003	0.03292950616026027
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0021556500000000003	0.03292950616026027
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0021556500000000003	0.03292950616026027
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0021556500000000003	0.03292950616026027
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.0021556500000000003	0.03292950616026027
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0021556500000000003	0.03292950616026027
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0021556500000000003	0.03292950616026027
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.0021556500000000003	0.03292950616026027
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0021556500000000003	0.03292950616026027
GEMIGNANI SYNDROME	0.0021556500000000003	0.03292950616026027
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0021556500000000003	0.03292950616026027
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0021556500000000003	0.03292950616026027
TRIPLE A SYNDROME	0.0021556500000000003	0.03292950616026027
JOHANSON-BLIZZARD SYNDROME	0.0021556500000000003	0.03292950616026027
NEUTRAL LIPID STORAGE MYOPATHY	0.0021556500000000003	0.03292950616026027
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0021556500000000003	0.03292950616026027
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.0021556500000000003	0.03292950616026027
NASODIGITOACOUSTIC SYNDROME	0.0021556500000000003	0.03292950616026027
FEINGOLD SYNDROME	0.0021556500000000003	0.03292950616026027
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.0021556500000000003	0.03292950616026027
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0021556500000000003	0.03292950616026027
KEARNS-SAYRE SYNDROME; KSS	0.0021556500000000003	0.03292950616026027
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0021556500000000003	0.03292950616026027
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.0021556500000000003	0.03292950616026027
ERMINE PHENOTYPE	0.0021556500000000003	0.03292950616026027
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0020630040000000002	0.03151425459914252
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0020630040000000002	0.03151425459914252
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0020630040000000002	0.03151425459914252
20Q11.2 MICRODELETION SYNDROME	0.0020630040000000002	0.03151425459914252
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0020630040000000002	0.03151425459914252
TARP SYNDROME	0.0020630040000000002	0.03151425459914252
SWEENEY-COX SYNDROME; SWCOS	0.0020630040000000002	0.03151425459914252
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0020630040000000002	0.03151425459914252
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.03151425459914252
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.0020630040000000002	0.03151425459914252
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0020630040000000002	0.03151425459914252
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020630040000000002	0.03151425459914252
BRESEK SYNDROME	0.0020630040000000002	0.03151425459914252
HSD10 DISEASE	0.0020630040000000002	0.03151425459914252
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0020630040000000002	0.03151425459914252
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0020630040000000002	0.03151425459914252
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.0020630040000000002	0.03151425459914252
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0020630040000000002	0.03151425459914252
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0020630040000000002	0.03151425459914252
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0020630040000000002	0.03151425459914252
HYDROXYKYNURENINURIA	0.0020630040000000002	0.03151425459914252
EAR-PATELLA-SHORT STATURE SYNDROME	0.0020630040000000002	0.03151425459914252
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0020630040000000002	0.03151425459914252
TAY-SACHS DISEASE	0.0020630040000000002	0.03151425459914252
PEROXISOME BIOGENESIS DISORDER 6B	0.002049314	0.03130512744986784
EAST SYNDROME	0.002049314	0.03130512744986784
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002049314	0.03130512744986784
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002049314	0.03130512744986784
INFANTILE LIVER FAILURE SYNDROME 1	0.002049314	0.03130512744986784
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002049314	0.03130512744986784
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 5B	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002049314	0.03130512744986784
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.002049314	0.03130512744986784
WAARDENBURG-SHAH SYNDROME	0.002049314	0.03130512744986784
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002049314	0.03130512744986784
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002049314	0.03130512744986784
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002049314	0.03130512744986784
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.03130512744986784
DONNAI-BARROW SYNDROME	0.002049314	0.03130512744986784
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00189722	0.02898175384564701
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00189722	0.02898175384564701
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00189722	0.02898175384564701
MULTIMINICORE MYOPATHY	0.00189722	0.02898175384564701
CEREBROFACIOTHORACIC DYSPLASIA	0.00189722	0.02898175384564701
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00189722	0.02898175384564701
PROGEROID SYNDROME, PETTY TYPE	0.00189722	0.02898175384564701
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00189722	0.02898175384564701
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00189722	0.02898175384564701
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00189722	0.02898175384564701
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00189722	0.02898175384564701
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00189722	0.02898175384564701
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00189722	0.02898175384564701
MOWAT-WILSON SYNDROME	0.00189722	0.02898175384564701
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00189722	0.02898175384564701
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00189722	0.02898175384564701
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00189722	0.02898175384564701
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00189722	0.02898175384564701
SECKEL SYNDROME 5; SCKL5	0.00189722	0.02898175384564701
ODONTOCHONDRODYSPLASIA	0.00189722	0.02898175384564701
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001790884	0.02735737513525458
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.02735737513525458
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001790884	0.02735737513525458
TETRASOMY X	0.001790884	0.02735737513525458
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001790884	0.02735737513525458
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001790884	0.02735737513525458
SCHINDLER DISEASE, TYPE I	0.001790884	0.02735737513525458
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.02735737513525458
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.02735737513525458
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001790884	0.02735737513525458
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.02735737513525458
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.02735737513525458
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001790884	0.02735737513525458
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.02735737513525458
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001790884	0.02735737513525458
CHAR SYNDROME	0.001790884	0.02735737513525458
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001790884	0.02735737513525458
BAKER-GORDON SYNDROME; BAGOS	0.001790884	0.02735737513525458
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.02735737513525458
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.001790884	0.02735737513525458
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.02735737513525458
MUCOLIPIDOSIS IV; ML4	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001790884	0.02735737513525458
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001790884	0.02735737513525458
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001790884	0.02735737513525458
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.02735737513525458
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001790884	0.02735737513525458
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001790884	0.02735737513525458
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.02735737513525458
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001790884	0.02735737513525458
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.02735737513525458
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.02735737513525458
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001790884	0.02735737513525458
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.02735737513525458
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001790884	0.02735737513525458
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.02735737513525458
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.02735737513525458
SENIOR-LOKEN SYNDROME 9	0.001790884	0.02735737513525458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.02735737513525458
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.02735737513525458
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.02735737513525458
SCHIZENCEPHALY	0.001790884	0.02735737513525458
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001790884	0.02735737513525458
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.02735737513525458
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.02735737513525458
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.02735737513525458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.02735737513525458
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.02735737513525458
MENTAL RETARDATION, X-LINKED 90	0.001790884	0.02735737513525458
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.02735737513525458
MONOSOMY 9P	0.001790884	0.02735737513525458
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.02735737513525458
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02735737513525458
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001790884	0.02735737513525458
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.02735737513525458
COENZYME Q10 DEFICIENCY	0.00178253	0.027229760218889305
ANIRIDIA 3	0.00178253	0.027229760218889305
ANIRIDIA 2	0.00178253	0.027229760218889305
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00178253	0.027229760218889305
DERMATITIS, ATOPIC	0.00178253	0.027229760218889305
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00178253	0.027229760218889305
BIRDSHOT CHORIORETINOPATHY	0.00178253	0.027229760218889305
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00178253	0.027229760218889305
CATARACT-MICROCORNEA SYNDROME	0.00178253	0.027229760218889305
PHENYLKETONURIA	0.00178253	0.027229760218889305
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00178253	0.027229760218889305
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00178253	0.027229760218889305
TRIPLOIDY	0.00178253	0.027229760218889305
GALACTOKINASE DEFICIENCY	0.00178253	0.027229760218889305
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00178253	0.027229760218889305
MEGALOCORNEA	0.00178253	0.027229760218889305
ANIRIDIA AND ABSENT PATELLA	0.00178253	0.027229760218889305
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00178253	0.027229760218889305
ANIRIDIA	0.00178253	0.027229760218889305
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00178253	0.027229760218889305
CEREBROTENDINOUS XANTHOMATOSIS	0.00178253	0.027229760218889305
BARDET-BIEDL SYNDROME 18; BBS18	0.00178253	0.027229760218889305
MONILETHRIX	0.00178253	0.027229760218889305
AMOEBIC KERATITIS	0.00178253	0.027229760218889305
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00178253	0.027229760218889305
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00178253	0.027229760218889305
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00178253	0.027229760218889305
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00178253	0.027229760218889305
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00178253	0.027229760218889305
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00178253	0.027229760218889305
ISOLATED ECTOPIA LENTIS	0.00178253	0.027229760218889305
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00178253	0.027229760218889305
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00178253	0.027229760218889305
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00178253	0.027229760218889305
CATARACT, CRYSTALLINE CORALLIFORM	0.00178253	0.027229760218889305
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00178253	0.027229760218889305
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00178253	0.027229760218889305
MYOTONIC DYSTROPHY 1	0.00178253	0.027229760218889305
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00178253	0.027229760218889305
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00178253	0.027229760218889305
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00178253	0.027229760218889305
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00178253	0.027229760218889305
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00178253	0.027229760218889305
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00178253	0.027229760218889305
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00178253	0.027229760218889305
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00178253	0.027229760218889305
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00178253	0.027229760218889305
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	0.00178253	0.027229760218889305
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00178253	0.027229760218889305
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00178253	0.027229760218889305
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00178253	0.027229760218889305
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00178253	0.027229760218889305
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00178253	0.027229760218889305
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00178253	0.027229760218889305
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00178253	0.027229760218889305
ALG8-CDG	0.00178253	0.027229760218889305
CONE-ROD DYSTROPHY 16	0.00178253	0.027229760218889305
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00178253	0.027229760218889305
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00178253	0.027229760218889305
ISOLATED ANIRIDIA	0.00178253	0.027229760218889305
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.027229760218889305
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00178253	0.027229760218889305
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00178253	0.027229760218889305
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00178253	0.027229760218889305
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00178253	0.027229760218889305
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.00178253	0.027229760218889305
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00178253	0.027229760218889305
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.027229760218889305
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00178253	0.027229760218889305
IDIOPATHIC PANUVEITIS	0.00178253	0.027229760218889305
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00178253	0.027229760218889305
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00178253	0.027229760218889305
CATARACT AND CONGENITAL ICHTHYOSIS	0.00178253	0.027229760218889305
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00178253	0.027229760218889305
INTERMEDIATE UVEITIS	0.00178253	0.027229760218889305
RETINITIS PIGMENTOSA 84; RP84	0.00178253	0.027229760218889305
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00178253	0.027229760218889305
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00178253	0.027229760218889305
RETINITIS PIGMENTOSA 4; RP4	0.00178253	0.027229760218889305
MICROPHTHALMIA, ISOLATED 5	0.00178253	0.027229760218889305
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00178253	0.027229760218889305
ALG2-CDG	0.00178253	0.027229760218889305
STROMME SYNDROME; STROMS	0.00178253	0.027229760218889305
GALACTOKINASE DEFICIENCY	0.00178253	0.027229760218889305
TRICHOMEGALY; TCMGLY	0.00178253	0.027229760218889305
ANTERIOR SEGMENT DYSGENESIS 8	0.00178253	0.027229760218889305
EXFOLIATION SYNDROME; XFS	0.00178253	0.027229760218889305
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00178253	0.027229760218889305
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00178253	0.027229760218889305
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00178253	0.027229760218889305
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00178253	0.027229760218889305
PACHYONYCHIA CONGENITA	0.00178253	0.027229760218889305
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00178253	0.027229760218889305
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00178253	0.027229760218889305
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00178253	0.027229760218889305
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00178253	0.027229760218889305
PROXIMAL MYOTONIC MYOPATHY	0.00178253	0.027229760218889305
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00178253	0.027229760218889305
HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.027229760218889305
ENHANCED S-CONE SYNDROME	0.00178253	0.027229760218889305
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00178253	0.027229760218889305
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00178253	0.027229760218889305
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.023180423131253652
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.023180423131253652
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.023180423131253652
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.023180423131253652
BARBER-SAY SYNDROME	0.00151745	0.023180423131253652
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.023180423131253652
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.023180423131253652
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.023180423131253652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.023180423131253652
ADRENOLEUKODYSTROPHY	0.00151745	0.023180423131253652
ABCD SYNDROME	0.00151745	0.023180423131253652
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.023180423131253652
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00151745	0.023180423131253652
MYASTHENIA GRAVIS	0.00151745	0.023180423131253652
ARACHNOIDITIS	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.023180423131253652
CAMURATI-ENGELMANN DISEASE	0.00151745	0.023180423131253652
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.023180423131253652
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.023180423131253652
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.023180423131253652
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.023180423131253652
CANAVAN DISEASE	0.00151745	0.023180423131253652
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.023180423131253652
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.023180423131253652
184705 STEINFELD SYNDROME	0.00151745	0.023180423131253652
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.023180423131253652
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.023180423131253652
RICHARDS-RUNDLE SYNDROME	0.00151745	0.023180423131253652
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.023180423131253652
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.023180423131253652
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.023180423131253652
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.023180423131253652
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.023180423131253652
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.023180423131253652
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.023180423131253652
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.023180423131253652
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.023180423131253652
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.023180423131253652
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00151745	0.023180423131253652
TIETZ SYNDROME	0.00151745	0.023180423131253652
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.023180423131253652
ANUS, IMPERFORATE	0.00151745	0.023180423131253652
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.023180423131253652
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.023180423131253652
KEARNS-SAYRE SYNDROME	0.00151745	0.023180423131253652
CHIARI MALFORMATION TYPE I	0.00151745	0.023180423131253652
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.023180423131253652
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.023180423131253652
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.023180423131253652
USHER SYNDROME, TYPE ID	0.00151745	0.023180423131253652
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.023180423131253652
FRIEDREICH ATAXIA	0.00151745	0.023180423131253652
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.023180423131253652
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.023180423131253652
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.023180423131253652
3MC SYNDROME	0.00151745	0.023180423131253652
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.023180423131253652
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.023180423131253652
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.023180423131253652
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.023180423131253652
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.023180423131253652
MENIERE DISEASE	0.00151745	0.023180423131253652
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.023180423131253652
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.023180423131253652
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.023180423131253652
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.023180423131253652
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.023180423131253652
ATYPICAL RETT SYNDROME	0.00151745	0.023180423131253652
WAARDENBURG SYNDROME TYPE 3	0.00151745	0.023180423131253652
OTOSCLEROSIS 3; OTSC3	0.00151745	0.023180423131253652
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.023180423131253652
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00151745	0.023180423131253652
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.023180423131253652
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.023180423131253652
GRACILE SYNDROME	0.00151745	0.023180423131253652
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.023180423131253652
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00151745	0.023180423131253652
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.023180423131253652
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.023180423131253652
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.023180423131253652
WAARDENBURG-SHAH SYNDROME	0.00151745	0.023180423131253652
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.023180423131253652
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.023180423131253652
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.023180423131253652
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00151745	0.023180423131253652
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.023180423131253652
AUROCEPHALOSYNDACTYLY	0.00151745	0.023180423131253652
NAGER SYNDROME	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.023180423131253652
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.023180423131253652
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.023180423131253652
LOCKED-IN SYNDROME	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.023180423131253652
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.023180423131253652
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.023180423131253652
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.023180423131253652
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.023180423131253652
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.023180423131253652
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.023180423131253652
XYLOSIDASE DEFICIENCY	0.00151745	0.023180423131253652
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.023180423131253652
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.023180423131253652
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.023180423131253652
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.023180423131253652
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.023180423131253652
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.023180423131253652
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00151745	0.023180423131253652
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.023180423131253652
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.023180423131253652
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.023180423131253652
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.023180423131253652
ISOLATED BRACHYCEPHALY	0.00151745	0.023180423131253652
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.023180423131253652
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.023180423131253652
BRANCHIOOTIC SYNDROME 2	0.00151745	0.023180423131253652
PFEIFFER SYNDROME TYPE 3	0.00151745	0.023180423131253652
TIBIAL HEMIMELIA	0.00151745	0.023180423131253652
GLYCOGEN STORAGE DISEASE II	0.00151745	0.023180423131253652
DIABETIC EMBRYOPATHY	0.00151745	0.023180423131253652
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.023180423131253652
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.023180423131253652
TUNE DEAFNESS	0.00151745	0.023180423131253652
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.023180423131253652
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.023180423131253652
RETINAL VENOUS BEADING	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.023180423131253652
PILI TORTI	0.00151745	0.023180423131253652
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.023180423131253652
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.023180423131253652
OTOSCLEROSIS 8; OTSC8	0.00151745	0.023180423131253652
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.023180423131253652
BRITTLE CORNEA SYNDROME	0.00151745	0.023180423131253652
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.023180423131253652
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.023180423131253652
PFEIFFER SYNDROME TYPE 1	0.00151745	0.023180423131253652
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.023180423131253652
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00151745	0.023180423131253652
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.022971295981978977
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.022971295981978977
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.022971295981978977
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.022971295981978977
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.022971295981978977
KEIPERT SYNDROME; KPTS	0.00150376	0.022971295981978977
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.022971295981978977
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.022971295981978977
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.022971295981978977
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.022971295981978977
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.022971295981978977
KALLMANN SYNDROME	0.00150376	0.022971295981978977
SCLEROSTEOSIS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.022971295981978977
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.022971295981978977
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.022971295981978977
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.022971295981978977
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.022971295981978977
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.022971295981978977
3P25.3 MICRODELETION SYNDROME	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.022971295981978977
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.022971295981978977
BRACHYDACTYLY, TYPE B2	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.022971295981978977
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.022971295981978977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.022971295981978977
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.022971295981978977
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.022971295981978977
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.022971295981978977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.022971295981978977
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 1	0.00150376	0.022971295981978977
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.022971295981978977
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.022971295981978977
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 47	0.00150376	0.022971295981978977
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.022971295981978977
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.022971295981978977
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.022971295981978977
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.022971295981978977
ADENOHYPOPHYSITIS	0.00150376	0.022971295981978977
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.022971295981978977
PANHYPOPHYSITIS	0.00150376	0.022971295981978977
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.022971295981978977
COGAN SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.022971295981978977
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.022971295981978977
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.022971295981978977
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.022971295981978977
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.022971295981978977
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IIIA	0.00150376	0.022971295981978977
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.022971295981978977
SHEEHAN SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.022971295981978977
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.022971295981978977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.022971295981978977
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IG	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.022971295981978977
ACROCALLOSAL SYNDROME	0.00150376	0.022971295981978977
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.022971295981978977
FAMILIAL LONG QT SYNDROME	0.00150376	0.022971295981978977
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.022971295981978977
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.022971295981978977
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.022971295981978977
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.022971295981978977
OPTIC ATROPHY 8	0.00150376	0.022971295981978977
ERMINE PHENOTYPE	0.00150376	0.022971295981978977
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.022971295981978977
WORSTER-DROUGHT SYNDROME	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.022971295981978977
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.022971295981978977
THYROCEREBRORENAL SYNDROME	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.022971295981978977
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.022971295981978977
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.022971295981978977
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.022971295981978977
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.022971295981978977
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.022971295981978977
BJÖRNSTAD SYNDROME	0.00150376	0.022971295981978977
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.022971295981978977
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.022971295981978977
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.022971295981978977
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.022971295981978977
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.022971295981978977
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.022971295981978977
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.022971295981978977
DEAFNESS, X-LINKED 1	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.022971295981978977
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.022971295981978977
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.022971295981978977
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00150376	0.022971295981978977
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.022971295981978977
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.022971295981978977
MADRAS MOTOR NEURON DISEASE	0.00150376	0.022971295981978977
THYROCEREBRORETINAL SYNDROME	0.00150376	0.022971295981978977
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
CADASIL	0.00150376	0.022971295981978977
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.022971295981978977
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.022971295981978977
WOLFRAM SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED 21	0.00124533	0.019023543667365722
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.019023543667365722
LEIGH SYNDROME	0.00124533	0.019023543667365722
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.019023543667365722
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00124533	0.019023543667365722
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.019023543667365722
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.019023543667365722
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.019023543667365722
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.019023543667365722
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.019023543667365722
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.019023543667365722
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.019023543667365722
NON-DISTAL MONOSOMY 10Q	0.00124533	0.019023543667365722
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.019023543667365722
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.019023543667365722
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.019023543667365722
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.019023543667365722
X-LINKED RETINAL DYSPLASIA	0.00124533	0.019023543667365722
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.019023543667365722
OCULAR ALBINISM	0.00124533	0.019023543667365722
LERI PLEONOSTEOSIS	0.00124533	0.019023543667365722
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.019023543667365722
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.019023543667365722
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365722
EEM SYNDROME	0.00124533	0.019023543667365722
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.019023543667365722
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.019023543667365722
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.019023543667365722
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.019023543667365722
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.019023543667365722
JACKSON-WEISS SYNDROME	0.00124533	0.019023543667365722
RETINAL CONE DYSTROPHY 3B	0.00124533	0.019023543667365722
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.019023543667365722
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.019023543667365722
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.019023543667365722
JACOBSEN SYNDROME	0.00124533	0.019023543667365722
GLUTATHIONURIA	0.00124533	0.019023543667365722
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.019023543667365722
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.019023543667365722
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.019023543667365722
5Q14.3 MICRODELETION SYNDROME	0.00124533	0.019023543667365722
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.019023543667365722
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.019023543667365722
WHITE FORELOCK WITH MALFORMATIONS	0.00124533	0.019023543667365722
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.019023543667365722
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00124533	0.019023543667365722
LAMBOTTE SYNDROME	0.00124533	0.019023543667365722
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.019023543667365722
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.019023543667365722
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.019023543667365722
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.019023543667365722
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.019023543667365722
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.019023543667365722
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.019023543667365722
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.019023543667365722
GASTROCUTANEOUS SYNDROME	0.00124533	0.019023543667365722
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.019023543667365722
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.019023543667365722
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.019023543667365722
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.019023543667365722
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.019023543667365722
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.019023543667365722
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.019023543667365722
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.019023543667365722
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.019023543667365722
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.019023543667365722
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.019023543667365722
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.019023543667365722
ABDUCENS PALSY	0.00124533	0.019023543667365722
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.019023543667365722
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.019023543667365722
PETERS ANOMALY	0.00124533	0.019023543667365722
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.019023543667365722
GAUCHER DISEASE TYPE 2	0.00124533	0.019023543667365722
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	0.019023543667365722
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.019023543667365722
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365722
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00124533	0.019023543667365722
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.019023543667365722
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00124533	0.019023543667365722
ANGELMAN SYNDROME	0.00124533	0.019023543667365722
NANOPHTHALMOS	0.00124533	0.019023543667365722
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.019023543667365722
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.019023543667365722
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.019023543667365722
GAUCHER DISEASE TYPE 3	0.00124533	0.019023543667365722
DESMOSTEROLOSIS	0.00124533	0.019023543667365722
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.019023543667365722
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.019023543667365722
OPTIC ATROPHY 1; OPA1	0.00124533	0.019023543667365722
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00124533	0.019023543667365722
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.019023543667365722
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.019023543667365722
NOONAN SYNDROME 9; NS9	0.001197444	0.018292041646170154
CULLER-JONES SYNDROME; CJS	0.001197444	0.018292041646170154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001197444	0.018292041646170154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001197444	0.018292041646170154
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001197444	0.018292041646170154
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001197444	0.018292041646170154
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001197444	0.018292041646170154
NETHERTON SYNDROME	0.001197444	0.018292041646170154
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001197444	0.018292041646170154
PITUITARY STALK INTERRUPTION SYNDROME	0.001197444	0.018292041646170154
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001197444	0.018292041646170154
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001197444	0.018292041646170154
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001197444	0.018292041646170154
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001197444	0.018292041646170154
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001197444	0.018292041646170154
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001197444	0.018292041646170154
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.001197444	0.018292041646170154
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001197444	0.018292041646170154
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001197444	0.018292041646170154
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001197444	0.018292041646170154
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001197444	0.018292041646170154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001197444	0.018292041646170154
CEREBELLOFACIODENTAL SYNDROME	0.001197444	0.018292041646170154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.001197444	0.018292041646170154
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.001197444	0.018292041646170154
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001197444	0.018292041646170154
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001197444	0.018292041646170154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001197444	0.018292041646170154
JOUBERT SYNDROME 26	0.001197444	0.018292041646170154
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.001197444	0.018292041646170154
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001197444	0.018292041646170154
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001197444	0.018292041646170154
ALAZAMI-YUAN SYNDROME	0.001197444	0.018292041646170154
HARTNUP DISORDER	0.001197444	0.018292041646170154
17Q11.2 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170154
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001197444	0.018292041646170154
HOLOPROSENCEPHALY 1; HPE1	0.001197444	0.018292041646170154
MENTAL RETARDATION, X-LINKED 99	0.001197444	0.018292041646170154
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.001197444	0.018292041646170154
OXOGLUTARIC ACIDURIA	0.001197444	0.018292041646170154
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.001197444	0.018292041646170154
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.001197444	0.018292041646170154
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.001197444	0.018292041646170154
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.001197444	0.018292041646170154
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001197444	0.018292041646170154
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001197444	0.018292041646170154
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.001197444	0.018292041646170154
SEPTOOPTIC DYSPLASIA	0.001197444	0.018292041646170154
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001197444	0.018292041646170154
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001197444	0.018292041646170154
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001197444	0.018292041646170154
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001197444	0.018292041646170154
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001197444	0.018292041646170154
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001197444	0.018292041646170154
DIAMOND-BLACKFAN ANEMIA 5	0.001197444	0.018292041646170154
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170154
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.001197444	0.018292041646170154
GRISCELLI SYNDROME	0.001197444	0.018292041646170154
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001197444	0.018292041646170154
FRIAS SYNDROME	0.001197444	0.018292041646170154
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001197444	0.018292041646170154
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001197444	0.018292041646170154
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001197444	0.018292041646170154
GRACILE BONE DYSPLASIA; GCLEB	0.001197444	0.018292041646170154
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001197444	0.018292041646170154
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001197444	0.018292041646170154
LISSENCEPHALY 4	0.001197444	0.018292041646170154
XQ25 DUPLICATION SYNDROME	0.001197444	0.018292041646170154
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001197444	0.018292041646170154
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.001197444	0.018292041646170154
XQ27.3Q28 DUPLICATION SYNDROME	0.001197444	0.018292041646170154
15Q11Q13 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170154
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001197444	0.018292041646170154
XQ25 MICRODUPLICATION SYNDROME	0.001197444	0.018292041646170154
8P11.2 DELETION SYNDROME	0.001197444	0.018292041646170154
CHROMOSOME 15Q25 DELETION SYNDROME	0.001197444	0.018292041646170154
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.009958210178281291
COHEN SYNDROME	0.00065189	0.009958210178281291
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00065189	0.009958210178281291
WILLIAMS-BEUREN SYNDROME (WBS)	0.00065189	0.009958210178281291
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.009958210178281291
PYGMY	0.00065189	0.009958210178281291
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.009958210178281291
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00065189	0.009958210178281291
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00065189	0.009958210178281291
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.009958210178281291
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.009958210178281291
RETT SYNDROME	0.00065189	0.009958210178281291
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.009958210178281291
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00065189	0.009958210178281291
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.009958210178281291
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.009958210178281291
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.009958210178281291
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.009958210178281291
SACCHAROPINURIA	0.00065189	0.009958210178281291
2Q33.1 DELETION SYNDROME	0.00065189	0.009958210178281291
MYOTONIA PERMANENS	0.00065189	0.009958210178281291
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.009958210178281291
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.009958210178281291
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00065189	0.009958210178281291
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.009958210178281291
BIEMOND SYNDROME II	0.00065189	0.009958210178281291
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.009958210178281291
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.009958210178281291
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00065189	0.009958210178281291
SMITH-MAGENIS SYNDROME	0.00065189	0.009958210178281291
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.009958210178281291
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.009958210178281291
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.009958210178281291
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.009958210178281291
HYALURONIDASE DEFICIENCY	0.00065189	0.009958210178281291
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00065189	0.009958210178281291
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.009958210178281291
ISOLATED SPINA BIFIDA	0.00065189	0.009958210178281291
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.009958210178281291
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.009958210178281291
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.009958210178281291
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.009958210178281291
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.009958210178281291
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.009958210178281291
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.009958210178281291
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.009958210178281291
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.009958210178281291
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.009958210178281291
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.009958210178281291
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.009958210178281291
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.009958210178281291
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.009958210178281291
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00065189	0.009958210178281291
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00065189	0.009958210178281291
AURICULOOSTEODYSPLASIA	0.00065189	0.009958210178281291
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.009958210178281291
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.009958210178281291
BRACHYDACTYLY TYPE C	0.00065189	0.009958210178281291
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.009958210178281291
EIKEN SYNDROME	0.00065189	0.009958210178281291
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00065189	0.009958210178281291
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.009958210178281291
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.009958210178281291
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.009958210178281291
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.009958210178281291
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.009958210178281291
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.009958210178281291
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.009958210178281291
BRACHYDACTYLY TYPE E	0.00065189	0.009958210178281291
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.009958210178281291
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.009958210178281291
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.009958210178281291
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.009958210178281291
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.009958210178281291
BRACHYDACTYLY TYPE A4	0.00065189	0.009958210178281291
BRACHYDACTYLY TYPE A1	0.00065189	0.009958210178281291
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00065189	0.009958210178281291
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.009958210178281291
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00065189	0.009958210178281291
CAREY-FINEMAN-ZITER SYNDROME	0.00065189	0.009958210178281291
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.009958210178281291
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.009958210178281291
RING CHROMOSOME 6 SYNDROME	0.00065189	0.009958210178281291
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.009958210178281291
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.009958210178281291
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.009958210178281291
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281291
BIEMOND SYNDROME TYPE 2	0.00065189	0.009958210178281291
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.009958210178281291
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.009958210178281291
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00065189	0.009958210178281291
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00065189	0.009958210178281291
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.009958210178281291
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.009958210178281291
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.009958210178281291
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.009958210178281291
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.009958210178281291
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.009958210178281291
NEUROFACIODIGITORENAL SYNDROME	0.00065189	0.009958210178281291
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.009958210178281291
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.009958210178281291
RADIAL-RENAL SYNDROME	0.00065189	0.009958210178281291
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.009958210178281291
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.009958210178281291
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.009958210178281291
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.009958210178281291
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00065189	0.009958210178281291
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.009958210178281291
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281291
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.009958210178281291
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00065189	0.009958210178281291
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.009958210178281291
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.009958210178281291
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.009958210178281291
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.009958210178281291
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.009958210178281291
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.009958210178281291
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.009958210178281291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.009958210178281291
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.009958210178281291
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.009958210178281291
STIMMLER SYNDROME	0.00065189	0.009958210178281291
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.009958210178281291
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.009958210178281291
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.009958210178281291
STÜVE-WIEDEMANN SYNDROME	0.00065189	0.009958210178281291
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281291
BONNEMANN-MEINECKE-REICH SYNDROME	0.00065189	0.009958210178281291
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.009958210178281291
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.009958210178281291
LARYNX ATRESIA	0.00065189	0.009958210178281291
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.009958210178281291
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00065189	0.009958210178281291
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.009958210178281291
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.009958210178281291
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00065189	0.009958210178281291
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.009958210178281291
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.009958210178281291
CATEL-MANZKE SYNDROME	0.00065189	0.009958210178281291
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.009958210178281291
CHITAYAT SYNDROME	0.00065189	0.009958210178281291
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.009958210178281291
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.009958210178281291
NOONAN SYNDROME 4; NS4	0.00065189	0.009958210178281291
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.009958210178281291
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.009958210178281291
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00065189	0.009958210178281291
LAMELLAR ICHTHYOSIS	0.00065189	0.009958210178281291
SATOYOSHI SYNDROME	0.00065189	0.009958210178281291
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.009958210178281291
AROMATASE EXCESS SYNDROME	0.00065189	0.009958210178281291
SHOX-RELATED SHORT STATURE	0.00065189	0.009958210178281291
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.009958210178281291
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.009958210178281291
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.009958210178281291
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.009958210178281291
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.009958210178281291
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.009958210178281291
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00065189	0.009958210178281291
LOWRY-WOOD SYNDROME	0.00065189	0.009958210178281291
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281291
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.009958210178281291
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.009958210178281291
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.009958210178281291
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.009958210178281291
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.009958210178281291
PERIPHERAL DYSOSTOSIS	0.00065189	0.009958210178281291
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00065189	0.009958210178281291
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.009958210178281291
5Q35 MICRODUPLICATION SYNDROME	0.00065189	0.009958210178281291
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.009958210178281291
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.009958210178281291
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.009958210178281291
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.009958210178281291
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.009958210178281291
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.009958210178281291
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.009958210178281291
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.009958210178281291
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.009958210178281291
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.009958210178281291
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00065189	0.009958210178281291
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00065189	0.009958210178281291
EPILEPSY-TELANGIECTASIA SYNDROME	0.00065189	0.009958210178281291
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.009958210178281291
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.009958210178281291
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.009958210178281291
ENG-STROM SYNDROME	0.00065189	0.009958210178281291
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.009958210178281291
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.009958210178281291
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00065189	0.009958210178281291
ARGININOSUCCINIC ACIDURIA	0.00065189	0.009958210178281291
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.009958210178281291
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.009958210178281291
SANJAD-SAKATI SYNDROME	0.00065189	0.009958210178281291
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.009958210178281291
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.009958210178281291
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00065189	0.009958210178281291
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.009958210178281291
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.009958210178281291
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.009958210178281291
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.009958210178281291
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.009958210178281291
XP22.3 MICRODELETION SYNDROME	0.00065189	0.009958210178281291
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.009958210178281291
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.009958210178281291
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.009958210178281291
DISTAL MONOSOMY 13Q	0.00065189	0.009958210178281291
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.009958210178281291
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00065189	0.009958210178281291
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.009958210178281291
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.009958210178281291
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.009958210178281291
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.009958210178281291
CONGENITAL LARYNGEAL WEB	0.00065189	0.009958210178281291
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.009958210178281291
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.009958210178281291
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.009958210178281291
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.009958210178281291
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.009958210178281291
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00065189	0.009958210178281291
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00065189	0.009958210178281291
MASA SYNDROME	0.00065189	0.009958210178281291
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.009958210178281291
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.009958210178281291
TRISOMY 18P	0.00065189	0.009958210178281291
ACROGERIA	0.00065189	0.009958210178281291
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.009958210178281291
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.009958210178281291
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.009958210178281291
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.009958210178281291
SATOYOSHI SYNDROME	0.00065189	0.009958210178281291
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.009958210178281291
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.009958210178281291
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.009958210178281291
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00065189	0.009958210178281291
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.009958210178281291
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.009958210178281291
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.009958210178281291
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.009958210178281291
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.009958210178281291
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.009958210178281291
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.009958210178281291
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.009958210178281291
BRADDOCK SYNDROME	0.00065189	0.009958210178281291
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.009958210178281291
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.009958210178281291
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.009958210178281291
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.009958210178281291
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.009958210178281291
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.009958210178281291
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.009958210178281291
STIFF SKIN SYNDROME	0.00065189	0.009958210178281291
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.009958210178281291
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.009958210178281291
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.009958210178281291
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.009958210178281291
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.009958210178281291
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.009958210178281291
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.009958210178281291
THORACOPELVIC DYSOSTOSIS	0.00065189	0.009958210178281291
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.009958210178281291
GURRIERI SYNDROME	0.00065189	0.009958210178281291
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.009958210178281291
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.009958210178281291
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.009958210178281291
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00065189	0.009958210178281291
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00065189	0.009958210178281291
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.009958210178281291
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.009958210178281291
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.009958210178281291
HYPOPHOSPHATASIA	0.00065189	0.009958210178281291
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.009958210178281291
EIKEN SYNDROME	0.00065189	0.009958210178281291
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.009958210178281291
STORMORKEN SYNDROME; STRMK	0.00065189	0.009958210178281291
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.009958210178281291
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.009958210178281291
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00065189	0.009958210178281291
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.009958210178281291
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.009958210178281291
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.009958210178281291
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.009958210178281291
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.009958210178281291
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.009958210178281291
CHROMOSOME XP11.3 DELETION SYNDROME	0.00065189	0.009958210178281291
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.009958210178281291
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.009958210178281291
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.009958210178281291
METAPHYSEAL ANADYSPLASIA	0.00065189	0.009958210178281291
ROIFMAN SYNDROME	0.00065189	0.009958210178281291
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.009958210178281291
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.009958210178281291
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.009958210178281291
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.009958210178281291
CASPASE 8 DEFICIENCY	0.00065189	0.009958210178281291
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.009958210178281291
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.009958210178281291
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.009958210178281291
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.009958210178281291
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.009958210178281291
DENT DISEASE 1	0.00065189	0.009958210178281291
AURICULOOSTEODYSPLASIA	0.00065189	0.009958210178281291
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.009958210178281291
BARTTER SYNDROME	0.00065189	0.009958210178281291
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.009958210178281291
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.008333831467888863
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.008333831467888863
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.008333831467888863
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.008333831467888863
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.008333831467888863
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.008333831467888863
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.008333831467888863
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.008333831467888863
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.008333831467888863
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.008333831467888863
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.008333831467888863
BARDET-BIEDL SYNDROME 2	0.000545554	0.008333831467888863
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888863
MOSAIC TRISOMY 14	0.000545554	0.008333831467888863
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.008333831467888863
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.008333831467888863
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.008333831467888863
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.008333831467888863
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.008333831467888863
TRISOMY 8Q	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.008333831467888863
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.008333831467888863
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.008333831467888863
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.008333831467888863
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.008333831467888863
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.008333831467888863
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.008333831467888863
PFEIFFER SYNDROME TYPE 2	0.000545554	0.008333831467888863
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.008333831467888863
AUSTRALIA ANTIGEN	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.008333831467888863
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.008333831467888863
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.008333831467888863
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.008333831467888863
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.008333831467888863
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.008333831467888863
XQ28 (MECP2) DUPLICATION	0.000545554	0.008333831467888863
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.008333831467888863
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888863
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.008333831467888863
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.008333831467888863
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.008333831467888863
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.008333831467888863
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.008333831467888863
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.008333831467888863
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.008333831467888863
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.008333831467888863
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.008333831467888863
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.008333831467888863
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.008333831467888863
JOUBERT SYNDROME 28	0.000545554	0.008333831467888863
JOUBERT SYNDROME 27	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.008333831467888863
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.008333831467888863
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.008333831467888863
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.008333831467888863
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.008333831467888863
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.008333831467888863
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.008333831467888863
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.008333831467888863
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.008333831467888863
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888863
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.008333831467888863
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.008333831467888863
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.008333831467888863
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.008333831467888863
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.008333831467888863
RIGID SPINE SYNDROME	0.000545554	0.008333831467888863
ZEBRA BODY MYOPATHY	0.000545554	0.008333831467888863
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.008333831467888863
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.008333831467888863
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.008333831467888863
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.008333831467888863
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.008333831467888863
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.008333831467888863
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.008333831467888863
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.008333831467888863
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.008333831467888863
JOUBERT SYNDROME 25	0.000545554	0.008333831467888863
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.008333831467888863
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.008333831467888863
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.008333831467888863
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888863
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.008333831467888863
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.008333831467888863
JOUBERT SYNDROME 24	0.000545554	0.008333831467888863
DISTAL MONOSOMY 9P	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.008333831467888863
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.008333831467888863
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.008333831467888863
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.008333831467888863
EVEN-PLUS SYNDROME	0.000545554	0.008333831467888863
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.008333831467888863
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.008333831467888863
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.008333831467888863
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.008333831467888863
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.008333831467888863
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.008333831467888863
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.008333831467888863
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.008333831467888863
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.008333831467888863
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.008333831467888863
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.008333831467888863
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.008333831467888863
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.008333831467888863
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.008333831467888863
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.008333831467888863
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888863
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.008333831467888863
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.008333831467888863
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.008333831467888863
ISOVALERIC ACIDEMIA	0.000545554	0.008333831467888863
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.008333831467888863
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.008333831467888863
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.008333831467888863
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.008333831467888863
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.008333831467888863
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.008333831467888863
PEHO SYNDROME; PEHO	0.000545554	0.008333831467888863
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.008333831467888863
LISSENCEPHALY 1; LIS1	0.000545554	0.008333831467888863
PROPIONIC ACIDEMIA	0.000545554	0.008333831467888863
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.008333831467888863
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.008333831467888863
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.008333831467888863
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.008333831467888863
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.008333831467888863
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.008333831467888863
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.008333831467888863
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.008333831467888863
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.008333831467888863
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.008333831467888863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.008333831467888863
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.008333831467888863
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.008333831467888863
OROTIC ACIDURIA	0.000545554	0.008333831467888863
FILIPPI SYNDROME	0.000545554	0.008333831467888863
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.008333831467888863
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.008333831467888863
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.008333831467888863
HEREDITARY OROTIC ACIDURIA	0.000545554	0.008333831467888863
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.008333831467888863
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.008333831467888863
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.008333831467888863
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.008333831467888863
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.008333831467888863
JOUBERT SYNDROME 6	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.008333831467888863
NETHERTON SYNDROME; NETH	0.000545554	0.008333831467888863
ALG1-CDG	0.000545554	0.008333831467888863
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.008333831467888863
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.008333831467888863
ALG3-CDG	0.000545554	0.008333831467888863
ALG6-CDG	0.000545554	0.008333831467888863
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.008333831467888863
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.008333831467888863
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.008333831467888863
LISSENCEPHALY 2; LIS2	0.000545554	0.008333831467888863
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.008333831467888863
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.008333831467888863
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.008333831467888863
ABETAL34V AMYLOIDOSIS	0.000545554	0.008333831467888863
STT3A-CDG	0.000545554	0.008333831467888863
STT3B-CDG	0.000545554	0.008333831467888863
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.008333831467888863
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.008333831467888863
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.008333831467888863
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.008333831467888863
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.008333831467888863
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.008333831467888863
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.008333831467888863
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888863
TARP SYNDROME; TARPS	0.000545554	0.008333831467888863
WAISMAN SYNDROME; WSMN	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.008333831467888863
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.008333831467888863
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.008333831467888863
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.008333831467888863
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.008333831467888863
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.008333831467888863
MAPLE SYRUP URINE DISEASE	0.000545554	0.008333831467888863
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.008333831467888863
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.008333831467888863
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.008333831467888863
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.008333831467888863
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.008333831467888863
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.008333831467888863
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.008333831467888863
SULFOCYSTEINURIA	0.000545554	0.008333831467888863
LOWRY-MACLEAN SYNDROME	0.000545554	0.008333831467888863
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.008333831467888863
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.008333831467888863
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.008333831467888863
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.008333831467888863
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.008333831467888863
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.008333831467888863
DYSTONIA-APHONIA SYNDROME	0.000545554	0.008333831467888863
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.008333831467888863
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.008333831467888863
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.008333831467888863
REVESZ SYNDROME	0.000545554	0.008333831467888863
COG2-CDG	0.000545554	0.008333831467888863
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.008333831467888863
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.008333831467888863
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.008333831467888863
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.008333831467888863
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.008333831467888863
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.008333831467888863
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.008333831467888863
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.008333831467888863
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.008333831467888863
JOUBERT SYNDROME 8	0.000545554	0.008333831467888863
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.008333831467888863
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.008333831467888863
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.008333831467888863
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.008333831467888863
ARGININEMIA	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.008333831467888863
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888863
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.008333831467888863
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888863
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.008333831467888863
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.008333831467888863
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.008333831467888863
MICROVILLUS INCLUSION DISEASE	0.000545554	0.008333831467888863
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.008333831467888863
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888863
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.008333831467888863
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.008333831467888863
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.008333831467888863
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.008333831467888863
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.008333831467888863
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.008333831467888863
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.008333831467888863
DPAGT1-CDG	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.008333831467888863
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.008333831467888863
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.008333831467888863
GRISCELLI SYNDROME TYPE 1	0.000545554	0.008333831467888863
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.008333831467888863
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.008333831467888863
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.008333831467888863
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.008333831467888863
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.008333831467888863
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.008333831467888863
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.008333831467888863
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.008333831467888863
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.008333831467888863
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.008333831467888863
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.008333831467888863
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.008333831467888863
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.008333831467888863
HYPERPROLINEMIA, TYPE I	0.000545554	0.008333831467888863
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.008333831467888863
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.008333831467888863
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.008333831467888863
KETOADIPICACIDURIA	0.000545554	0.008333831467888863
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.008333831467888863
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.008333831467888863
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.008333831467888863
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.008333831467888863
OKAMOTO SYNDROME	0.000545554	0.008333831467888863
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.008333831467888863
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.008333831467888863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.008333831467888863
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.008333831467888863
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.008333831467888863
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.008333831467888863
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.008333831467888863
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.008333831467888863
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.008333831467888863
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.008333831467888863
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.008333831467888863
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.008333831467888863
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.008333831467888863
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.008333831467888863
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.008333831467888863
JAWAD SYNDROME	0.000545554	0.008333831467888863
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.008333831467888863
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.008333831467888863
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.008333831467888863
1P21.3 MICRODELETION SYNDROME	0.000545554	0.008333831467888863
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.008333831467888863
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.008333831467888863
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.008333831467888863
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.008333831467888863
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.008333831467888863
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.008333831467888863
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.008333831467888863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.008333831467888863
LANDAU-KLEFFNER SYNDROME	0.000545554	0.008333831467888863
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.008333831467888863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.008333831467888863
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.008333831467888863
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.008333831467888863
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.008333831467888863
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.008333831467888863
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.008333831467888863
JOUBERT SYNDROME 15	0.000545554	0.008333831467888863
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.008333831467888863
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.008333831467888863
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.008333831467888863
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.008333831467888863
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.008333831467888863
MACDERMOT-WINTER SYNDROME	0.000545554	0.008333831467888863
HOLOPROSENCEPHALY 11	0.000545554	0.008333831467888863
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888863
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888863
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.008333831467888863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.008333831467888863
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.008333831467888863
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.008333831467888863
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.008333831467888863
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.008333831467888863
